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ABSTRACT 
The Tetraviridae are a family of ss (+) RNA viruses that specifically infect 
lepidopteran insects. Their icosahedral capsids are non-enveloped and approximately 
40 nm in diameter with T=4 quasi-equivalent symmetry. The omegatetraviruses, 
which are structurally the best characterised in the family, include Helicoverpa 
armigera stunt virus (HaSV) and Nudaurelia capensis omega virus (NωV). The 
omegatetravirus procapsid is composed of 240 identical copies of the capsid 
precursor proteins, which undergo autoproteolytic cleavage at its carboxyl-terminus 
generating the mature capsid protein (β) and γ-peptide.  This process occurs in vitro 
following a shift from pH 7.6 to pH 6.0.  The viral capsid encapsidates two ss 
genomic RNAs: The larger RNA1 encodes the viral replicase as well as three small 
ORFs while RNA2 encodes the capsid precursor protein together with an 
overlapping ORF designated P17.  While a wealth of structural data pertaining to the 
assembly and maturation of omegatetraviruses is available, little is known about how 
this relates to their lifecycle. The principle aim of the research described in this thesis 
was to use an experimental system developed in the yeast, Saccharomyces 
cerevisiae, to investigate the assembly of HaSV and NωV virus-like particles (VLPs) 
in terms of maturation and encapsidation of viral RNAs, in vivo.   
 
The yeast expression system used two promoter systems for expression of capsid 
precursor protein:  in the first, a hybrid promoter (PGADH) was used for high-level 
expression, while the second, PGAL1, produced substantially lower levels of the virus 
capsid protein precursors.  An increase in the level of HaSV capsid protein precursor 
(p71) via the PGADH promoter resulted in a dramatic increase in VLP assembly as 
compared with the PGAL system.  A protein equivalent to the mature capsid protein 
(p64) appeared at later time intervals following induction of transcription.  
Transmission electron microscopic studies showed that p64 correlated with the 
presence of mature VLPs as opposed to procapsids in cells containing p71. This 
confirmed that the presence of p64 denoted maturation of VLPs in vivo. Further 
investigation indicated that maturation correlated with cell aging and the onset of 
apoptosis. It was shown that induction of apoptosis resulted in VLP maturation while 
 II 
inhibition of apoptosis prevented maturation. These results suggested that the process 
of apoptosis might be the trigger for maturation of virus procapsids in their host cells.     
 
The increase in the efficiency of VLP assembly observed in the high-level expression 
system was proposed to be due to an increase in the cellular concentrations of viral 
RNA. To test this hypothesis, HaSV P71 was co-expressed with either P71 mRNA 
or full length RNA2. An increase in the solubility of p71 was observed in cells 
expressing increased levels of both RNAs, but there was no increase in the efficiency 
of VLP assembly. Northern analysis of encapsidated RNAs revealed that there was 
no selective encapsidation of either P71 mRNA or viral RNA2. This data indicated 
that the increase in viral RNA was not the reason for increased efficiency of VLP 
assembly, but most likely resulted from higher concentrations of p71 itself. It was 
decided to determine whether a highly efficient nodavirus replication system 
developed in yeast for heterologous production of proteins, could be used as a 
method for expressing the capsid protein precursor. The aim of using this system was 
to determine if VLPs assembled in a replication system specifically encapsidated 
viral RNA. Transcripts encoding the NωV capsid protein precursor (p70) were 
generated in yeast cells by replication of a hybrid RNA template by the Nodamura 
virus (NoV) replicase. Western analysis confirmed the presence of p70 as well as a 
protein of 62 kDa corresponding to the mature NωV capsid protein. Northern 
analysis of purified VLPs showed that NoV RNA1 and RNA3 were encapsidated, 
but no RNA2 was detected. Taken together, the data lead to the conclusion that 
specific encapsidation of tetraviral RNAs required more than close proximity of the 
viral RNAs and assembling virus-like particles.  Encapsidation specificity in the 
omegatetraviruses may require additional viral proteins such as p17 during 
encapsidation or specific viral RNA encapsidation was replication-dependent. 
Replication-dependent assembly has been shown in the nodaviruses. 
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CHAPTER  1.  LITERATURE REVIEW 
 
1.1 THE TETRAVIRIDAE 
The Tetraviridae are a group of small insect RNA viruses which encapsidate one or 
two single strands of positive sense genomic RNA into a non-enveloped icosahedral 
capsid of approximately 40 nm in size with a T=4 quasi-equivalent symmetry 
(reviewed in Hanzlik et al., 1997). The family is classified into the monopartite 
Betatetraviridae and the bipartite Omegatetraviridae genera. The Tetraviridae are 
highly tropic for lepidopteran insects (Fauquet et al., 2005). 
 
1.1.1 History 
In the early 1970s the first tetravirus, Nudaurelia β virus (NβV) was isolated from 
infected larvae of the pine emperor moth (Nudaurelia cytherea capensis), in South 
Africa (Table 1.1; Juckes, 1970). In addition to NβV the larvae were also infected 
with Nudaurelia γ, δ, α, and ε viruses (Juckes, 1970). NβV, the dominant virus 
characterised by Struthers and Hendry in 1974, had a major capsid protein of 
approximately 60 to 62 kDa. Later, Finch and Crowther (1974) determined that the 
capsid was composed of 240 subunits which had a T=4 quasi-equivalent symmetry. 
Thosea asigna virus (TaV) was later isolated from Setothosea asigna larvae, which 
were serologically related to NβV and had an identical buoyant density of          
1.275 g/cm3 in CsCl (Table 1.1; Reinganum et al., 1978). Biophysical analysis of 
Nudaurelia β and ε viruses named the new virus group Nudaurelia β-like virus 
(NβV), which was the first genus of the family Tetraviridae (Matthews, 1982; 
Juckes, 1979). The two viruses had different sedimentation coefficients and buoyant 
densities but more importantly the particles had a diameter of between 39 to 40 nm 
(Juckes, 1979). Later a third member of the family, Nudaurelia ω virus (NωV) was 
isolated from Nudaurelia larvae (Table 1.1; Hendry et al., 1985). This virus was 
serologically distinct from NβV and differed further by having a bipartite RNA 
genome as opposed to the monopartite genome of NβV. The family was named 
Tetraviridae referring to the Greek word tettares (four) because their capsid was 
characterised as having a T=4 quasi-equivalent symmetry (Francki et al., 1991). 
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Table 1.1. Members of the family Tetraviridae (Fauquet et al., 2005). 
Virus name Abbreviation Host Family Location 
Discovered 
References 
Genus: 
Betatetraviruses 
    
Nudaurelia 
capensis β virus 
NβV  Saturniidae South Africa Juckes, 1970 
Antheraea eucalypti 
virus 
AeV Saturniidae Australia Grace and 
Mercer, 1965 
Darna trima virus DtV Limacodidae Malaysia Reinganum 
et al., 1978 
Dasychira 
pudibunda virus* 
DpV Lymantriidae United 
Kingdom 
Greenwood 
and Moore, 
1984 
Philosamia Cynthia 
x ricini virus 
PxV Saturniidae United 
Kingdom 
Reinganum 
et al., 1978 
Pseudoplusia 
includens virus 
PiV Noctuidae United 
States 
Chao et al., 
1983 
Thosea asigna 
virus** 
TaV Limacodidae Malaysia Reinganum 
et al., 1978 
Euprosterna 
elaeasa virus 
EeV Noctuidae - Zeddam et 
al., 
unpublished 
Trichoplusia ni 
virus  
TnV Noctuidae United 
States 
Morris et al., 
1979 
Providence virus PrV Noctuidae United 
States 
Pringle et al., 
2003 
Genus: 
Omegatetraviruses 
    
Nudaurelia 
capensis ω virus 
NωV Saturniidae South Africa Hendry et 
al., 1985 
Helicoverpa 
armigera stunt 
virus 
HaSV Noctuidae Australia Hanzlik et 
al., 1993 
Dendrolimus 
punctatus tetravirus 
DpTV Lasicampidae China Yi et al., 
2005 
*  Known previously as Calliteara pudibunda virus. 
** Known previously as Sethosea asigna virus. 
 
 
The second genus named, Nudaurelia ω-like, was joined by Helicoverpa armigera 
stunt virus (HaSV), which was isolated by Hanzlik et al. (1993) from infected 
Helicoverpa armigera larvae (Table 1.1). In 2003 a betatetravirus, named Providence 
virus (PrV), was described from a persistently infected Helicoverpa zea cell line 
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(Table 1.1; Pringle et al., 2003). To this day PrV remains the only tetravirus, which 
is able to infect a cell line and thus offer the potential to study the infectious cycle of 
the Tetraviridae. Recently a new member of the Omegatetraviridae named 
Dendrolimus punctatus tetravirus (DpTV) was isolated from Dendrolimus punctatus 
larvae in China (Yi et al., 2005). To date the Betatetraviridae have 10 confirmed 
members, while the Omegatetraviridae have 3 confirmed members (Fauquet et al., 
2005; Table 1.1). 
 
1.1.2 Pathology 
The Tetraviridae are highly pathogenic to the hosts they infect (reviewed in Hendry 
and Agrawal, 1994). The symptoms of infection by the Nudaurelia viruses involve 
the larvae becoming increasingly lethargic, discoloured and flaccid followed by 
vomiting and death (reviewed in Hendry and Agrawal, 1994). Infected larvae have 
been shown to hang from their prolegs following infection (Hendry and Agrawal, 
1994; personal observation). The primary site of infection has been elucidated as the 
midgut for a number of tetraviruses (Grace and Mercer, 1965; Greenwood and 
Moore, 1984; Brookes et al., 2002), but the pathobiology of infection has only been 
well document for HaSV (Brookes et al., 2002). The response of H. armigera larvae 
to HaSV infection of its goblet and regenerative cells is cell sloughing or cell 
removal, which is linked to the cells undergoing programmed cell death (PCD) or 
apoptosis (Brookes et al., 2002). Older H. armigera larvae in the fourth or fifth instar 
are less sensitive to infection than younger larvae. This decreased susceptibility to 
infection is thought to be as a consequence of the larvae having an increased ability 
to remove their midgut cells during infection (Brookes et al., 2002). 
 
1.1.3 Tetravirus genome organisation 
Currently among the tetraviruses the entire genomes of two omegatetraviruses 
(HaSV and DpTV) and three betatetraviruses are known (NβV, TaV and EeV) 
(Zeddam et al., unpublished; Hanzlik et al., 1995; Gordon et al, 1995; Gordon et al., 
1999; Pringle et al., 1999; Yi et al., 2005). In addition, the partial genome sequence 
is available for PrV (capsid precursor protein coding sequence) and NωV (RNA2) 
(Agrawal and Johnson, 1992; Pringle et al., 2003; du Plessis et al., 2005). 
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1.1.3.1 The betatetraviruses. 
NβV, the type member of the genus, contains a single (+) RNA molecule which is 
approximately 6.5 kb in size and represents 10% of the particle mass (Fauquet et al., 
2005). This RNA encodes both the RNA dependent RNA polymerase (replicase) and 
capsid protein precursor (Figure 1.1). The major open reading frame (ORF) from 
nucleotides 93 to 5870 encodes the replicase with a predicted molecular mass of 216 
kDa (Figure 1.1). This ORF accounts for 87% of the genome and is at the 5’ end 
(Gordon et al., 1999). The replicase contains a methyltransferase, helicase and RNA-
dependent RNA polymerase (RdRP) domain, which are conserved among the (+) 
RNA Alphaviruses (Gordon et al., 1999).  The capsid precursor gene overlaps the 
replicase gene at the 3’ end between nucleotides 4039 to 5874. The capsid precursor 
protein (66.4 kDa) is encoded by a subgenomic RNA (Figure 1.1). During assembly 
240 copies of the capsid precursor protein associate to form the procapsid. The 
capsid precursor is cleaved between Asn 536 and Gly 537 to generate the mature 
capsid (β protein) of 58.4 kDa and a smaller γ-peptide of 8 kDa (Gordon et al., 
1999).  
 
 
 
 
 
 
 
 
 
 
Figure 1.1 The genome organization for NβV (Gordon et al., 1999). 
 
The 3’ end of the NβV genome can be folded into a tRNA-like structure, with a 
valine anticodon (Gordon et al., 1999). This structure has been identified in some 
plant viruses, but is different because it forms without a pseudoknot (Gordon et al., 
1999). The function of the authentic tRNAVal has been hypothesised to aid in 
replication of the genome and is a common feature in both tetravirus genera (Hanzlik 
et al., 1995; Gordon et al., 1999).   
RNA-dependent RNA polymerase (216kDa)
Procapsid (70kDa)
Procapsid (70kDa)sgRNA
Capsid (66kDa)
Maturation
662595
Capsid (66kDa)
Capsid (66kDa)
i (58k a)
8kDa
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The genome of TaV is 6.5 kb in size and contains two overlapping ORFs (Pringle et 
al., 1999). The first encodes a putative replicase and the second, a capsid precursor 
polyprotein (Pringle et al., 1999). The capsid precursor protein in TaV is cleaved 
twice to generate an N-terminal cleavage product of 17 kDa (P17), the large capsid 
protein of 58.3 kDa (L) and a small capsid protein of 6.8 kDa (S) (Pringle et al., 
1999). The 17 kDa protein has been hypothesised to stabilise the capsid during 
assembly (Pringle et al., 2001). In TaV a NPGP tripeptide was identified between the 
P17/L cleavage site in the polyprotein, which are conserved domains among the 
picornaviruses where cleavage occurs, and are called 2A-like domains (Donnelley et 
al., 2001).  These 2A-like domains have also been identified in PrV, indicating that 
the processing of their polyprotein occurs in a similar way (Pringle et al., 2003). 
Cleavage of the procapsid in PrV results in the generation of a 60 kDa mature capsid 
and two smaller proteins of 7.4 kDa and 13 kDa (Pringle et al., 2003).    
 
1.1.3.2 The omegatetraviruses. 
The larger genome segment (RNA1) of HaSV is 5312 nucleotides in length and is 
capped at the 5’ end. The RNA molecule contains a major ORF encoding the 1704 
amino acid replicase (Figure 1.2). The replicase has a predicted molecular mass of 
187 kDa (Gordon et al., 1995). Three additional ORFs are located at the 3’ end of the 
replicase ORF called p11, p15 and p8 with no known functions. In DpTV RNA1 is 
5492 nucleotides in length and encodes a replicase with predicted molecular weight 
of 180 kDa (Yi et al., 2005). Additionally there are also three ORFs at the 3’ end 
designated ORFp15, ORFp13 and ORFp11 (Yi et al., 2005). Sequence analysis of 
the replicase protein revealed that like HaSV, DpTV contains the three domains 
(methyltransferase domain, the helicase domain and the polymerase domain), which 
are conserved among other Alphaviruses (Yi et al., 2005). The replicase was shown 
to have polymerase activity, which was lost when the GDD motif within the 
polymerase domain was mutated (Zhou et al., 2006). The different domains of the 
DpTV replicase display different sequence identities with other viruses in the family. 
The methyltransferase domain shares 67% homology with HaSV and 38% with NβV 
(Yi et al., 2005). The helicase domain is more distantly related to HaSV with 63% 
identity and the polymerase domain is 76% and 36% similar to HaSV and NβV 
respectively (Yi et al., 2005).  
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Figure 1.2 The genome organization for HaSV (Gordon et al., 1995; Hanzlik et al., 
1995). 
 
The sequence of HaSV RNA2 is 2478 nucleotides in length and is capped at the 5’ 
end. RNA2 encodes two overlapping ORFs (Figure 1.2). The first ORF (p17) 
encodes a protein with predicted mass of 17 kDa, which has been hypothesised to 
function as a movement protein (Hanzlik et al., 1995). The p17 ORF protein is 
conserved among the omegatetraviruses (Hanzlik et al., 1995; Hanzlik and Gordon, 
1997; du Plessis et al., 2005; Yi et al., 2005). The second ORF of HaSV RNA2 
encodes a 647 amino acid capsid precursor protein with a molecular mass of 71 kDa 
(p71) (Figure 1.2). During maturation p71 is cleaved at an Asn-Phe site after amino 
acid 575 to generate the mature capsid protein of 64 kDa and a small gamma peptide 
of 7 kDa. Cleavage of p71 has been shown to occur upon assembly of the capsid in 
baculoviruses (Hanzlik et al., 1995) and release of the minor protein by the assembly 
dependent cleavage reaction is proposed to be essential for viral infectivity (Hanzlik 
and Gordon, 1997). 
 
The RNA2 molecules of NωV and DpTV contain a major ORF which encodes a 
capsid precursor protein with predicted molecular weight of 70 kDa, that is cleaved 
at a similar Asn-Phe site to HaSV resulting in a mature protein of approximately     
62 kDa and a smaller protein of 8 kDa (Agrawal and Johnson, 1992; Yi et al., 2005).  
 
RNA1
RNA-dependent RNA polymerase (p187)
37 5312
p8p11 p15
+Capsid (p64)
RNA2
Capsid (p71)
VLP Assembly Maturation
p7
Capsid (p71)
p17 2153
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Table 1.2. Sequence similarity and identity between the capsid encoding sequences 
of the omegatetraviruses (HaSV, NωV and DpTV) and three betatetrarviruses (NβV, 
TaV and PrV) (adapted from Pringle et al., 2003) 
 
 
 
 
 
 
 
 
 
 
 
 
As in NβV the 3’ termini of NωV, HaSV and DpTV RNA2 have been shown to have 
the potential to fold into secondary structures resembling tRNAs with a valine codon 
(Hanzlik et al., 1995; Yi et al., 2005). These structures can also from in HaSV and 
DpTV RNA1 (Gordon et al., 1995; Yi et al., 2005). This ability of the RNA to fold is 
not localised to the 3’ end in HaSV. The 5’ end and an internal region of the RNAs 
can also fold into loop structures (Hanzlik et al., 1995). These structures are thought 
to play a role in virus replication, RNA encapsidation and gene regulation. It has 
been suggested that they may even protect the RNA from degradation by the host 
cell (Hanzlik and Gordon, 1997).   
 
1.1.4 Virus structure- the theory of quasi-equivalence 
The theory of quasi-equivalence, first described by Casper and Klug (1962), 
proposed that an icosahedral virus particle is formed from hexameric and pentameric 
structures of the same protein. In order for the icosahedral structure to form, it must 
be composed of 12 pentamers. The greater the T number, the greater the number of 
hexamers there are between the pentamers. For a given quasi-equivalent symmetry 
the subunits associate through either a two-fold, three-fold or five-fold axis. 
 
 
 
 9
 
 
 
 
 
 
 
 
 
Figure 1.3 Diagrammatic representation of a virus particle with T=1 (A) and T=4 (B) 
quasi-equivalent symmetry. (A) The arrangement of the identical subunits A in the 
T=1 particle are in the same environment and only form a bent contact. (B) The 
subunits A, B, C and D in the T=4 particle, indicate subunits from identical gene 
products in a different environments in the icosahedral shell. The symmetrical two-
fold, three-fold and five-fold axes are depicted by solid eclipses, triangles and 
pentagons respectively. (C) The bent contact and flat contact formed between the 
A/B and C/D subunits respectively at the two-fold axis of the T=4 particle are shown 
(Johnson and Reddy, 1998). 
 
Viruses with the simplest structure have identical subunits which adopt a T=1 quasi-
equivalent symmetry and are composed of 60 subunits (Figure 1.3, A). According to 
the theory of quasi-equivalence this dictates that each subunit lies in an identical 
environment, and associates through a 2-fold axis with a bent contact (138°). The 
small size of the particle indicates that they are unable to encapsidate their genome 
(Johnson, 1996). The formation of particles with more than 60 subunits requires that 
while all the subunits are identical, they must adopt slightly different conformation in 
the capsid shell. The theory of quasi-equivalence states that all capsids adopt their 
structure through a given vertex and the way in which different environments are 
occupied dictates the T number (Baker et al., 1999). The number of possible subunits 
for a given viral conformation indicate that the number is equal to 60T, where T 
refers to the number of subunits in different environments.  
 
1.1.4.1 The T=4 quasi-equivalent structure of the tetraviruses 
In the tetraviruses, the T=4 quasi-equivalent capsid shell is composed of subunits A, 
B, C, D, which are derived from the same gene product in slightly different 
environments. A total of 240 subunits make up the viral shell (Figure 1.3, B). The 
A B C
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shell forms two different trimers ABC and DDD (Munshi et al., 1996; Canady et al., 
2000; Helgstrand et al., 2004). The ABC trimers surround the 5–fold axis and the 
DDD trimers associate at the 3–fold axis. Three ABC trimers and one DDD trimer 
form each face of the capsid. Additionally, at the 2–fold axis there are two copies of 
subunits BCD making a quasi 6–fold axis. There are also two distinct 2–fold axes. 
One related to 6–fold axes and the other to a 5 and 6–fold axes (Helgstrand et al., 
2004). The interactions between these axes have two types of contacts; a flat contact 
where the angle between the subunits is 180°, and a bent contact, where the angle 
between the subunits is 144°. The flat contacts occur at the 2–fold axis between C/D 
subunits and the 6–fold axis between B/D subunits. The bent contacts have been 
shown at the 5–fold axis between B/C subunits and the 6–fold axis between A/B 
subunits (Helgstrand et al., 2004). 
 
1.1.5 Tetravirus subunit structure 
The structure of wild-type NωV was solved to 2.8 Å resolution by Munshi et al., 
(1996) and subsequently refined by Helgstrand et al., (2004). Each capsid subunit is 
composed of three domains: the internal helical domain, a β-sandwich domain and an 
external immunoglobulin (Ig)-like domain (Figure 1.4). The β-sandwich domain 
located in the centre of the capsid subunit is composed of eight anti-parallel β-sheets 
designated βB, βC etc. to βI and the loops connecting the strand are designated BC, 
CD etc. (Munshi et al., 1996). The β-sandwich domain relates to residues 121 
through 543. The boundary between the β-sandwich domain and internal helical 
domain interact with each other at Asp 44, Phe 121 and Gln 543 (Munshi et al., 
1996).  
 
The internal helical domain resides at both the N and C-terminus of the protein 
(Figure 1.4) comprising helices, designated αN1-αN4 and αC1-αC4 respectively 
(Helgstrand et al., 2004). The two regions represent residues 1 to 43 at the                 
N-terminus and 591 to 607 at the C-terminus (Munshi et al., 1996, Helgstrand et al., 
2004). Helix αC4 and αC2 are the γ-peptides, which are cleaved during maturation. 
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Figure 1.4 The structure of the NωV subunits A, B, C and D. The three domains of 
each subunit are shown: internal helical domain, β-sandwich domain and the external 
or immunoglobulin (Ig)-like domain (Helgstrand et al., 2004).   
 
The γ-peptides formed from cleavage of the helical domain in NωV were originally 
thought to be arranged in a similar way to the nodaviruses. This led to assumptions 
that the helical bundle, formed at the 5-fold axis between the A subunit γ-peptides, of 
NωV and the nodaviruses had conserved functions in membrane translocation of 
RNA (Cheng et al., 1994; Munshi et al., 1996). Since then the refined structure of 
NωV revealed a number of differences between the helical domains in the two virus 
families (Helgstrand et al., 2004). Firstly, the γ-peptide of NωV is longer [(74 amino 
acids in NωV versus 44 amino acid in Flock house virus (FHV) or black beetle virus 
(BBV)] than FHV or BBV. Secondly, the helical bundle is formed from five           
C-terminal γ-peptides of the A subunit and five N-terminal γ-peptides of the B 
subunit in NωV, whereas in the nodaviruses the bundle only consists of five C-
terminal γ-peptides of the A subunit (Cheng et al., 1994; Helgstrand et al., 2004). 
This would indicate that externalisation of the helical bundle for RNA translocation 
would almost certainly be impossible in NωV because the bundle would have to 
move 75 Å in order to be exposed (Helgstrand et al., 2004).    
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The internal domain includes a number of positively charged residues. At the          
C-terminus, the last twenty residues have a net charge of +8 while the first 40 
residues of the N-terminus have a net charge of +11 (Agrawal and Johnson, 1995). 
For this reason it is possible that the genomic RNA interacts with this region, which 
has the potential to neutralise up to 50% of the genomic RNA charge (Agrawal and 
Johnson, 1995; Helgstrand et al., 2004). The difference in the individual subunits A, 
B, C and D primarily exists at the α-helix N1 and N2 (Figure 1.4). The C and D 
subunits are very similar, with the A and B subunits differing in the loop that connect 
αN1 and αN2 (Helgstrand et al., 2004). The external domain exists between the βF 
and βE strands of the internal domain, and folds into a structure representing an Ig-
like domain (Figure 1.4). The structure is formed by 10 folded β-sheets and consists 
of 133 amino acids (Munshi et al., 1996). 
 
1.1.6 Tetravirus capsid structure. 
The first structural study on the tetraviruses was the cryo-electron microscopic 
(cryoEM) examination of frozen hydrated NβV particles by Olson et al. (1990). The 
surface structure of this virus revealed that each of the twenty triangular faces was 
composed of twelve protein subunits grouped into four Y–shaped trimeric aggregates 
(Figure 1.5, B).   
 
 
 
 
 
 
 
Figure 1.5 Cryo-EM reconstructions of NωV (A) and NβV (B) virions. The bar 
represents 500 Å (Baker et al., 1999). 
 
Comparisons of the NωV and NβV surface structures by cryoEM show that NβV is 
pitted and more porous (Figure 1.5, B). Three pits were visible on each triangular 
face, while NωV has a solid trimeric face (Figure 1.5, A).  Since 1990, a wealth of 
structural information has been generated by cryoEM and X-ray crystallographic 
A B
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analysis of NωV (Munshi et al., 1996; Canady et al., 2000; 2001; Taylor et al., 2002; 
Helgstrand et al., 2004; Bothner et al., 2005).  This data will be discussed in detail 
below. 
 
 
1.1.6.1 Procapsids and mature capsids are structurally distinct  
The procapsid and capsid are structurally distinct (Figure 1.6). Cryo-EM 
reconstruction of baculoviral-derived NωV VLPs purified at a pH of 7.6 revealed 
that the particles exist as procapsids (Canady et al., 2000). At an acidic pH of 5.0 a 
transition occurs from the procapsid state to the mature capsid (Canady et al., 2000, 
2001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Cryo-EM reconstruction of the NωV procapsid and capsid structures. (A) 
Three-dimensional view of the NωV particle and (B) a section through the procapsid 
(left) and capsid (right) down the 2-fold axis, showing 3-fold (black triangle) and 
quasi 3-fold (white triangle) axis (Canady et al., 2000). 
 
As a result large structural changes occur causing the shrinking of the rounded, 
porous, procapsid (spanning 450 Å), into the compact, polyhedral capsid (spanning 
410 Å) (Figure 1.6, compare A to B). The inner surface of the procapsid is larger 
than the capsid and spans 240 Å compared to 220 Å (Canady et al., 2000).  
A
B
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Furthermore, the external or Ig-like domains at the surface of the particle are 
dumbbell shaped in the procapsid as opposed to trimeric in the mature capsid (Figure 
1.6, A). The structural rearrangements from the procapsid to the capsid state at an 
acidic pH of 5.0 occurs rapidly (100 ms), while autocatalytic cleavage has a half-life 
of hours (Canady et al., 2001). This extended time period is believed to be as a result 
of the initial expansion of the procapsid during the transition as protein-protein and 
protein-RNA interactions need to be broken (Taylor et al., 2002).  
 
 
1.1.7 Capsid assembly  
The first model for procapsid assembly was proposed by Canady et al. (2000). In the 
procapsid AB and CD dimers are predominant, while in the mature capsid the 
trimeric ABC and DDD interactions are predominant (Candy et al., 2000). The 
porous nature of the procapsid exists because of the disordered configuration of the 
subunits at the 6–fold axis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7 Proposed mechanism of NωV assembly through subunit dimer 
association. The colour change (from grey to purple) represents slight structural 
changes upon assembly into procapsids (Canady et al., 2000). 
 
Assembly of the procapsid initially involves the formation of AB and CD subunit 
dimers (Figure 1.7). These dimers further associate through their internal domains 
resulting in the procapsid shell. It is possible that the genomic RNA plays a role in 
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the assembly process by gathering the individual subunits and forming the dimers, 
which are believed to be essential during assembly. This mechanism is based on the 
refined structural data of NωV where genomic RNA is believed to interact with the 
internal domain offering the particle structural stability (Helgstrand et al., 2004). 
 
1.1.8 The mechanism of capsid maturation   
The proposed mechanism of capsid maturation by Canady et al. (2000) was based on 
X-ray solution scattering. The model proposed that arginine residues within the 
molecular switch have low pKa values that become positively charged at an acidic 
pH. This causes the repulsion of arginine residues resulting in the bent A/B contacts 
between the two subunits (Canady et al., 2000). The transition causes a shift from the 
3-fold axes to the quasi 2-fold axes resulting in the “shrinking” of the particle 
causing the trimeric associations.  
 
Two mechanisms of cleavage have been proposed from the refined structure of NωV 
(Taylor et al., 2002; Helgstrand et al., 2004). The first proposes that when cleavage 
occurs, residues Thr 246 and Glu 103 position Asn 570 to enable the cleavage event 
(Figure 1.8, A and B). A succinimide intermediate is formed by the nucleophilic 
attack of the asparagine side chain on the carbonyl group (Figure 1.8, B). The ring 
structure is then opened by hydrolysis, forming either an iso-asparagine or 
asparagine intermediate at the C-terminus of the 62 kDa β-peptide. Cleavage of the 
γ-peptide does not occur if Asn 570 is replaced by threonine, glutamine or aspartic 
acid, indicating that asparagine is vital for the maturation process. Cleavage of the γ-
peptide was shown to be essential for stabilising the mature capsid (Taylor et al., 
2002).  
 
The second mechanism of cleavage proposed that the aspartate and glutamate 
residues at the 2–fold bent contact may be important during the maturation of 
procapsids at low pH (Helgstrand et al., 2004). A number of acidic residues (Asp 83, 
Asp 85, Asp 87, Glu 110 and Asp 124) exist at the surface of the A subunit in the flat 
contact between C and D subunits. These interact with the N-terminus in the subunit. 
At an acidic pH of 6.5, an expansion above the pI of the residues results in a charge 
repulsion causing the bent contact to form (Helgstrand et al., 2004; Bothner et al., 
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2005). The maturation models indicate that an acidic pH is required for cleavage to 
occur by allowing the normally hydrophobic N-terminal regions of the subunits to 
interact (Helgstrand et al., 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8 Side view of a NωV A subunit (A) and mechanism of Asn 570/Phe 571 
cleavage in the helical domain (B). The inset in (A) depicts residues in the helical 
domain where cleavage occurs (Taylor and Johnson, 2005).    
 
Taylor et al., (2002) proposed that during cleavage, the irreversible transition of a 
helix to coil was induced by an acidic pH within the helical domain. The change 
from a helix state to a coil state occured upon lowering the pH from 7.6 to 5.0 at 
residues 1 to 44 and 571 to 644 (Figure 1.9). The model proposed that at a pH of 5.0 
the helix transformed into a coil resulting in cleavage of the γ-peptide causing the 
coils to migrate to the centre of the particle (Figure 1.9, compare A to C). In this state 
the process is irreversible and if the pH is raised to 7.4 the coil reverts back to 
helices, but the particle resembles a capsid (Figure 1.9, D). If cleavage does not 
occur at pH 5 the process is reversible (Figure 1.9, B).  
 
 
A B
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Figure 1.9 Schematic representation of the helix ( ) to coil (•) transition of the NωV 
particle from a procapsid state at pH 7.6 to a capsid state at pH 5.0 See text for 
details (Taylor et al., 2002).  
 
1.1.9 RNA and assembly 
Baculoviral-derived expression of the NωV capsid encoding sequence (P70) in a 
Spodoptera frugiperda 21 (Sf 21) cell line resulted in the assembly of NωV VLPs, 
which represented native virions (Agrawal and Johnson, 1995). The VLPs 
specifically encapsidated their own message, indicating that the NωV particles do not 
require full length genomic RNA1 or RNA2 for assembly. These authors concluded 
that the specific manner in which P70 mRNA was encapsidated indicated that the 
capsid-encoding sequence may contain an encapsidation signal. Similarly expression 
of HaSV RNA1, RNA2 and P71 in plant protoplasts resulted in the assembly of 
VLPs that had the ability to encapsidate their capsid-encoding message and RNA1 
(Gordon et al., 2001). The encapsidation of the viral RNA in the VLPs implied that 
viral RNA was importantant during the assembly process. This is interesting to note 
because viral RNA has been observed to interact with the highly positively charged 
γ-peptide (Helgstrand et al., 2004). Viral RNA has been hypothesised to stabilise the 
Procapsid; pH 7.6; 
uncleaved
A B
C D
Capsid; pH 5.0; 
uncleaved
Capsid; pH 5.0; 
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virus particle during maturation through the neutralisation of the particle interior 
(Agrawal and Johnson, 1995; Taylor et al., 2002).  
 
 The replication and RNA encapsidation strategy of the Nodaviridae (a virus family 
which also infects insects) is well understood and offer important clues for studying 
the Tetraviridae (Venter et al., 2005; Schneemann, 2006; Venter and Schneemann, 
2007).  
          
1.2 THE NODAVIRIDAE 
The Nodaviridae are a family of non-enveloped icosahedral bipartite (+) ss RNA 
viruses which are 29 to 39 nm in diameter with a T=3 quasi-equivalent symmetry 
(Fauquet et al., 2005). The family consists of two genera; the Alphanodaviridae, 
which predominately infect insects and the Betanodaviridae, which infect fish 
(reviewed in Ball and Johnson, 1998). The two genera are classified by the hosts they 
infect, their serological relatedness and their structural and genomic characteristics 
(van Rogenmortel et al., 2000). The alphanodaviruses include the type member 
Nodamura virus (NoV) and FHV for which the replication systems have been well 
characterised (Ball and Johnson, 1998). The alphanodaviruses have been shown to 
replicate in a number of organisms, which include yeast, insects, mammals and 
plants (Garzon et al., 1990; Selling et al., 1990; Ball et al., 1992; Price et al., 1996; 
Dasgupta et al., 2001; Dasgupta et al., 2003; Price et al., 2005; Dasgupta et al., 
2007). More importantly, the yeast Saccharomyces cerevisiae has been shown to 
support robust FHV and NoV replication, with the replicated genomic RNA 
approaching ribosomal RNA levels (Price et al., 1996; 2005). For the scope of this 
thesis the review of the literature will focus on NoV, FHV and BBV. 
 
 1.2.1 Genomic organisation. 
Like the omegatetraviruses, the nodaviruses have a bipartite genome consisting of 
two ss (+) RNA molecules; RNA1 and RNA2 (Dearing et al., 1980; Scotti et al., 
1983). Both RNAs are capped at their 5’ ends, co-packaged in the viral shell and are 
non-polyadenylated (Dasgupta et al., 1984; Krishna and Schneemann, 1999).  
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The large genomic segment of FHV (RNA1) is 3107 nucleotides in length and 
encodes 3 ORFs designated proteins A, B1 and B2 (Figure 1.10). Protein A, the 
replicase, is 998 amino acids in length with a predicted molecular weight of 112 kDa 
(Dasgupta et al., 1994). The replicase was shown to form its own group (group 2) in 
the classification scheme according to Koonin et al., (1992). The RNA1 sequence of 
BBV is 3106 nucleotides in length and also encodes a 998 amino acid replicase with 
a predicted molecular weight of 101 kDa (Dasmahapatara et al., 1985). The two 
smaller ORFs are translated from a subgenomic RNA, RNA3, (which is 
approximately 390 nucleotides in length) with predicted MRs of 10.8 kDa and      
11.6 kDa for B1 and B2 respectively (Figure 1.10). RNA3 corresponds to nucleotides 
2719-3107 of RNA1 with the ORF for protein B1 overlapping the ORF for protein 
A. Protein B1 has an unknown function. Protein B2 has been shown to be involved in 
inhibiting RNA interference in NoV (Sullivan and Ganem, 2005) and FHV (Li et al., 
2002; Chao et al., 2005) and facilitating viral RNA accumulation in NoV (Johnson et 
al., 2004).  
 
FHV RNA2 is 1400 nucleotides long and encodes the capsid precursor protein, α  
(44 kDa) (Friesen and Rueckert, 1981; Gallagher and Rueckert, 1988). During 
assembly 180 copies of protein α associate to form the procapsid. The procapsid is 
autoproteolytically cleaved to yield the mature protein, β (39 kDa) and the γ-peptide 
(4.4 kDa) (Gallagher and Rueckert, 1988; Schneemann et al, 1992). The NoV and 
BBV RNA2 is 1335 and 1399 nucleotides in length respectively (Dasgupta et al., 
1984; Dasgupta and Sgro, 1989). Protein α, the capsid precursor protein, is 407 and 
399 amino acids in size for BBV and NoV respectively.  
 
The 3’ end of BBV RNA1, RNA2 and FHV RNA2 fold into a stem-loop structure. 
This differs from the tRNA-like structure of the omegatetraviruses (Dasgupta et al., 
1984; Kaesberg et al., 1990; Hanzlik et al., 1995). While the tRNA-like structure has 
no known function, it has been hypothesised that it may have a function in virus 
replication (Kaesberg et al., 1990; Hanzlik et al., 1995).   
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Figure 1.10 Schematic representation of the genome organisation and replication 
strategy for FHV (adapted from van Rogenmortel, 2000 and Ball and Johnson, 
1998). The FHV particle depicted was taken from the Viper database 
(http://viperdb.scripps.edu/info_page.php?VDB=fhv).  
 
1.2.2 RNA replication  
FHV replication occurs on the outer mitochondrial membranes in Drosophila cells, 
with replication resulting in major structural changes (Miller et al., 2001). Later 
during infection spherules are formed, which encompass the replicating virions, and 
the matrix swells. The major protein encoded from RNA1, protein A, contains a 
mambrane localisation signal (Miller and Ahlquist, 2002). The protein is the RNA 
polymerase, which has the ability to replicate RNA1 in trans (Gallagher et al., 1983; 
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Ball, 1995). During the replication cycle the RdRp binds to the 3’ end of the            
(+) RNA1 and uses it as a template for (-) RNA1 synthesis (Figure 1.10). The RdRP 
then binds to the 3’ end of the negative sense RNA1 strand, synthesizing (+) RNA1. 
RNA3 is in turn believed to be synthesized from RNA1 through either an internal 
transcription mechanism or a termination mechanism (Zhong and Ruekert, 1993). 
The internal transcription mechanism involves the initiation of (+) RNA3 synthesis 
from an internal site in the (-) RNA1. The termination mechanism describes that as  
(-) RNA1 is synthesised, premature termination occurs producing a (-) RNA3. This 
negative strand is then used as a template for (+) RNA3 synthesis. The replication of 
RNA2 occurs in the same way as RNA1. RNA1 can regulate the synthesis of RNA3 
and the replication of RNA2 through interaction (Lindenbach et al., 2002). 
Replication of RNA1 is dependent on an intact RNA3 3’ end and RNA3 has the 
ability to regulate RNA2 replication (Albarino et al., 2003; Eckerle et al., 2003). The 
replication of RNA2 down-regulates the production of RNA3 (Zhong and Rueckert, 
1993). Extensions at the 5’ and 3’ ends of the genomic RNAs were shown to abolish 
replication (Ball and Li, 1993; Ball, 1995). The regions on RNA1 and RNA2 which 
are important during replication will be discussed in chapter 4. 
 
1.2.3  Nodavirus capsid structure  
The nodaviruses form their capsid shell from three subunits corresponding to the 
same gene product, which are in slightly different conformations A, B, and C  
(Figure 1.11, A). Each of the 60 capsid faces are composed of three trimers A, B and 
C. The T=3 particle is related at the 5-fold axis by A subunits and B/C subunits at the 
three fold axis (Johnson, 1996). At the two icosahedral two-fold axes, one relates two 
C subunits and the other A/B subunits. The two C subunits form a flat contact while 
the A/B subunits form a bent contact of 144° (Figure 1.11, B). The genomic RNA 
interacts with or lies between the two C subunits at the flat contact offering the 
subunits stability (Fisher and Johnson, 1993).  Cleavage of the γ–peptide occurs at 
the C/C contacts, forming the flat and bent contacts (Johnson, 1996).   
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Figure 1.11 Diagrammatic representation of the T=3 quasi-equivalent particle.  
(A) The quasi 2-fold, 3-fold and 5-fold axis are depicted as solid eclipses, triangles 
and pentagons respectively. (B) The flat and bent contacts occurring at the 2-fold 
axis between two C and the A/B subunits respectively (Taken from Johnson, 1996; 
Johnson and Reddy, 1998). 
 
The structures of both BBV and FHV have been determined by X-ray 
crystallography at a resolution of 3.0 Å  (Hosur et al., 1987; Fisher and Johnson, 
1993). Like NωV, each capsid subunit consists of an internal helical domain and a  
β-sandwich domain (Figure 1.12, A and B). However, the two structures differ from 
each other in that the NωV subunit has an external Ig-like domain (Munshi et al., 
1996) while in the nodaviruses, this domain is a continuation of the β-sandwich 
domain, formed by three β sheets. In the nodaviruses this domain is proposed to be 
the receptor binding domain (Hosur et al., 1987; Dasgupta et al., 1994; Wery et al., 
1994). Like NωV, the nodavirus β-sandwich domain consist of eight anti-parallel β 
sheets designated βB, βC…etc to βI (Rossmann and Johnson, 1989).  
 
The internal domain of the nodaviruses consists of 3 helices named helix I (residues 
61 to 73), helix II (residues 341 to 353) and helix III (residues 365 to 379) (Figure 
1.12, A; Hosur et al., 1987). Helix II and helix III are cleaved during autoproteolytic 
cleavage between Asn 363 and Ala 364 releasing helix III that is referred to as the γ-
peptide. The contacts between the genomic RNA occur at helix I and the γ-peptide 
(Fisher and Johnson, 1993).  
 
A B
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1.2.4 Nodavirus assembly  
Schneemann et al. (1994) demonstrated that FHV capsid assembly begins with 
genomic RNA interacting with individual capsid subunits. These interactions enable 
the rapid formation of the viral capsid. The function of RNA in the assembly process 
was proposed to be both structural and physical. RNA could recruit individual 
subunits into the assembly process and either chaperone these subunits into a stable 
conformation or act like a scaffold bringing the individual subunits together 
(Schneemann et al., 1994; Schneemann, 2006). In so doing the RNA could associate 
different subunits together, ensuring the highly compact nature of the RNA in the 
interior of the particle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.12 Structural similarity between the capsid subunits of BBV and NωV. 
Side view of the 5-fold axis between the BBV (A) and NωV (B) subunits, showing 
the similarity between the β-sandwich domains (blue). The γ-peptides are shown in 
red and the Ig-like domain (yellow) in NωV was not present in BBV (Taken from 
Munshi et al., 1996).   
 
A more model proposed by Larson and McPherson (2001) and reviewed by 
Schneemann (2006) for Satellite tobacco mosaic virus (STMV), suggests that the 
viral RNA is packaged while it is being synthesised. In this way the packaging of the 
A
B
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genome is controlled and energetically efficient producing a stable icosahedral 
structure (Schneemann, 2006). Because of the stability offered by this mechanism, 
the uncoating and re-folding of the viral genome during translation and transcription 
is thought to be feasible (Schneemann, 2006).  
 
1.2.5 Nodavirus maturation 
In FHV cleavage of the γ-peptide is assembly-dependent (Schneemann et al., 1992). 
The proposed cleavage mechanism of the nodaviruses during maturation is believed 
to involve the protonation of Asp 75, which in turn causes the polarization of Asn 
363 (Figure 1.13; Zlotnick et al., 1994; Johnson and Reddy, 1998). This protonation 
makes Asn 363 more susceptible to nucleophilic attack by a water molecule. This 
leads to the formation of a tetrahedral intermediate causing the loss of an amide 
group and leading to the generation the γ-peptide and the N-terminal peptide 
(Zlotnick et al., 1994).  
 
 
 
 
 
 
 
 
 
 
Figure 1.13 Similarity between the cleavage sites of BBV (A) and NωV (B). 
Cleavage of the γ-peptide in BBV and NωV occur between Asn 363-Ala 364 and 
Asn 570-Phe 571 respectively. The mechanism of cleavage between the two viruses 
is strikingly similar. The hydrophobic nature of the cleavage region leads to the 
protonation of Asp 75 (BBV) or Glu 103 (NωV). This results in positioning Asn 363 
(BBV) or Asn 570 (NωV) in such a way that they are more susceptible to 
nucleophlic attack by a water molecule leading to cleavage of the γ-peptide. The 
dotted lines represent hydrogen bonding distances (Munshi et al., 1996). 
 
Viral RNA has been shown to be important in capsid assembly and maturation in the 
Nodaviridae (Schneemann et al., 1992; Fisher and Johnson 1993; Schneemann et al., 
A BBBV NωV
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1994; Zontnick et al., 1994; Schneemann and Marshall, 1998). The mechanisms used 
by these viruses has provided insight into the complex nature by which RNA and the 
capsid protein interact during the assembly of (+) ss RNA insect viruses. X-ray 
crystallographic analysis of the FHV and BBV capsids shows the genomic RNA as 
an integral component of the viral shell. The RNA controls the interactions between 
subunits at the two-fold symmetrical axes (Figure 1.14). The amino acids that 
interact with the sugar phosphate backbone of the RNA in FHV are conserved 
glutamine (Glu 61) and lysine residues (Lys 68, 371 and 375) (Fisher and Johnson, 
1993; Wery et al., 1994; Schneemann and Marshall, 1998). This interaction is 
thought to position the RNA correctly between subunits, such that optimal protein-
protein contacts can form (Schneemann and Marshall, 1998).  
 
 
 
 
 
 
 
 
 
Figure 1.14 Interaction between the viral RNA and internal helical regions in FHV. 
Organization of the γ-peptides at the 2-fold axis in the FHV particle and their 
interactions with genomic RNA (Schneemann and Marshall, 1998).  
 
The RNA also lies in close association with the Asn–Phe cleavage site indicating that 
RNA–protein interaction may not only be important for assembly, but also in the 
maturation of the virus particle (Schneemann and Marshall, 1998). The viral RNA 
has been proposed to polarize water molecules that allow nucleophilic attack of the 
carbonyl group at the cleavage site (Cheng et al., 1994). Furthermore, deletions of 
residues 2-31 from the N-terminus of FHV coat protein interfered with its ability to 
recognize RNA2 (Marshall and Schneemann, 2001).  
 
Using crystallography and cryoEM analysis, Tang et al (2001) later resolved the 
structure of another nodavirus, Pariacoto virus (PaV) (Figure 1.15). They showed 
that RNA was in close association with the inner surface of the protein shell. The 
RNA is a structural component of the viral shell, which forming a highly ordered 
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dodecahedral cage of duplex RNA (representing 35% of the total genomic RNA) 
through interactions with the capsid at the two-fold and three-fold axes. The amino 
acids involved are twelve arginine and lysine positioned between residues 7 and 43 
of the coat protein subunits. The other 65% of the RNA is packaged within the 
interior of the particle. Similarly, cellular RNA has been shown to form a highly 
ordered structure in FHV and PaV VLPs, indicating that nodavirus capsids can 
encapsidate heterologous RNAs which are compatible (Johnson et al., 2004; Tihova 
et al., 2004). The degree of plasticity displayed by these capsids is difficult to 
determine. It is assumed that the genomic RNA would be preferentially packaged if 
it is available, which means the viral RNA must have a function in maintaining 
stability within the particles. 
 
 
 
 
 
 
 
 
Figure 1.15 Cryo-EM reconstruction of a section through a PaV virus particle 
revealing the dodecahedral cage of duplex RNA (Tang et al., 2001). 
 
1.2.6 RNA encapsidation in the nodaviruses  
The two genomic RNA molecules in the nodaviruses are co-packaged in equimolar 
concentrations (Krishna and Schneemann, 1999). The exact mechanism of RNA 
encapsidation has until recently been poorly understood. The ability of baculoviral-
derived PaV and FHV VLPs to encapsidate a mixture of highly ordered cellular and 
genomic RNA indicates that the packaging mechanism of viral RNA may be random 
(Johnson et al., 2004; Tihova et al., 2004). Venter et al. (2005) demonstrated that the 
packaging of viral RNA in FHV was coupled to replication and that encapsidation of 
RNA1 was dependent on the replication of RNA2.  However, encapsidation of 
RNA2 was not dependent on the replication of RNA1. Further evidence for 
replication-dependent encapsidation was provided by the assembly of two distinct 
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populations of FHV VLPs from replicating and non-replicating coat protein (Venter 
and Schneemann, 2007). Virus particles which were purified from replicating coat 
protein templates had the ability to specifically encapsidate RNA1 and RNA2. In 
contrast VLPs purified from non-replicating templates encapsidated mostly cellular 
RNA. In the absence of replication, FHV VLPs package random cellular RNAs, 
presumably due to insufficient amounts of RNA produced by transcription as 
opposed to replication (Venter and Schneemann, 2007). The advantage of 
replication-dependent RNA encapsidation ensures that there is a high initial 
concentration of viral RNA, which can interact with the capsid subunits in the 
vicinity of one another (Venter et al., 2005). In this way the replicating viral RNA 
and synthesis of capsid protein occur within a “microenvironment” in the cell. 
 
1.3 PROJECT PROPOSAL 
The tetraviruses are some of the genetically simplest ss (+) RNA viruses, but 
studying these viruses has proved to be a challenge. PrV was the only tetravirus 
shown to replicate in a Helicoverpa zea cell line (Pringle et al., 2003) and HaSV 
failed to replicate in 13 different insect and 1 mammalian cell line (Bawden et al., 
1999). Expression of HaSV P71 and the capsid encoding sequence of PrV, in a 
bacterial expression system, resulted in formation of insoluble aggregates (Hanzlik et 
al., 1995; Taylor et al., 2005). A similar result was obtained when HaSV RNA1 and 
RNA2 were transfected into plant protoplasts. No replicating virus was detected, but 
the authors did speculate that p71 had the ability to assemble in vivo (Gordon et al., 
2001). Venter (2001) exploited the possibility of using the yeast S. cerevisiae to 
produce authentic HaSV VLPs by expressing the capsid encoding sequence (P71) 
with the genomic RNAs using PGAL1. There was some evidence that infectious virus 
was produced and VLPs had the ability to assemble, but the system was largely 
inefficient. 
 
In contrast when the capsid encoding sequence of NωV (P70) or the full length 
genomic RNA of TaV were expressed using a baculoviral expression system in a     
Sf 21 cell line, VLPs were detected (Agrawal and Johnson, 1995; Pringle et al., 
2001) and in the case of NωV shown to encapsidate their own P70 mRNA (Agrawal 
and Johnson, 1995). This system was extensively and successfully used to study the 
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assembly and maturation of NωV in vitro by cryoEM and crystallographic 
reconstruction (Munshi et al., 1996; Canady et al., 2000; 2001; Taylor et al., 2002; 
Helgstrand et al., 2004; Bothner et al., 2005). From all the data generated from the in 
vitro studies, little is known about how the omegatetraviruses assemble and mature in 
vivo. 
 
The aim of the research presented in this thesis was to develop an alternative 
expression system in the yeast S. cerevisiae to produce substantially higher levels of 
capsid protein. This system was then used to study VLP assembly and RNA 
encapsidation. 
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CHAPTER 2.  ASSEMBLY OF HaSV VLPs IN YEAST 
 
2.1 INTRODUCTION 
Yeast cells have been successfully used as a non–host system for the production of 
several different types of VLPs including Hepatitis B virus surface antigen particles 
(Valenzuela et al., 1982; Fu et al., 1996), Hepatitis delta virus (Wu et al., 1997), 
polio subviral particles (Rombaut and Jore, 1997), Human papillomavirus (Hofmann 
et al., 1995; 1996; Neeper et al., 1996) and Influenza A virus non–structural protein 
NS1 (Ward et al., 1994). From here forward yeast will refer to S. cerevisiae because 
there is no mention of another strain. 
 
The coding sequence of the HaSV capsid precursor (P71) was expressed via the 
GAL1 promoter on a multicopy plasmid or from a single copy of the P71 gene under 
control of the same promoter inserted on the chromosome (Venter, 2001). The 
presence of p71 was detected and a small amount of immature VLPs were purified. 
These VLPs appeared to mature in vitro at pH 6.5. However, Venter (2001) was 
unable to confirm the presence of VLPs by TEM due to the low levels of VLPs he 
was able to purify. He concluded that the system was permissive to VLP production, 
but inefficient. Thus an alternative system was required to study assembly and 
maturation of HaSV VLPs in yeast. Venter (2001) suggested that an increase in the 
levels of transcription of P71 mRNA might result in more efficient VLP assembly. 
Venter (2001) concluded this from the observation that higher concentrations of 
NωV capsid precursor mRNA (P70) were expressed from insect cells infected with 
baculovirus vectors and this mRNA could be encapsidated (Agrawal and Johnson, 
1995). The polyhedrin promoter used for the baculoviral–derived expression is a 
strong promoter, which drives the expression of the desired protein such that it 
constitutes 25–50% of the total cellular protein (Miller, 1988). This is in direct 
contrast to PGAL1–dependent expression that drives expression of the protein of 
interest such that it constitutes 0.3 to 1.5% of total yeast protein (Johnson, 1987).   
 
The alcohol dehydrogenase-2 (ADH2) promoter has been the promoter of choice for 
the expression of many heterologous proteins (Price et al., 1990, Romanos et al., 
1992; La Grange et al., 1996; Ramjee et al., 1996). The amount of PADH2-derived 
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protein can represent up to 1% of soluble cellular protein (Price et al., 1990). The 
promoter is repressed several hundred fold in the presence of glucose and is referred 
to as de-repression (Price et al., 1990; Verdone et al, 1996; 1997). The method of 
PADH2 expression is uncomplicated and involves the depletion of glucose in the 
growth medium (Price et al., 1990; Donoviel et al., 1995; Verdone et al, 1996, 1997; 
Görgens et al., 2001) or the induction of the promoter by incubation in a non-
fermentable carbon source (i.e. ethanol) (Denis et al., 1982). 
 
A hybrid promoter with dramatically increased levels of transcriptional activation 
has been created. This was achieved by fusing the 5’ end of the ADH2 promoter, 
containing the 22 bp dyad sequence (important for ADH2 de-repression) and placing 
it approximately 320 nucleotides from the glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) TATA element (see Appendix 3 for the entire sequence). 
In this way Cousens et al. (1987) believed that the hybrid promoter, PADH2-GAPDH  
(PGADH) increased expression levels above that of the ADH2 promoter alone. 
However, transcription was still repressed in the presence of glucose and was still 
induced by glucose depletion or growth in ethanol. 
  
The hybrid promoter was able to support the production of 100 mg/L of superoxide 
dismutase (SOD)–proinsulin in yeast (Cousens et al., 1987). Expression of the 
protein using this promoter represented more than 15% of total cellular yeast protein, 
which is substantially higher than the maximum reported for PGAL1 (1.5%) or PADH2 
(5%) (Johnson, 1987; Shuster, 1989). The number of mRNA copies transcribed from 
this hybrid promoter can be greater than 50 per cell, which is in contrast to mRNAs 
in yeast that are present at 1 or 2 copies per cell (Cousens et al., 1987; Johnson, 
1987; Shuster, 1989; Wodicka et al., 1997).  
 
This chapter describes the construction and optimisation of a HaSV P71 expression 
system based upon the ADH2-GAPDH promoter (PGADH). The effect of increased 
expression levels on VLP assembly was investigated and a possible in vivo 
maturation mechanism elucidated. 
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2.2  MATERIALS AND METHODS 
2.2.1 Microbial strains and plasmids.   
Recombinant plasmids were maintained in Escherichia coli DH5α (Appendix 1; 
Table A1.1) or E. coli JM110 (Appendix 1; Table A1.1), which was used to prepare 
plasmids carrying methylated restriction sites. Plasmids were purified from E. coli 
cells using the Qiagen plasmid purification kit and the inserts sequenced using an 
Applied Biosystems 373A DNA sequencer. 
 
Yeast strain INVScI (Appendix 1; Table A1.1; Invitrogen) was used for P71 
expression and VLP assembly studies described chapters 2 and 3.  The HaSV capsid 
coding sequence, P71 (pAV3; Figure 2.1) was obtained from P.A. Venter (Venter, 
2001). The vectors pUC18 (Figure 2.1) and pGEMT-Easy (Promega) were used for 
sub-cloning of restriction fragments and PCR products.  Plasmid pYES2 (Invitrogen) 
was used as the backbone for P71 expression in yeast while plasmid pY2TG (Figure 
2.1), which carried PGADH, was obtained from Professor Laszlo Szilagyi (Department 
of Biochemistry at Eotvos Lorand University, Budapest, Hungary).  
 
2.2.2 Microbial culture conditions 
E. coli cells were grown in Luria-Bertani broth (LB) or on LB agar (Sambrook et al., 
1989) plates at 37°C with the relevant antibiotic for plasmid selection (Appendix 6). 
Competent E. coli cells were prepared using a CaCl2 method. E. coli DH5α cells 
cultured on LA overnight at 37°C were inoculated into 5 mL LB broth and allowed 
to incubate for a further 16 hours at 37°C.  Four 250 mL Erlenmeyer flasks 
containing 100 mL of LB were inoculated with 1.5, 1.0, 0.7 and 0.3 mL of the pre-
inoculum, and incubated on an orbital shaker at 37°C for approximately 2 hours. 
When the optical density (OD600nm) of the culture inoculated with the 1.5 mL pre-
inoculum reached the mid–log phase of growth (OD600nm = 0.6-0.8), all the flasks 
were cooled for 5-10 min on ice and the cells harvested by centrifugation at 5000 
rpm for 10 minutes at 4°C in a Beckman JA–14 rotor (Beckman centrifuge T2-21). 
The pellets were re-suspended in 25 mL of buffer RF1 (100 mM KCl; 50 mM 
MnCl2; 30 mM CH3COOK; 10 mM CaCl2; 15% glycerol (volume/volume) pH 5.8), 
followed by a further 20 minutes incubation on ice. The cultures, which were 
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inoculated with the 1.5 mL and 0.3 mL pre-inoculum and 1.0 mL and 0.7 mL pre-
inoculum, were pooled. The cells were pelleted as described above and both pellets 
re-suspended in 4 mL buffer RF2 (10 mM MOPS; 10 mM KCl; 75 mM CaCl; 15% 
(weight/volume) glycerol pH 6.8). All the cultures were pooled, aliquoted and stored 
at -80°C. 
 
YEPD [2% yeast extract (weight/volume), 1% peptone (weight/volume) and 2% 
glucose (volume/volume)] was used as the medium for preparation of the competent 
yeast cells. Competent yeast cells were prepared and transformed using the Frozen-
EZ Yeast Transformation II Kit (Zymo Research). Transformations were plated onto 
SMM [0.17% (weight/volume) yeast nitrogen base (YNB) without amino acids or 
ammonium sulphate (DIFCO); 0.5% (weight/volume) ammonium sulphate] agar 
(1.5%) with 0.002% histidine, 0.002% tryptophan, 0.01% leucine and 2% glucose 
(volume/volume) (Kaiser et al., 1994). The plated cells were incubated at 28°C for 3 
days. Colonies were patched onto fresh selective SMM agar plates and incubated at 
28°C for an additional 2 days. Freshly transformed yeast cells were used for each 
experiment to ensure that the 2µ-based expression vector/s were not lost during 
subsequent cell divisions. All liquid cultures were incubated on an orbital shaker at 
200 rpm. 
 
2.2.3 Preparation of wild-type HaSV 
Wild-type HaSV was purified from infected H. armigera larvae according to Hanzlik 
et al. (1993). Approximately 25 g of infected larvae, which were stored at -80°C, 
were homogenized in 50 mL of 50 mM Tris-HCl (pH 7.4) and filtered through 
cheesecloth. The homogenate was centrifuged at 9000 rpm in a Beckman JA-20 rotor 
for 30 minutes at 4°C. The supernatant was layered upon 4 mL of 30% sucrose 
[prepared in 50 mM Tris-HCl (pH 7.4)] and centrifuged at 23500 rpm for 3 hours in 
a Beckmann SW-28 rotor at 11°C. The supernatant was discarded and the pellet was 
allowed to re-suspend in 250 µL of 50 mM Tris-HCl (pH 7.4) at 4°C overnight. The 
virus suspension was then layered upon a 10-40% sucrose gradient [prepared in 50 
mM Tris-HCl (pH 7.4)] and centrifuged at 40000 rpm in a Beckman SW-41 rotor for 
one hour and fifteen minute. The virus band was removed with a syringe and the 
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virus re-pelleted in a Beckman SW-41 rotor at 24150 rpm for 3 hours at 11°C. The 
pellet was allowed to re-suspend overnight in 100 µL of 50 mM Tris-HCl (pH 7.4). 
 
2.2.4 Construction of P71 expression vector, pMT9 
The GADH promoter sequence used in the cource of this study varies from that 
published by Cousens et al., (1987). The 22 bp dyad sequence of the ADH2 promoter 
is placed 101 bps from the TATA box of the GAPDH gene.  
 
A 1443 bp Hind III fragment carrying the GADH hybrid promoter was excised from 
pY2Tg and inserted into pUC18 generating pAV16MT (Figure 2.1, Step I).  Next, a 
1026 bp Bam HI / Pvu II fragment from pAV3, which carries the 5’ end of HaSV 
P71, was inserted into the Bam HI / Sma I site of pAV16MT, downstream of the 
GADH promoter sequence, generating pMT7 (Figure 2.1, Step II). The 236 bp 
sequence between the GAPDH translational start and the translational start of p71, 
was deleted by reverse PCR. At the same time an optimal Kozak sequence (Table 
2.1)  for efficient translational initiation was inserted using primers MT1 (Appendix 
4; Table A4.1) and MT2 (Appendix 4; Table A4.1; Figure 2.1 Step III). In this was 
the GAPDH TATA box is placed 127 bps from the AUG of HaSV P71, placing the 
coding sequence in frame with the AUG of the GAPDH gene. The thermal cycling 
conditions are shown in Appendix 5, program 1. A 935 bp Bcl I / Bgl II fragment 
from the resulting plasmid (pMT8) was removed and inserted into pAV17 generating 
pMT9 (Figure 2.1 Step IV). Plasmid pMT9 is a multi-copy yeast expression vector 
for PGADH –derived P71 expression flanked by a CYC1 (TCYC1) terminator at the 3’ 
end, a uracil 3 auxotophic marker (URA3) and a β-lactamase for ampicillin 
resistance.   
 
2.2.5 P71 expression in yeast 
 
2.2.5.1 Comparison of PGAL1 versus PGADH-derived P71 Expression 
Yeast cells transformed with pAV3 or pMT9 were grown on SMM agar plates 
supplemented with 0.002% histidine, 0.002% tryptophan, 0.01% leucine and 2% 
glucose (volume/volume) for three days at 28°C. The colonies were patched onto 
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fresh selective plates and incubated at 28ºC for an additional two days.  Cells were 
scraped from the patches, re-suspended in a small volume of sterile triple distilled 
water and then inoculated into SMM with 0.002% histidine, 0.002% tryptophan, 
0.01% leucine, 0.1% glucose and 5% glycerol (volume/volume) at an OD600nm of 0.1.  
After 12 hours incubation at 28°C, 0.01% galactose was added to cells containing 
pAV3 for PGAL1 induction (galactose induction medium) and either no additional 
carbon source added (carbon-limiting medium) or ethanol added to a final 
concentration of 3% (volume/volume) to cells containing pMT9 for PGADH  induction.  
 
Table 2.1 Comparison of the sequences surrounding the start codon of HaSV P71 
mRNA to the yeast translational initiation consequence sequence. The nucleotide 
which varies from the consensus is underlined. 
 
Origin Sequence surrounding 
start codon 
Reference 
S.cerevisiae consensus Y A X A A U G U C U Cigan and Donahue, 1987 
P71 (pMT9) A A C A A UG G G A  This study 
P71 (pAV3) C A C A A U G G G A Venter, 2001 
X = A/U 
Y = A/C/T 
 
2.2.5.2 Optimisation of growth conditions for PGADH expression 
To investigate the effect of glycerol on PGADH–derived P71 expression, cells 
containing pMT9 were patched as indicated above. The patched cells were scrapped 
off the plates re-suspended in a small volume of sterile triple distilled water and 
inoculated into SMM with 0.002% histidine, 0.002% tryptophan, 0.01% leucine and 
either 0.1% glucose (glucose-starvation medium) or 0.1% glucose and 5% glycerol 
(carbon-limiting medium). The culture was incubated at 28°C for up to 50 hours.  
 
2.2.5.3 Growth conditions for apoptosis experiments 
Cells containing pMT9 were patched as indicated before. The patched cells were 
scrapped off the plates and inoculated into a small volume of sterile triple distilled 
water. The cell suspension was inoculated into carbon-limiting medium as indicated 
and incubated at 28°C for 28 hours. 
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Figure 2.1 Diagrammatic representation of the process followed for construction of the yeast HaSV P71 expression vector, pMT9. The 
restriction enzymes utilized for each cloning step are highlighted in larger font and the steps followed represented by Roman numerals The       
5’ end of the ADH2 promoter and 5’end of the GAPDH untranslated region are represented by ADH2 5’ and GAPDH respectively. HaSV P71, 
the capsid encoding sequence of HaSV (P71); TCYC1, CYC1 terminator (TCYC1); AMP-R, β-lactamase gene for ampicillin resistance; ORI,       
E. coli origin of replication; 2µ ORI, yeast origin of replication; URA3, uracil 3 auxotrophic marker.    
Ligate
• Hind III Digest
• Purify 1443bp Insert
• Hind III Digest
• Purify 2686bp Vector
I
pUC18
2686 bp
ALPHA
AMP-R
Ava I (435)
BamH I (430)
EcoR I (451)
Hind III (400)
Pst I (416)
Sma I (437)
Xma I (435)
Apa LI (178)
Apa LI (1121)
Apa LI (2367) Hind III (400)
AMP-R
2u ORI
ADH2-GAPDH Promoter
Hind III (2740)
Hind III (1297)
pAV16MT
4069 bp
AMP-R
ADH2 5'
GAPDH 3'
ORI
BamH I (31)
Cla I (2707)
Nco I (3877)
Sma I (38)
Hind III (1)
Hind III (2687)
a I (38)
Bam HI (31)
pAV3
7810 bp
URA3
AMP-R
HaSV P71
2u ORI
PGAL1
TCYC1Cla I (5351)
Hind III (51)
Nco I (4908)
BamH I (69)
BamH I (2022)
EcoR I (303)
EcoR I (2053)
Pvu II (21)
Pvu II (1095)
Pst I (1022)
Pst I (1641)
Pst I (2062)
Pst I (5139)
Pst I (5627)
Bam HI (69)
u II (1095)
• Bam HI + Pvu II Digest
• Purify 1026bp Insert
• Bam HI + Sma I Digest
• Purify 4062bp Vector
Ligate
II pMT7
5089 bp
AMP-R
HaSV P71 5'
MT1 forward primer
MT2 reverse primer
ADH2 5'
GAPDH 3'
ORI
BamH I (1)
Cla I (3697)
Nco I (4867) EcoR I (235)
EcoR I (1041)
Hind III (3676)
Hind III (5060)
Pst I (954)
Pst I (4895)
Pst I (5076)
III
• Reverse PCR  with 
primers MT1 and MT2
• Re-ligate
• Bcl I + Bgl II Digest
• Purify 935bp Insert
• Bcl I + Bgl II Digest
• Purify 7518bp Vector
IV
pMT8
4848 bp
HaSV 5'
AMP-R
ADH2 5'
GAPDH 3'
ORI
Cla I (4229)
Hind III (4208)
Pst I (1486)
Bcl I (1)
Bgl II (936)
EcoR I (767)
EcoR I (1573)
Bcl I (1)
Bgl II (936)
a  P71
pAV17
8609 bp
HaSV P71
AMP-RURA 3
ADH2 5'
GAPDH 3'
2u ORI
TCYC1
Bcl I (8067)
Bgl II (549)
Nco I (4985)
EcoR I (91)
EcoR I (380)
EcoR I (2130)
Bcl I (8067)
gl II (549)pMT9
8458 bp
HaSV capsid
AMP-R
URA 3
GAPDH 3'
ADH2 5'
2u ORI
Inverted repeat
TCYC1
Cla I (5275)
Nco I (4832)
Apa LI (2777)
Apa LI (4023)
BamH I (1946)
BamH I (7295)
EcoR I (227)
EcoR I (1977)
Ava I (973)
Ava I (2010)Ava I (6156)
Pst I (946)
Pst I (1565)
Pst I (1986)
Pst I (5063)
Pst I (5551)
 37
2.2.6 Protein analysis 
To monitor P71 expression, two OD600nm units of culture were removed, the cells 
harvested by microfuging at 2500 ×g for 5 minutes at 4°C, and the pellet re-
suspended in 30 µL of extraction buffer (EB: 50 mM Tris-HCl (pH 7.4), 250 mM 
NaCl, 1 mM DTT, 1 mM PMSF, 1 µM Pepstatin A). The cells were lysed by 
homogenisation with 0.1 g of 0.2 mm acid-washed glass beads (Sigma) in 30 second 
intervals on ice, with a total time of 10 minutes. The yeast lysate was then diluted by 
addition of 60 µL EB and vortexed briefly. After vortexing the supernatant that 
represented the total yeast extract was collected with an autopipette and placed into a 
fresh eppendorf tube. For soluble yeast extracts, the total yeast lysates were 
microfuged at 15500×g for 5 minutes at 4ºC and the supernatant used directly for 
Western analysis. 
 
The Bradford method was used to determine the protein concentration of samples 
(Bradford, 1976). Approximately 1 µg of total yeast protein was subjected to        
SDS-PAGE on a 7.5% polyacrylamide gel according to Laemmli (1970). Coomassie 
staining was used to confirm that equal concentrations of total yeast protein were 
loaded onto the polyacrylamide gel (Sambrook et al., 1989).  Electrophoretic transfer 
to Hybond-C+ membranes (Amersham) and immunoblot processing was performed 
according to the manufacturers instructions (Amersham). A premixed unstained 
protein molecular marker (116-14 kDa; Fermentas) was used to determine the 
relative molecular mass of visualised protein bands. For Western analysis, the 
polyclonal antibody RB2 (Andrew Dinsmore, Syngenta, UK) specific for the HaSV 
virus was used as a primary antibody at a dilution of 3.5 × 105 to detect p71. The 
Roche Chemiluminescence Western Blotting Kit was used for immunodetection.  
 
2.2.7 Induction and detection of apoptosis  
The growth conditions for these experiments are described in section 2.2.5.3. 
Apoptosis was induced by the addition of either 80 mM acetic acid or H2O2 was 
added at varying concentrations between 0 and 180 mM. The cells were incubated 
for three hours and twenty minutes at 28ºC.  To inhibit the onset of apoptosis, 
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cycloheximide was added to a final concentration of 15 µg/mL in conjunction with 
80 mM acetic acid or 40 mM H2O2. 
 
Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end-labelling 
(TUNEL) and 4,6-diamidino-2-phenylindole (DAPI) were used to test for apoptosis 
according to the method described by Madeo et al (1999) (Appendix 7, A7.1 and 
A7.2). In the TUNEL test, DNA fragments were end-labelled using the in situ Cell 
Death Detection kit, POD (Boehringer Mannheim). Yeast cells were fixed with 
formaldehyde, digested with lyticase (Sigma) and applied to a polylysine coated slide 
(MP biomedicals) (Adams et al., 1984; Appendix 7, A7.1). Cellular 
permeabilization, treatment of the cells with the TUNEL mixture and detection of 
peroxidase were carried out according to Madeo et al (1999). Three hundred cells 
were counted using an Olympus BX-60 reflected light microscope to determine the 
number of TUNEL positive cells. DAPI stained nuclei were viewed with an Olympus 
BX-61 fluorescence microscope. Cell viability was determined by staining with 
methylene blue (counting 1000 cells under the light microscope), or plate counts. 
 
2.2.8 VLP purification 
VLP purification was performed essentially according to the method described by 
Taylor et al (2002). Three litres of induced yeast cells were harvested at the 
appropriate time by centrifugation at 2500 ×g for 5 minutes at 4°C and the pellet re-
suspended in 2 ml EB per gram wet cell mass. Cells were lysed with 0.2 mm acid-
washed glass beads (Sigma) in a bead beater (Biospec Products), followed by 
centrifugation in a Beckman JA-20 rotor at 12500 rpm for 15 minutes at 4°C. The 
supernatant was layered on 4 mL of 30% sucrose, and centrifuged at 25000 rpm in a 
Beckman SW-28 rotor for 5.5 hours at 11ºC. The supernatant was discarded and the 
pellet re-suspended overnight in 100 µL EB at 4ºC. The VLP suspension was then 
layered on a 10-40% sucrose gradient followed by centrifugation at 40000 rpm in a 
Beckman SW-41 rotor for 75 minutes at 11ºC. Selected fractions were either 
collected by fractionation or the viral band was removed from the gradient with a 
syringe. Fractions, which had an absorbance at 260 nm, were pooled and centrifuged 
at 25000 rpm in a SW-28 rotor for 5.5 hours at 11ºC to pellet the VLPs. The 
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supernatant was discarded and the pellet re-suspended overnight in 100 µL EB at 
4ºC. The purified VLPs were then used directly for Western or TEM analysis. 
 
2.2.9 Electron microscopy 
Virus particles were stained with 2% uranyl acetate according to the method of Dong 
et al., (1998) and viewed using a JOEL JEM-1210 electron transmission microscope.  
Approximately, 5×1011 virus particles representing 5 µL of the VLP suspension were 
placed on each copper coated grid. 
 
2.3 RESULTS 
Previously, Venter (2001) had shown that PGAL1-derived expression of P71 in yeast 
cells resulted in low concentrations of assembled VLPs, and the majority of p71 
appeared to be insoluble. In contrast baculoviral expression of the same P71 coding 
sequence resulted in more efficient VLP assembly (Mosisili, 2003).  Since the levels 
of expression in the PGAL1 system are several orders of magnitude lower than those 
achieved from baculovirus promoters, it was decided to investigate the effect of a 
higher expression level on VLP assembly in yeast cells. 
 
2.3.1 Construction of the P71 expression vector, pMT9 
An expression system based upon PGADH, which activates transcription under glucose 
limiting conditions and is induced by the presence of ethanol in the growth medium, 
was selected. This promoter supports at least a 10-fold increase in RNA when 
compared to levels produced from PGAL1 (Denis et al., 1982). The expression vector, 
pMT9, which was derived from Venter’s (2001) expression construct pAV3, is based 
on the multicopy expression vector pYES2 with a URA3 auxotrophic marker and 
CYC1 terminator (TCYC1). However the PGAL1 promoter was replaced with the GADH 
promoter derived from the vector pY2Tg as described in the materials and methods 
(Section 2.2.4).  
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2.3.2 PGADH-derived expression of P71 in yeast 
It has been reported that transcription from PGADH is repressed several hundred-fold 
in the presence of glucose and induced when glucose is depleted from the growth 
media or when the cells are grown in glycerol or ethanol as carbon sources (Denis et 
al., 1982). Upon induction, the promoter can produce greater than 50 copies of the 
mRNA per cell (Shuster, 1989). To determine whether the PGADH promoter would 
produce significantly higher levels of p71, cells containing pAV3 (PGAL) or pMT9 
(PGADH) were initially grown in SMM supplemented with 0.1% glucose and 5% 
glycerol for 12 hours at 28°C. Galactose was then added at a concentration of 0.01% 
to cells containing pAV3. Cells containing pMT9 were either grown further without 
additional carbon (carbon-limiting) or in the presence of 3% ethanol. Cell free lysates 
were subjected to Western analysis to determine the level of P71 expression 
 
As observed previously by Venter (2001), p71 was detected in cells containing pAV3 
4 hours after induction but after 12 hours no p71 was detected (Figure 2.2, lane 7 
versus 16).  In cells containing pMT9, p71 was detected immediately and was still 
present in cells after 26 hours, irrespective of whether cells were grown under 
carbon-limiting conditions or in medium containing ethanol (Figure 2.2 lanes 2 and 3 
versus 17 and 18).  There was a significant increase in the levels of p71 in cells 
carrying pMT9 as opposed to pAV3, in which P71 expression was directed by PGAL1.  
More importantly after 4 hours of incubation in carbon-limiting medium a band was 
detected which co-migrated with wild-type HaSV, indicating that the HaSV VLPs 
may be maturing in the yeast cells (Figure 2.2, lanes, 9, 12, 15 and 18). Induction of 
the hybrid promoter in carbon-limiting medium produced higher levels of p71 as 
opposed to when cells were incubated in the presence of 3% ethanol after 4 hours 
incubation (Figure 2.2). In the presence of ethanol, p71 levels appeared to decrease 
substantially after 12 hours (Figure 2.2, lanes 14 and 17), suggesting that the 
presence of ethanol in the growth medium might inhibit PGADH –derived expression 
or result in increased levels of protein degradation. It was therefore decided to select 
the carbon-limiting growth medium for further optimisation, to increase the yield of 
p71. 
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Figure 2.2 Comparison of PGAL1 versus PGADH-directed P71 expression levels. 
Western analysis of total yeast lysates, which were prepared from cells that were 
expressing P71 under control of PGAL1 or PGADH. Cells containing pAV3            
(PGAL1-derived expression of P71) or pMT9 (PGADH–derived expression of P71) were 
initially incubated in SMM with 0.1% glucose and 5% glycerol for 12 hours at 28°C. 
For expression of P71 cells were incubated in the presence of 0.01% galactose (Gal) 
for PGAL1 and either 3% ethanol (EtOH) or depletion of glucose in the growth media 
(Gluc) for PGADH. The arrows indicate the position of bands migrating at an 
approximate molecular weight of 64 kDa (p64) and 71 kDa (p71), 1 ng of wild-type 
virus was loaded as a positive control (HaSV).   
 
2.3.3 Optimisation of growth conditions for PGADH-derived expression of 
P71 
While glucose limitation induces PGADH activity, low levels of carbon in the medium 
can also limit the amount of biomass produced and therefore, the yield of p71.  It was 
important to characterise the growth of INVScI cells containing pMT9 to determine 
the general growth profile. Accordingly, yeast
 
cells containing pMT9 were 
inoculated into medium containing various concentrations of glucose and the level of 
p71 production relative to cell growth determined.  
 
When cells containing pMT9 were grown in the presence of 0.5, 1 or 1.5% glucose a 
significant higher concentration of biomass was produced, than when the cells were 
incubated in 0.1% glucose (OD600 = 2.3 in 0.5, 1 and 1.5% glucose versus OD600 =1.5 
in 0.1% glucose; Figure 2.3, A). Cells grown in the different glucose concentrations 
had the same growth profile irrespective of the glucose concentration in the growth 
medium (Figure 2.3, A). Western analysis of yeast lysates after 24 and 39 hours 
showed that p71 was only expressed in cells grown in 0.1% and 0.5% glucose 
(Figure 2.3, B). Higher levels of p71 were produced when cells were incubated in a 
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glucose concentration of 0.1% compared to 0.5% and no p71 could be detected when 
cells were incubated in glucose concentrations of 1 or 1.5%. This most likely 
indicated that the glucose was significantly depleted in the medium, which contained 
0.1% and 0.5% glucose to induce expression of the promoter.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3 Growth and expression of P71 in yeast cells. (A) Growth curve of yeast 
cells containing pMT9 incubated in SMM with various concentrations of glucose at 
28°C. (B) Western analysis of selected total yeast lysates from cells expressing 
PGADH –derived P71 incubated in SMM with various concentrations of glucose. (C) 
Western analysis of total yeast lysates from cells expressing P71 incubated in 0.1% 
glucose. The contrast in (C) was adjusted to make the protein bands clearer. Arrows 
indicate the position of bands migrating at an approximate molecular weight of       
64 kDa (p64) and 71 kDa (p71). HaSV represents wild-type HaSV.    
 
As the incubation time progressed a protein band, which co-migrated with wild-type 
HaSV could be detected when cells were grown in 0.1% glucose (Figure 2.3, B, 
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lanes 9 and 13). This was in direct contrast to when cells were grown in the presence 
of 0.5% glucose where only p71 was detected. Cells grown in 0.1% glucose 
produced the highest levels of p71 and it was important to determine if p71 had the 
ability to be expressed after 39 hours of incubation.  
 
The increase in p71 levels as incubation time progressed and its presence after        
52 hours of incubation (Figure 2.3, C) was in contrast to PGAL1-derived expression, 
where p71 could not be detected after 12 hours post-induction (Compare Figure 2.2 
with Figure 2.3, C). As observed previously, a protein which co-migrated with p64 
after 32 hours of incubation was detected, which was possibly linked to glucose 
depletion or starvation in the cells (Figure 2.3, C, lane 6).  
 
To determine if the appearance of p64 was dependent on glucose starvation, cells 
were grown in 0.1% glucose with (carbon-limiting) or without (glucose-starvation) 
5% glycerol. If there was a link between starvation and p64 glycerol would prolong 
the growth phase of the cells and possibly delay the appearance of p64. 
 
 
 
 
 
Figure 2.4 PGADH –derived expression of HaSV P71in yeast cells.  Western analysis 
of total protein extracts from PGADH-derived expression of P71. Cells were incubated 
at 28°C in glucose–starvation (-) or carbon–limiting medium (+). Arrows indicate the 
position of bands migrating at an approximate molecular weight of 64 kDa (p64) and 
71 kDa (p71). HaSV refers to wild-type HaSV used as a positive control. 
 
High-level expression of p71 was detected after 16 hours of growth in glucose-
starvation medium while p71 was detected only after 32 hours in cells grown in 
carbon-limiting medium (Figure 2.4). In both sets of cells p71 was still present after 
50 hours (Figure 2.4, lanes 12 and 13) and as observed previously, a band              
co-migrating with the wild-type virus (p64) was detected after 32 hours growth in 
glucose-starvation medium (Figure 2.4, lane 9 compared with lane 14). In cells 
grown in carbon-limiting medium, a band co-migrating with p64 was observed after 
45 hours (Figure 2.4, lane 10 vs lane 14). The appearance of p64 suggested the 
possibility that the VLPs were undergoing maturation cleavage. 
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2.3.4 Assembly and maturation of HaSV VLPs in yeast cells 
To determine whether VLPs were assembling in the yeast cells, cells grown under 
glucose-starvation or carbon-limiting conditions were subjected to a VLP 
purification protocol. Selected fractions from sucrose gradients were examined for 
the presence of p71 and p64 by Western analysis. Both p71 and p64 were detected in 
the glucose-starved sample, but p64 was the major protein band (Figure 2.5, A, lane 
1). Similarly both p71 and p64 were present in VLP samples prepared from carbon-
limited cells, but here p71 was the major protein band (Figure 2.5, A, lane 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5 Purification of HaSV VLPs from yeast cells expressing P71. (A) Western 
analysis of VLPs purified from cells containing pMT9 incubated in SMM under 
glucose–starvation (-) or carbon–limiting conditions (+). Arrows indicate the position 
of bands migrating at an approximate molecular weight of 64 kDa (p64) and 71 kDa 
(p71). HaSV indicates wild-type HaSV. (B) Transmission electron micrograph of 
VLPs purified from cells expressing P71, incubated in SMM under glucose–
starvation or (C) carbon–limiting conditions. (D) Wild-type HaSV. The bar 
represents 50 nm. 
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Transmission electron microscope (TEM) analysis revealed that both preparations 
contained two types of VLPs: a proportion of approximately 42 nm in diameter that 
were penetrable to the stain or 38 nm in diameter that were indistinguishable from 
wild-type HaSV (Figure 2.5). These virus particles are consistent with the presence 
of procapsids and mature capsids respectively. The proportion of procapsids to 
mature capsids correlated to the relative levels of p71 versus p64 observed by 
Western analysis. Mature capsids were predominant in the glucose-starved sample 
(Figure 2.5, B) while procapsids were in the majority in the carbon-limiting sample 
(Figure 2.5, C). These results confirmed that the presence of p64 indicated that the 
HaSV VLPs had the ability to assemble and mature in the yeast cells. 
 
2.3.5 Induction of apoptosis results in spontaneous maturation of 
tetravirus procapsids in vivo. 
The data presented thus far shows a correlation between the carbon (and therefore 
energy) status of yeast cells and the appearance of p64 as opposed to p71. It has been 
shown that nutritional starvation leads to programmed cell death (PCD) or apoptosis 
(Herker et al., 2004). This raises the possibility that the appearance of p64 could be 
linked to the onset of PCD in the yeast cells. 
 
To determine whether the appearance of p64 and hence VLP maturation correlated 
with the onset of apoptosis, yeast cells expressing P71 (pMT9) were grown in 
carbon–limiting medium for 28 hours to ensure the production of procapsids only, 
after which apoptosis was induced by adding either H2O2 or acetic acid. Cells were 
grown for a further 3 hours and 20 minutes. Both p64 and p71 were present in cells 
treated with acetic acid (Figure 2.6, A, lane 2) or H2O2 at concentrations of 40 mM 
and higher (Figure 2.6, A, lanes 10-13). In contrast only p71 was present in untreated 
cells (Figure 2.6, A, lanes 1 and 3) or when H2O2 was added at concentrations lower 
than 40 mM (Figure 2.6, A, lanes 4-6). The viability of the treated cells, determined 
by counting methylene blue-stained cells in a haemocytometer, was significantly 
lower than the untreated control (Figure 2.6, B). This data suggested that apoptosis 
might be correlating with VLP maturation of the procapsids in vivo. 
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Figure 2.6 Induction of apoptosis and spontaneous maturation of HaSV VLPs in 
vivo.  (A) Western analysis of crude protein extracts from cells expressing P71 under 
control of PGADH (pMT9) treated with either acetic acid (HOAc) or varying 
concentrations of H2O2. Arrows indicate the position of bands migrating at an 
approximate molecular weight of 64 kDa (p64) and 71 kDa (p71), while HaSV 
indicates wild-type HaSV. (B) Viability of untreated cells or cells treated with 80 
mM acetic acid (HOAc) or 40 mM H2O2.  
 
Apoptosis can be differentiated from necrosis on the basis that apoptosis requires de 
novo protein synthesis while necrosis does not (Madeo et al., 1999; Ludovico et al., 
2001). To confirm that the onset of apoptosis and not cell necrosis was promoting 
VLP maturation, yeast cells transformed with pMT9, were treated with either acetic 
acid or H2O2 in the presence or absence of cycloheximide, a compound which 
inhibits de novo protein synthesis. 
 
Western analysis of cell-free extracts showed only p71 present in untreated cells or 
cells treated with cycloheximide alone (Figure 2.7, lanes 1 and 2). When cells were 
treated with acetic acid or H2O2, both p64 and p71 were detected (Figure 2.7, lanes 3 
and 5).  VLP maturation occurred in cells treated with acetic acid in the presence of 
cycloheximide (Figure 2.7, lane 4), but p64 was not observed when cells were 
exposed to H2O2 in conjunction with cycloheximide (Figure 2.7, lane 6). Thus, 
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cycloheximide appeared to inhibit maturation of VLPs in cells treated with H2O2 but 
not in those treated with acetic acid.  This data confirmed that at least in the case of 
H2O2, maturation of the VLPs was dependent upon de novo protein synthesis in the 
yeast cells.   
 
 
 
 
 
 
Figure 2.7 Inhibition of apoptosis and VLPs maturation. The methods for this 
experiment are described in section 2.2.7. (-) Indicates cells incubated without 
cycloheximide (Cyc), acetic acid (HOAc) or H2O2 and arrows show the position of 
p71 and p64.  
 
The TUNEL test and DAPI staining were used to confirm that the yeast cells treated 
with acetic acid or H2O2 were undergoing apoptosis. TUNEL was selected because it 
is a useful and specific test to label free 3’-OH termini from fragmented DNA as a 
result of apoptosis. Essentially, terminal deoxynucleotidyl transferase (TdT), transfer 
fluorescien labelled nucleotides to the free 3’-OH DNA ends of fragmented DNA. 
The fluorescent signal can then be converted by the detection of the fluorescien with 
anti-fluorescien conjugated with horseradish peroxidase (POD). Finally the substrate 
3,3'-diaminobenzidine (DAB) is added, which utilizes cobalt and nickel chloride in 
the presence of POD resulting in the formation of a brown precipitate, which can be 
visualised by light microscopy.   
 
DAPI staining was used to confirm the results from the TUNEL test, because the 
fluorescent molecule complexes with double-stranded DNA. In this way the 
morphology of the nuclei can be viewed with a fluorescence microscope and 
apoptotic nuclei characterised by chromatin condensation, which are observed as 
semi-circles (Madeo et al., 1999). 
 
As expected, p64 was detected in the lysates of cells treated with acetic acid and 
H2O2, while no p64 was detected in untreated cells (Figure 2.8, A, lanes 2 and 3 
versus 1). Samples of cells were fixed and subjected to a TUNEL test to detect 
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fragmented DNA represented by a brown precipitate, which could be visualised 
using light microscopy.  The test showed that approximately 80% of cells treated 
with either acetic acid or H2O2 were TUNEL positive (Figure 2.8, B), while only 5% 
of untreated cells exhibited a positive reaction (Figure 2.8, B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8 TUNEL test and DAPI staining to confirm the onset of PCD in yeast cells 
treated with acetic acid or H2O2. (A) Western analysis of total yeast lysates from 
cells expressing P71, untreated (-), treated with 80 mM acetic acid (HOAc) or 40 
mM H2O2 for 200 minutes at 28ºC. Arrows indicate the position of bands migrating 
at an approximate molecular weight of 64 kDa (p64) and 71 kDa (p71). HaSV 
indicates wild-type HaSV. TUNEL reaction (B) or DAPI stained (C) untreated cells 
(-), cells treated with 80 mM acetic acid (HOAc) or cells treated with 40 mM H2O2 
as indicated. The bar represents 5 µm. 
 
The DAPI stains confirmed that the majority of nuclei of treated cells were 
fragmented, with the chromatin forming a semi circle, which is indicative of 
chromatin condensation (Figure 2.8, C).  This observation was consistent with 
reports of chromatin condensation induced by apoptosis (Madeo et al., 1998; 1999; 
2002; Herker et al., 2004). In contrast, the nuclei of untreated cells were solid, round 
and no chromatin condensation was evident (Figure 2.8, C). These tests confirmed 
that apoptosis was induced by the addition of acetic acid and H2O2 which correlated 
in VLP maturation.  
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2.3.6 H2O2 treatment does not result in maturation in vitro 
To rule out the possibility that maturation of procapsids was as a result of direct 
interaction with H2O2, yeast cells expressing P71 were grown in carbon-limiting 
medium for 24 hours to ensure the presence of procapsids only. The cells were lysed 
and the cell-free extract treated with acetic acid or H2O2, followed by Western 
analysis.
 
Acetic acid caused maturation of the procapsids in vitro after 3.5 hours 
(Figure 2.9, lane 2), but no maturation was observed when the lysates were untreated 
or treated with H2O2 even after 19 hours of incubation (Figure 2.9, lane 9). VLPs 
have previously been shown to mature in the presence of a 70 mM sodium acetate   
(pH 5.0) buffer in vivo (Canady et al., 2000; Venter, 2001), which could explain why 
the VLPs had the ability to mature in the presence of acetic acid.  These results 
showed that induction of VLP maturation by H2O2 could only occur in vivo, 
supporting the hypothesis that VLP maturation correlated with the onset of apoptosis. 
 
 
 
 
 
 
 
 
 
Figure 2.9 Maturation of VLPs in vitro in the presence of acetic acid and H2O2. 
Western analysis of crude yeast lysates from cells expressing P71 under control of 
PGADH (pMT9) lysed in EB containing either 80 mM acetic acid (HOAc) or 40 mM 
H2O2 over time (3 to 19 hours). Cells were initially incubated in carbon-limiting 
medium for 28 hours at 28ºC. (-) Indicates cells lysed in EB alone while HaSV 
indicates wild-type HaSV. Arrows indicate the position of bands migrating at an 
approximate molecular weight of 64 kDa (p64) and 71 kDa (p71).  
 
2.4  DISCUSSION  
The aim of this chapter was to develop a high-level HaSV P71 yeast expression 
system based upon the GADH promoter to study the assembly of VLPs in vivo. The 
increase in expression levels from PGADH compared to PGAL1 resulted in the assembly 
of VLPs, which had the ability to mature in vivo. Evidence was provided by the 
ability of the VLPs to mature and the detection of VLPs by TEM analysis that 
represented wild-type HaSV. 
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2.4.1 HaSV VLP assembly in yeast 
Venter (2001) observed that more than 95% of p71 produced in cells under control of 
PGAL1 were insoluble. He postulated that the disappearance of p71 after 12 hours 
induction could be attributed to proteolytic degradation of insoluble aggregates. 
Increasing the expression levels of a poorly soluble protein traditionally results in 
even higher levels of an insoluble protein. However, this was not the case with 
PGADH-directed expression of P71, which resulted in increased protein expression, 
solubility, and assembly of the VLPs, which were still detected after 50 hours 
incubation 
 
Evidence that p71 had the ability to assemble in vivo was provided by detection of 
mature VLPs by TEM analysis, which had identical average diameters (38 nm) to 
wild-type HaSV. However, even though it appeared that assembly had improved, a 
large proportion of p71 remained indicating that the protein which remained, may 
have been insoluble. The insolubility of p71 may be attributed to the protein forming 
aggregates within the yeast cells (Venter, 2001).  
 
The differences in efficiency between the PGAL and PGADH promoter systems with 
respect to p71 assembly cannot be attributed to the increase in p71 concentrations 
only, but may also be as a consequence of elevated P71 mRNA levels transcribed 
from the hybrid promoter, which are encapsidated by the VLPs. This seems likely 
because; firstly, NωV VLPs produced using a baculoviral expression system in a     
Sf 21 cell line encapsidated P70 mRNA; secondly, the stability of NωV particles 
appear to be governed by the necessity of viral RNA to neutralize the highly charged 
inner surfaces; thirdly, viral RNA forms a structural component of the inner surface 
of the nodaviruses which offer the capsid support and stability; and finally, in the 
nodaviruses, viral RNA was preferentially encapsidated ahead of cellular mRNA in 
competition experiments (Fisher et al., 1992; Schneemann et al., 1992; Agrawal and 
Johnson, 1995; Tang et al., 2001). From the above argument it seems highly unlikely 
that HaSV VLPs would form empty particles devoid of RNA. Both the tetraviruses 
and nodaviruses have the ability to package random cellular RNAs, but packaging 
non-viral RNA has been shown to result in particles which are less stable and more 
susceptible to proteolytic degradation (Bothner et al., 1999; Krishna et al., 2003). 
 51
The low number of VLPs detected by TEM analysis representing wild-type HaSV, 
most likely represent particles which solely or partly encapsidate P71 mRNA. 
However one cannot rule out the possibility that high concentration of p71 produced 
off the hybrid promoter resulted in the elevated assembly rates experienced. In this 
way a certain percentage of particles would encapsidate viral RNA or cellular RNA 
during assembly, depending on which was available and in close proximity. 
 
 2.4.2 Apoptosis and HaSV VLP maturation in vivo. 
Apoptosis is a translation-dependent pathway, which is energy-dependent and is a 
form of cellular suicide. It differs from necrosis in that apoptosis is a defined 
orchestrated pathway dependent on de novo protein synthesis by the cell in response 
to negative stimuli or mechanical cellular damage. In addition to cellular ageing 
compounds such as H2O2 or acetic acid can induce apoptosis in yeast cells (Madeo et 
al., 1999; Ludovico et al., 2001; Herker et al., 2004). The well orchestrated process 
initially involves the production of reactive oxygen species (ROS) in the cytosol, 
leading to expression of the caspase pathway, DNA fragmentation, chromatin 
condensation, the release of cytochrome C from the mitochondria and exposition of 
phosphatidyl serine on the cell surface (reviewed in Madeo et al., 2004). Release of 
cytochrome C from the mitochondria has been implicated in the acidification of the 
cytosol (Ludovico et al., 2002). 
 
Mitochondria play a central role in the regulation of apoptosis, since changes in the 
permeability of the mitochondrial membranes result in the release of apoptosis 
inducing factors into the cytoplasm which trigger the pathway (van Gurp et al., 
2003). It has been reported that the onset of apoptosis results in a drop of cytosolic 
pH due to release of cytochrome C from the mitochondria (Matsuyama and Reed, 
2000). This acidification was shown using pH-sensitive green fluorescent protein 
mutants and is critical for caspase activity (Matsuyama et al., 2000). Acidification of 
the cytosol has also been reported to occur from the release of protons from 
lysosomes (Nilsson et al., 2006). So it would be reasonable to propose that 
maturation could occur due to acidification of the cytosol from the onset of 
apoptosis.   
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NωV VLPs, have been shown to mature spontaneously in baculovirus-infected Sf 21 
cells as they age (Agrawal and Johnson, 1995) and in vitro at an acidic pH (Canady 
et al., 2000). So while the molecular mechanisms of autoproteolytic cleavage of the 
capsid precursor protein are well understood (Canady et al., 2001; Taylor et al., 
2002), the relevance of maturation in the context of the virus and its interaction with 
the host cell remains unclear. The ability of acetic acid and H2O2 to induce apoptosis 
provides a possible way to link this process to maturation. When acetic acid or H2O2 
were added to cells expressing P71, the VLPs had the ability to mature. The TUNEL 
tests confirmed that approximately 80% of the treated cells were undergoing 
apoptosis. DAPI staining of the nuclei indicated chromatin condensation, which is a 
characteristic of PCD. In the case of acetic acid it is impossible to distinguish 
between acetic acid-triggered maturation directly (by acidification of the cytosol) or 
indirectly (by induction of apoptosis) (Ludovico et al., 2001; this study). Either way 
the ability of H2O2 to cause maturation in vivo and not in vitro indicated a possible 
link between apoptosis and HaSV VLP maturation in yeast cells.  
 
To investigate the effect viral RNA has on the assembly of HaSV VLPs, assembly 
efficiency will be determined by co–expressing P71 with either P71 mRNA or 
RNA2. The VLPs purified from cells co–expressing protein and viral RNA will be 
assessed for encapsidated viral RNA with the aim of relating assembly to viral RNA 
encapsidation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 53
CHAPTER 3.  RNA ENCAPSIDATION BY HaSV VLPS 
ASSEMBLED IN YEAST 
 
 
3.1
 
INTRODUCTION ........................................................................................ 54 
 
3.2 MATERIALS AND METHODS .................................................................. 54 
3.2.1 Construction of HaSV RNA expression vectors ..................................... 54 
3.2.2 Chromosomal versus episomal expression of P71 .................................. 57 
3.2.3 Co-expression of P71 with viral RNA.................................................... 60 
3.2.4 Northern analysis ................................................................................... 60 
 
3.3 RESULTS .................................................................................................... 63 
3.3.1 Low versus high level expression of P71 and VLP assembly.................. 63 
3.3.2 Co-expression of P71 and P71 mRNA ................................................... 64 
3.3.3 Co-expression of P71 and RNA2 ........................................................... 67 
3.3.4 Effect of increased viral RNA concentration on VLP maturation............ 68 
3.3.5 p71 solubility and the presence of viral RNA ......................................... 70 
3.3.6 Encapsidation of viral RNA ................................................................... 72 
 
3.4 DISCUSSION .............................................................................................. 76 
3.4.1 Viral RNA and VLP assembly ............................................................... 76 
3.4.2 VLP morphology ................................................................................... 78 
 
 
 
 
 
 
 
 
 
 
 
 
 
 54
CHAPTER 3.  RNA ENCAPSIDATION BY HaSV VLPS 
ASSEMBLED IN YEAST. 
 
3.1 INTRODUCTION 
In the previous chapter the high-level expression system resulted in assembly of 
HaSV VLPs in yeast. The increase in the efficiency of assembly by expressing  
PGADH–P71 when compared to PGAL1–P71 could result from increased protein 
production. Alternatively the increase in assembly efficiency of the VLPs could be 
the result of increased P71 mRNA transcribed by the hybrid promoter, which may 
function (as in the nodaviruses) to nucleate capsid precursor association during 
assembly (Schneemann and Marshall, 1998). If the mRNA was being encapsidated it 
may contain an encapsidation signal.  
 
This chapter describes experiments to determine whether the co-expression of P71 
with viral RNA results in the VLPs specifically encapsidating viral RNA. 
 
3.2 MATERIALS AND METHODS 
 
3.2.1 Construction of HaSV RNA expression vectors 
 
P71 mRNA expression vector (pMT9–AUG).  The methionine start of HaSV p71 
was mutated by site–directed mutagenesis using the QuickChange II Site-Directed 
Mutagenesis Kit (Stratagene). To enable co-selection of the mRNA expression vector 
with pMT9 or pAV3, the URA3 selectable marker on pMT9 (section 2.2.4) was 
replaced with the LEU2 auxotrophic marker by ligating the 7017 bp Bcl I / Mlu I 
backbone from pPG45 (obtained from Petra Gentz, Department of Microbiology, 
Biochemistry and Biotechnology, Rhodes University), containing the LEU2 
auxotrophic marker into pMT9, generating pMT9Leu (Figure 3.1, Step I). Plasmid 
pMT9Leu was then used as a template for reverse PCR amplification with primers 
MT6F (Appendix 4; Table A4.1) and MT7R (Appendix 4; Table A4.1; Appendix 6, 
program 2). These overlapping primers altered the nucleotides encoding the p71 
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translational start, (ATG was mutated to ACG) introducing an Aat II restriction site. 
The plasmid pMT9-AUG was generated for the high-level expression of HaSV P71 
mRNA (Figure 3.1, Step II). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Construction of P71 mRNA expression vector, pMT9-AUG. The 
restriction enzymes utilized for each cloning step are highlighted in a larger font and 
the steps followed are represented by Roman numerals. The resulting mutation of the 
HaSV P71 methionine (AUG mutated to ACG) is shown above the plasmid map of 
pMT9-AUG. ADH2, 5' end of the ADH2 promoter; GAPDH, 5’ end of the GAPDH 
untranslated region; HaSV P71, the capsid encoding sequence of HaSV (P71); 
TCYC1, CYC1 terminator (TCYC1); AMP-R, gene encoding the β-lactamase enzyme 
for ampicillin resistance; 2µ ORI, yeast origin of replication; URA3, uracil 3 
auxotrophic marker; LEU2, leucine 2 auxotrophic marker.  
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Vectors for the expression of RNA2 (pMT22L and pMT29). The RNA2 
expression vectors were constructed with expression directed either by PGAL1 or 
PGADH. Venter (2001) constructed an RNA2 expression vector (pAV14HPTrp) in 
which the 5' end of HaSV RNA2 was fused to the -1 nucleotide of the GAL1 
promoter. The vector pAV14HPTrp carries a low copy number CEN/ARS replication 
origin (Figure 3.2), which replicates at approximately 1 to 2 copies per cell 
(Lundblad, 1997). To increase the plasmid copy number, the CEN/ARS origin of 
replication was replaced with the 2µ origin, which replicates at approximately 20-50 
copies per cell (Rose and Broach, 1990). To accomplish this, the entire PGAL1 
promoter and RNA2 sequence were removed from pAV14HPTrp by digesting with 
Age I and Kpn I. The resulting 3212 bp insert was ligated into identical restriction 
sites in the 2µ-based vector, pYES2 (Figure 3.2, Step I) with the resulting plasmid 
(pMT22) replicating at high copy number, and encoding a URA3 marker for selection 
in yeast. To ensure that pMT22 could be co-selected with pAV3 (which also carries a 
URA3 marker) the backbone of the plasmid was replaced with the backbone from 
pMT9Leu. The 6654 bp Age I / Bam HI fragment from pMT9Leu, encoding the 
LEU2 gene, was ligated into the 3320 bp Age I / Bam HI fragment from pMT22, 
replacing the URA3 marker with LEU2 (Figure 3.2, Step II). The resulting plasmid 
(pMT22L) supports higher levels of expression of RNA2 under control of PGAL1 than 
that of pAV14HPTrp and carries an exact fusion between PGAL1 and RNA2 (Table 
3.1). The plasmid contains a cis–cleaving tobacco ringspot virus (ToRSV) hairpin 
cassette (HC) ribozyme at the 3’ end of RNA2 (Figure 3.2).  
 
PGADH, was used for high-level expression of RNA2. A 2100 bp Bam HI / Not I 
fragment from pMLY2 (constructed by Michelle Williams, CSIRO Entomology, 
Canberra, ACT Australia), which represented the 5’ end of HaSV RNA2 was cloned 
upstream from PGADH into the vector pPG37 (obtained from Petra Gentz, Department 
of Microbiology, Biochemistry and Biotechnology, Rhodes University), resulting in 
pMT28  (Figure 3.3, Step I). Next a 5354 Age I / Not I fragment from pMT28, which 
represents the entire PGADH and RNA2 sequence were cloned into identical restriction 
sites in pMT22L, generating pMT29 (Figure 3.3, Step II; Table 3.1). Plasmid pMT29 
is a 2µ-based plasmid, contains a HC ribozyme at the 3’end of RNA2 and a LEU2 
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auxotrophic marker. This would place the start of the HaSV RNA2 159 bps from the 
TATA element of GAPDH.  
 
3.2.2 Chromosomal versus episomal expression of P71  
The yeast strain INVScI 3#20.1 (Matα, his3, P71:LEU2, trp1, ura3) (Venter, 2001) 
transformed with pYES2 was used for the expression of P71 under control of PGAL1 
from a single copy of the gene inserted into the LEU2 chromosomal locus. The yeast 
strain, INVScI L+ (Matα, his3, LEU2, trp1, ura3) (Venter, 2001) was used for the 
PGAL1 (pAV3) and PGADH (pMT9)-dependent expression of P71 from plasmid vectors. 
The cells were grown in SMM supplemented with 0.002% histidine, 0.002% 
tryptophan, 0.1% glucose and 5% glycerol (volume/volume) for 20 hours at 28°C. 
The cells were harvested and washed twice in sterile triple distilled water and re-
suspended in SMM supplemented with 0.002% histidine, 0.002% tryptophan, 0.01% 
galactose and 5% glycerol (volume/volume).  
 
   
Table 3.1.  Nucleotide sequences around junctions between PGADH or PGAL1 and the 
5’ ends of HaSV P71 or RNA2  
Plasmid 
Name 
Selectable 
Marker 
Promoter Promoter-RNA junction Translational 
start 
pMT9Leu URA3 PGADH  
AACACACAUAAACAAUGGGAGAU 
 
CAAUGGGA 
pMT9  
(-AUG) 
LEU2 PGADH  
AACACACAUAAACGACGUCAGAU 
 
CGACGUCA 
pMT22L LEU2 PGAL1  
UGUAAUAAAGUUUUUCUUUCUUU 
 
CAAUGUAC 
pMT29 LEU2 PGADH  
AACACACAUAAACA…36bp…GUUUUUCUUUCUUU 
 
CAAUGUAC 
The plasmid name, selectable auxotrophic marker and promoter are depicted.  The 
RNA sequence of P71 and RNA2 are shown in bold font. The promoters are double 
underlined and the region of the translational start in pMT9Leu which was mutated 
underlined, generating an Aat II site.  
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Figure 3.2 Construction of the PGAL1-derived HaSV RNA2 expression vector, 
pMT22L. The restriction enzymes utilized for each cloning step are highlighted in a 
larger font and the steps followed are represented by Roman numerals. ADH2, 5' end 
of the ADH2 promoter; GAPDH, 5’ end of the GAPDH untranslated region; PGAL1, 
GAL1 promoter; HaSV P71, the capsid encoding sequence of HaSV (P71); TCYC1, 
CYC1 terminator (TCYC1); AMP-R, gene encoding the β-lactamase enzyme for 
ampicillin resistance; 2µ ORI, yeast origin of replication; URA3, uracil 3 auxotrophic 
marker; LEU2, leucine 2 auxotrophic marker; Tobacco ringspot virus (ToRSV) 
hairpin cassette ribozyme, HC ribozyme; ARS, autonomous replication signals; CEN, 
yeast centromeric sequence.    
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Figure 3.3 Diagrammatic representation of the process followed for construction of 
the PGADH–derived HaSV RNA2 expression vector, pMT29. The restriction enzymes 
utilized for each cloning step are highlighted in a larger font and the steps followed 
are represented by Roman numerals. ADH2, 5' end of the ADH2 promoter; GAPDH, 
5’ end of the GAPDH untranslated region; PGAL1, GAL1 promoter; TCYC1, CYC1 
terminator (TCYC1); AMP-R, gene encoding the β-lactamase enzyme for ampicillin 
resistance; 2µ ORI, yeast origin of replication; URA3, uracil 3 auxotrophic marker; 
LEU2, leucine 2 auxotrophic marker; (ToRSV) hairpin cassette ribozyme, HC 
ribozyme; autonomous replication signals ARS; yeast centromeric sequences, CEN.  
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3.2.3 Co-expression of P71 with viral RNA 
Yeast strain INVScI was either transformed with pAV3 (medium-level expression of 
P71) or pMT9 (high-level expression of P71) in conjunction with the high-level P71 
mRNA (pMT9-AUG) expression vector. Cells containing the relevant plasmids were 
incubated in SMM supplemented with 0.002% histidine, 0.002% tryptophan, 0.1% 
glucose and 5% glycerol (volume/volume) for 20 hours at 28°C.  The cells were 
harvested washed twice in triple distilled water and then re-suspended in SMM 
supplemented with 0.002% histidine, 0.002% tryptophan, 0.01% galactose and 5% 
glycerol (volume/volume).  
 
For the in vivo maturation of HaSV VLPs, cells were co-transformed with pAV3 
(medium-level expression of P71) and either the low–level RNA2 (pMT22L) or 
high-level P71 mRNA (pMT9-AUG) expression vectors. The cells were grown in 
SMM supplemented with 0.002% histidine, 0.002% tryptophan, 0.1% glucose and 
5% glycerol (volume/volume) for 12 hours at 28°C. Acetic acid was added to a final 
concentration of 80 mM and the cells were grown for a further 200 minutes at 28°C. 
 
To ensure that an equal amount of total yeast protein was analysed from each 
preparation the total yeast lysates were probed for the yeast translational initiation 
factor (eIF-5A), encoded by TIF51A and TIF51B in yeast (Schwelberger et al., 
1993). The two proteins eIF-5Aa and eIF-5Ab are constitutively expressed under 
aerobic and anaerobic conditions respectively, with both having an approximate 
molecular weight of 17 kDa (Schwelberger et al., 1993). For this reason these 
proteins can be used as a marker during Western analysis to show that equal amounts 
of protein were analysed for each sample.    
 
3.2.4 Northern analysis  
Total yeast RNA was purified from ten OD600 nm units of culture using the hot phenol 
method of Leeds et al., (1991). The cells were harvested in a microfuge at 15500 ×g 
and re-suspended in 300 µL buffer A [(50 mM NaOAc (pH 5.2); 10 mM EDTA   
(pH 8.0); 1% SDS (weight/volume)]. Two volumes of acid phenol [(equilibrated to 
below pH 4.0 with 50 mM sodium acetate (pH 4.0)] was added to the lysate and the 
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suspension incubated at 65°C for five minutes. The suspension was gently mixed by 
inversion every 30 seconds during the incubation period. The two phases were 
separated by microfuging at 15500 ×g for 3 minutes. The phenol phase was removed 
while ensuring the pellet was not disrupted. The same volume of acid phenol was 
added as before followed by incubation at 65°C to disperse the pellet. To ensure that 
the pellet was properly re-suspended the sample was vortexed, followed by 
microfuging at 15500 ×g for 3 minutes. The aqueous phase was removed and the 
volume adjusted to 500 µL. An equal volume of phenol:chloroform:isoamyl alcohol 
(25:24:1) (pH 4.0) and 0.15 M sodium acetate (pH 5.5) was added to the suspension, 
which was subsequently vortexed and then microfuged at 15500 ×g  for 3 minutes. 
The upper aqueous was removed and placed into a fresh eppendorf. Three volumes 
of ethanol (at room temperature) was added to the aqueous phase which was briefly 
homogenised and then microfuged at 15500 ×g for 5 minutes. The supernatant was 
discarded and the pellet washed with 70% ethanol. The pellet was subsequently air 
dried for 5 minutes in a vacuum dryer and re-suspend in 20 µL diethyl pyrocarbonate 
(DEPC)–treated triple distilled water. Approximately 5 µg of total yeast RNA was 
extracted from each preparation. 
 
RNA was purified from HaSV VLPs according to Schneemann et al. (1993). One 
volume of phenol:chloroform:isoamyl alcohol (25:24:1) (pH 4.0) was added to 
approximately 1×1011 sucrose gradient purified VLPs. The suspension was vortexed 
for 1 minute and then microfuged for 3 minutes at 4°C. The aqueous phase was 
removed and 1 volume of DEPC–treated H2O added to the phenol phase. The 
suspension was vortexed, microfuged at 15500 ×g for 5 minutes and the aqueous 
phase removed as indicated above. Next, 0.3 M sodium acetate (pH 5.2), 20 mg of 
glycogen (Roche), and 3 volumes ice cold 200 proof ethanol (Sigma) was added to 
each RNA extract. The RNA was allowed to precipitate at -20°C over night and 
collected at 15500 ×g for 10 minutes. The pellets were subsequently washed with  
ice-cold 75% ethanol and dried in a vacuum dryer for 5 minutes. Ten microliters of 
DEPC–treated H2O was added to the pellets, which were re-suspended and pooled. 
Approximately 1-2 µg of RNA was used for Northern analysis.  
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Northern blot analysis, electrophoresis using a denaturing 1% agarose-formaldeyde 
gel and the transfer to a Hybond N+ nylon membrane (Amersham), were performed 
according to the manufacturers protocol (Roche). The probe used for the 
hybridisation was DIG–UTP labelled and complementary to nucleotides 2309-761 of 
HaSV RNA2 (Appendix 2; Figure A2.1). Plasmid pMT20F was used as a template to 
generate the negative sense HaSV RNA2 probe (Figure 3.4). The plasmid was 
generated by inserting a PCR product, which represented the HaSV P71 coding 
sequence, into the pGEM-T Easy vector. The PCR product was amplified with 
primers MT1 and RD2, which bind to nucleotides 1-23 and 1944-1924 of HaSV P71 
respectively (Appendix 4; Table A4.1) The thermal cycling conditions are shown in 
appendix 5, program 3. To synthesise the negative sense probe plasmid pMT20F was 
linearised with Bgl II and transcribed in vitro with SP6 RNA polymerase according 
to the manufacturers instructions (Roche). Subsequent hybridisation of the probe to 
the target sequence and autographic detection using a CDP–star substrate were also 
performed according to the manufacturer’s instructions (Roche). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4 Diagrammatic representation of pMT20F, which was used as a template 
to generate the HaSV RNA2 probe for (+) RNA2 detection. The vector was 
generated by inserting a PCR fragment, which included the HaSV P71 sequence, into 
pGEM-T Easy (Promega). The resultant plasmid contains the HaSV cDNA flanked 
by bacteriophage RNA polymerase T7 and SP6. The plasmid confers resistance to 
ampicillin (AMP-R) for selection in E. coli. F1 ORI, E.coli origin of replication. 
TCYC1,  CYC1 terminator (TCYC1) 
 
pMT20 F
4970 bp
AMP-R
HaSV P71
F1 ORI
SP6 Pol
T7 Pol
Bgl II (398)
Nco I (2)Nco I (4948)
EcoR I (229)
EcoR I (1963)
EcoR I (4963)
Pst I (948)
Pst I (1567)
Pst I (1981)
 
 63
3.3 RESULTS  
In the previous chapter, it was shown that increased expression of P71 under control 
of PGADH led to more efficient VLP assembly and maturation in vivo.  As discussed 
previously, this result was in contrast to the data obtained by Venter (2001) using the 
PGAL-derived expression system, where VLP assembly was very inefficient and no 
maturation was observed.  Thus it was hypothesised that the increase in the levels of 
viral RNA (represented by P71 mRNA) produced by the PGADH system and 
encapsidation of this RNA promoted efficient VLP assembly and maturation in the 
yeast cells.  To test this hypothesis, the approach was to co-express viral RNA (P71 
mRNA or RNA2) with P71 to determine whether increased levels of viral RNA 
resulted in more efficient capsid assembly and maturation.  
 
3.3.1 Low versus high-level expression of P71 and VLP assembly 
First the efficiency of VLP assembly supported by low, medium and high level 
expression of P71 was investigated. Low-level expression of P71 was achieved using 
yeast strain INVScI 3#20.1 (Venter, 2001), which contained a single chromosomal 
copy of the P71 gene under control of PGAL, while the multicopy plasmid pAV3 
(PGAL), was used for medium levels of expression. Cells containing the multicopy 
plasmid pMT9, with P71 expressed under the control of PGADH, was used for high-
level expression. For induction of P71 the yeast strains were grown in minimal 
medium containing 0.01% galactose and 5% glycerol, which induces transcriptional 
activation by PGAL and provides the carbon-limiting conditions required for inducing 
PGADH activity. 
  
Substantially higher levels of p71 were produced from the multicopy expression 
vectors compared to chromosomal expression (Figure 3.5). This was expected 
because 2µ-based vectors are present at a copy number of approximately 50 per cell 
(Rose and Broach, 1990). Lower levels of p71 were detected in cells with PGAL1-
derived plasmid expression of P71 when compared to PGADH  expression of P71. In 
both cases where P71 was expressed using the GAL1 promoter, the protein could not 
be detected after 12 hours or 48 hours in cells carrying the chromosomal copy versus 
pAV3, respectively (Figure 3.5). In contrast p71 could be detected in cells containing 
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pMT9 (PGADH) after up to 72 hours of incubation and there was no difference in the 
levels of p71 over the incubation time. In addition, p64 could be detected in these 
cells after 12 hours, indicating the VLPs matured in these cells.  No p64 was detected 
in cells expressing P71 from the chromosome or plasmid using PGAL. This result 
confirmed that higher levels of P71 expression promoted VLP assembly and 
maturation. It still remained unclear whether the reason for the improved VLP 
assembly in PGADH-P71 expression was as a consequence of increased protein or viral 
RNA concentrations. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5 Comparison between chromosomal PGAL1-directed P71 (A) and plasmid 
expression of P71 by PGAL1 (B) or PGADH (C). Western analysis of total yeast lysates 
extracted from cells that were induced for the expression of P71 as indicated in 
section 3.2.2. Arrows indicate the position of bands migrating at an approximate 
molecular weight of 64 kDa (p64) and 71 kDa (p71). HaSV refers to wild-type 
HaSV. 
 
3.3.2  Co-expression of P71 and P71 mRNA 
If an increase in viral mRNA was the reason for increased VLP assembly then it was 
expected that an increase in P71 mRNA would result in an increase in VLP assembly 
in cells expressing PGAL1-P71 (pAV3). To test the hypothesis a system enabling the 
co-expression of P71 under the control of PGAL1 (pAV3) or PGADH (pMT9) together 
with P71 mRNA (pMT9-AUG) under control of PGADH was devised. Throughout this 
chapter two methods of expression will be described. Where PGAL1 and PGADH-
dependent co-expression was required, cells were initially grown in SMM with 0.1% 
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glucose and 5% glycerol for 20 hours.  The cells were then re-suspended in SMM 
supplemented with 0.01% galactose and 5% glycerol (galactose-induction medium). 
Where only PGADH-dependent expression was required, cells were grown in SMM 
with 0.1% glucose (glucose-starvation medium). 
 
First it was important to confirm that the P71 mRNA expression vector did not result 
in the translation of p71. Cells were transformed with the high-level P71 (pMT9) or 
P71 mRNA expression vector (pMT9-AUG) and grown in galactose-induction or 
glucose-starvation medium. As expected no p71 was translated from the P71 mRNA 
expression vector in the two different sets of media (Figure 3.6, lanes 5-8 and 12-14), 
while p71 was detected in cells containing pMT9 (Figure 3.6, lanes 1- 4 and 9-11). 
These results showed that p71 was not detectable from the P71 mRNA expression 
vector, pMT9-AUG 
 
 
 
 
 
 
 
 
 
Figure 3.6 Mutation of the p71 methionine start abolishes translation. Western 
analysis of total yeast lysates prepared from cells containing either pMT9 (+AUG) or 
pMT9 minus the p71 translational start (-AUG). Cells were grown in galactose–
induction or glucose–starvation conditions at 28°C for the times indicated. The 
arrows indicate the position of bands migrating at an approximate molecular weight 
of 64 kDa (p64) and 71 kDa (p71). HaSV refers to wild type virus loaded as a 
positive control.  
 
To test whether increased mRNA levels in cells expressing P71 at lower levels 
would favour VLP assembly. Yeast cells transformed with pAV3 and pMT9-AUG 
(P71 mRNA minus the p71 start codon) were examined for the presence of p71 and 
p64. The levels of the constitutively expressed yeast translation factor, eIF-5A were 
used to ensure that comparable levels of protein were being analysed for the different 
samples.  
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A small increase in the amount of p71 could be detected when mRNA was             
co-expressed with PGAL1-derived P71 (pAV3), compared to when no additional 
mRNA was co-expressed (Figure 3.7, A). After 48 hours p71 could not be detected 
in the lysates (Figure 3.7, A lane7). After 12 hours a protein, which co-migrated with 
wild-type HaSV, was detected in the yeast lysate where P71 mRNA and P71 were 
co-expressed (Figure 3.7, A, lane 3). Since this band was not detected in later 
samples (24 hours-72 hours) this most likely represented a degradation product. 
Medium levels of p71 with additional mRNA did not therefore improve p71 
solubility and the absence of p64 suggested that there was no increase in the 
assembly of the VLPs.  
 
This result showed that the reason for increased VLP assembly in PGADH-P71 cells 
was not due to an increased mRNA level and was therefore likely due to the 
increased p71 concentrations. However the presence of pMT9-AUG did appear to 
increase levels of p71 in these cells. Since the AUG codon of p71 is missing in this 
clone, the increase in p71 must be due to increased mRNA concentrations. 
 
 
 
 
 
 
 
 
 
Figure 3.7 Co-expression of PGAL1-derived P71 with P71 mRNA. Western analysis 
of total yeast lysates, expressing medium-level P71 (pAV3) with (+mRNA) or 
without (-mRNA) high-level P71 mRNA. Cells were grown in galactose–induction 
medium as described in the text. Blots were either probed for p71/p64 (VCAP) or 
eIF-5A with anti-HaSV (A) or anti-eIF-5A (B) antibodies respectively. The eIF-5A 
blots illustrate that equivalent amounts of total yeast protein were loaded into each 
lane.
 
Arrows indicate the position of bands migrating at an approximately molecular 
weight of 64 kDa (p64) and 71 kDa (p71). 
 
To test whether an increase in P71 mRNA would have an effect on p71 expressed 
from PGADH, cells containing plasmids pMT9-AUG and pMT9 were grown in 
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galactose-induction medium. Elevated levels of p71 were also detected when        
P71 mRNA was co-expressed with PGADH-P71, when compared to the control 
(expression of P71 only) (Figure 3.8, A). This could not be attributed to loading 
different amounts of total yeast protein on the Western blot as the levels of eIF-5A 
protein were equivalent in all the samples (Figure 3.8, B). Furthermore, p64 was 
detected in cells co-expressing P71 mRNA with high-level P71 after 8 hours 
induction compared to 48 hours for the control (expression of P71 only) (Figure 3.8, 
A, compare lane 2 to 6). 
  
 
 
 
 
 
 
 
 
Figure 3.8 Co-expression of PGADH-derived P71 with P71 mRNA. Western analysis 
of total yeast lysates, expressing high-level P71 (pMT9) with (+mRNA) or without  
(-mRNA) high-level P71 mRNA. Cells were grown in galactose–induction medium 
as described in the text. Blots were either probed for p71/p64 (VCAP) or eIF-5A 
with anti-HaSV (A) or anti-eIF-5A (B) antibodies respectively. The eIF-5A blots 
illustrate that equivalent amounts of total yeast protein were loaded into each lane.
 
Arrows indicate the position of bands migrating at an approximately molecular 
weight of 64 kDa (p64) and 71 kDa (p71). 
 
3.3.3  Co-expression of P71 and RNA2 
The co-expression of the P71 mRNA appeared to result in an increase in the 
detectable levels of p71 and the appearance of p64 indicated that the VLPs had the 
increased ability to mature. This indicated that assembly may be dependent on high 
p71 and viral RNA concentrations. Next it was important to determine the effect 
RNA2 would have on ability of p71 to assemble. First it was important to show that 
no p71 was translated from the low-level and high-level RNA2 constructs, pMT22L 
and pMT29. No p71 was detected from either RNA2 construct, but p71 was detected 
from the positive control (pMT9) (Figure 3.9).  
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Figure 3.9 Expression of HaSV RNA2 in yeast cells does not result in the translation 
of p71. Western analysis of total yeast lysates prepared from cells containing pMT9 
(+AUG), the PGAL1-dependent (pMT22L; PGAL1R2) or PGADH-dependent (pMT29; 
PGADHR2) RNA2 expression constructs incubated under galactose–induction or 
glucose–starvation conditions at 28°C for the times indicated. The arrows indicate 
the position of bands migrating at an approximate molecular weight of 64 kDa (p64) 
and 71 kDa (p71) and HaSV refers to wild-type virus loaded as a positive control.  
 
As observed before, when P71 mRNA was expressed in conjunction with medium 
concentrations of P71 (pAV3), elevated levels of p71 were produced when compared 
to cells expressing P71 only, and in both cases no p71 was detected after 60 hours of 
induction (Figure 3.10). A similar trend was observed when RNA2 was co-expressed 
with P71, except that p71 could be detected after 72 hours of induction (Figure 3.10). 
The levels of p71 decreased dramatically after 24 hours when RNA2 was co-
expressed with P71, but more importantly no p64 was detected in any of the 
experiments. This indicated that the presence of RNA2, like P71 mRNA, do not 
increase the assembly of HaSV VLPs. The presence of the viral RNA did however 
increase the levels of p71. 
 
3.3.4 Effect of increased viral RNA concentration on VLP maturation 
The difference in the levels of p71 detected when viral RNA was expressed had to be 
as a consequence of the RNA. The eventual disappearance of p71 indicated that the 
protein was unable to form stable VLPs. To determine if p71 in the presence of viral 
RNA increased VLP assembly, P71 (pAV3) was co-expressed with or without viral 
RNA for an induction time of 12 hours and maturation induced with acetic acid. The 
reasoning was that the presence of mature capsid protein (p64) would indicate the 
assembly and maturation of the VLPs. 
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Figure 3.10 Co-expression of P71 mRNA and RNA2 with P71. Western analysis of 
total yeast lysates from cells co-expressing PGAL1–directed P71 with no RNA            
(-RNA), PGADH –directed P71 mRNA (P71 mRNA), or PGAL1–directed RNA2 
(RNA2). The cells were grown under galactose-induction conditions. Blots were 
either probed with anti-HaSV (VCAP) or anti-eIF-5A (eiF-5A) antibodies. Arrows 
indicate the position of bands migrating at an approximately molecular weight of 64 
kDa (p64) and 71 kDa (p71). 
 
Western analysis of crude cell extracts showed the presence of p64 in all samples 
treated with acetic acid, indicating the presence of mature VLPs irrespective of 
whether or not the viral RNA was present (Figure 3.11). Interestingly p64 was 
detected in cells co-expressing P71 and HaSV RNA2 that had not been treated with 
acetic acid (Figure 3.11, lane 5). This was in contrast to untreated cells co-expressing 
P71 and P71 mRNA or P71 alone, where only p71 was detected (Figure 3.11, lanes 
1 and 3). This suggested that the presence of HaSV RNA2 stimulated the 
spontaneous maturation of VLPs. This could be as a consequence of the cells 
inducing apoptosis because of the metabolic load imposed on the cells by expressing 
high concentrations of RNA2. 
 
 
 
 
VCAP eIF-5A
0 8 7260 48362412
Time (hrs)
0 8 726048362412
Time (hrs)
0 8 726048362412
Time (hrs)
-vRNA
0 8 726048362412
Time (hrs)
p64
p71
P71 mRNA
0 8 7260 48362412
Time (hrs)
p64
p71
RNA2
0 8 7248 60362412
Time (hrs)
p64
p71
 
 70
 
 
 
 
 
 
 
 
 
Figure 3.11 Maturation of procapsids purified from cells co-expressing medium-
level P71 and viral RNA. Western analysis of total yeast lysates prepared from cells 
co-expressing medium-level P71 (pAV3) with P17 mRNA (+mRNA), PGAL1-derived 
RNA2 (pMT22L) or without RNA (-RNA), grown in galactose-induction medium 
for 12 hours at 28ºC.  Cells were then treated with (+) or without (-) 80 mM acetic 
acid for 200 minutes at 28ºC. Arrows indicate the position of bands migrating at an 
approximately molecular weight of 64 kDa (p64) and 71 kDa (p71). Blots were 
either probed with anti-HaSV (VCAP) or anti-eIF-5A (eIF-5A) antibodies 
respectively.  
 
3.3.5 p71 solubility in the presence of viral RNA 
To determine whether an increase in RNA levels would influence p71 solubility, 
yeast cells expressing PGADH–derived P71 (pMT9) were co-transformed with 
plasmids pMT9-AUG or pMT29, which express either P71 mRNA or RNA2 under 
control of PGADH.  Western analysis showed that the co-expression of RNA2 resulted 
in substantially higher levels of total p71 and p64, as compared to cells co-expressing 
P71 with P71 mRNA or P71 alone (Figure 3.12, A, lanes 5 and 6). In cells 
expressing P71 only or co-expressing P71 and mRNA, the majority of both p71 and 
p64 appeared to remain in the insoluble fraction (Figure 3.12, A, lanes 1 and 3 versus 
2 and 4).  However, in the case of cells co-expressing P71 and RNA2, a significant 
increase in the levels of soluble p71 and p64 were observed with more than 50% of 
the protein remaining in the soluble fraction (Figure 3.10, A, lanes 5 and 6). The 
difference in the amounts of protein detected cannot be as a consequence of different 
protein levels loaded onto the blot (Figure 3.12, C). The presence of HaSV RNA2 
significantly increases the solubility of both p71 and p64 in the yeast cells and 
consequently VLP assembly and maturation.  
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Figure 3.12 Effect of the presence of viral RNA on the solubility of VLPs. Western 
analysis of total yeast lysates (i), soluble yeast lysates (s) (A) or VLPs purified 
through a 10-40% sucrose gradient (B), prepared from cells co-expressing high level 
P71 with (P71 mRNA/RNA2) or without (-RNA) viral RNA under glucose-
starvation conditions at 28ºC for 48 hours. Blots were either probed for p71/p64 with 
anti-HaSV (A and B) or for eIF-5A with anti-eIF-5A (C) antibodies respectively. 
Arrows indicate the position of bands migrating at an approximately molecular 
weight of 64 kDa (p64) and 71 kDa (p71). 
 
Yeast cells expressing P71 with or without viral RNA (P71 mRNA or RNA2) were 
subjected to VLP purification to determine whether or not the presence or absence of 
viral RNA was affecting the efficiency of VLP assembly. Western analysis of 
samples collected from the sucrose gradients showed the presence of both p71 and 
p64 in approximately the same concentration in all three samples, indicating the 
presence of both procapsids and mature capsids (Figure 3.12, B). The relatively high 
concentration of p71 remaining after VLP purification indicated that these particles 
may represent a proportion of p71 which were either able to assemble, but did not 
mature, or were aberrant VLPs. These results indicate that the HaSV RNA improved 
the solubility of the VLPs, but did not necessarily improve assembly of the VLPs. 
This is similar to what was observed before (chapter 2). 
i i is s s
-RNA P71mRNA RNA2
1 2 3 4 5 6
1 2 3 4
p71
p64
-
RN
A
P7
1m
R
N
A
R
N
A2
H
aS
V
-
RN
A
RN
A2
P7
1 
m
RN
A
1 2 3
C
A
B
p71
p64
-
RN
A
RN
A2
P7
1 
m
RN
A
-
RN
A
RN
A2
P7
1 
m
RN
A
-
RN
A
RN
A2
P7
1 
m
RN
A
 
 72
 3.3.6 Encapsidation of viral RNA 
VLPs were purified from cells co-expressing P71 in the absence or presence of viral 
RNA, which were incubated in glucose-starvation medium for 48 hours and then 
treated with acetic acid for 200 minutes to induce maturation in vivo to stabilize the 
VLPs. Western analysis of the VLP preparations revealed that only capsid protein 
was present whether additional RNA was expressed or not implying the presence of 
mature VLPs (Figure 3.13). This was in contrast to earlier experiments where both 
p71 and p64 could be detected when cells expressing P71 were not treated with 
acetic acid (Figure 3.12, B). The presence or absence of viral RNA had no added 
effect on the ability of the VLPs to assemble and subsequently mature. 
 
 
 
 
 
 
 
 
 
Figure 3.13 Western analysis of HaSV VLPs prepared from cells co-expressing P71 
and viral RNA. The VLPs were purified from cells expression P71 with (P17mRNA 
or PGADH-dependent RNA2) or without (-RNA) one of the RNA transcripts as 
indicated. Cells were incubated in SMM with 0.1% glucose for 48 hours at 28°C. 
Acetic acid was added to a final concentration of 80 mM and the culture was 
incubated for 200 minutes at 28°C. 
 
TEM analysis of the purified VLPs revealed that the there was a wide distribution of 
particle in terms of both size and shape in the different experimental systems (Figure 
3.14, A-D and E). When no additional viral RNA was expressed, the majority of 
particles (40%) had a diameter of 32 nm and a mean diameter of 30 nm (Figure 3.14, 
A 1-4). These particles were semicircular in shape and 8 nm smaller on average than 
wild-type HaSV (30 nm versus 38 nm). These particles may represent a species, 
which encapsidate random cellular RNAs. Additionally the surface morphology of 
these particles was different to wild-type HaSV. No predominant surface features 
were detected on the particles, which appeared smooth in texture compared to the 
pitted surface structure of wild-type HaSV particles (Figure 3.14, Compare A4 to 
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D4). In contrast when P71 mRNA was expressed with P71, the majority of particles 
(62%) were 38 nm in diameter, varied in shape to wild-type HaSV and thus did not 
represent the customary icosahedral symmetry (Figure 3.14, B2-4 and E).  
 
When P71 mRNA was co-expressed, 15% of the particles were less than or equal to 
32 nm in diameter, while 23% of the particles were greater than or equal to 44 nm in 
diameter. A large proportion of particles in this sample were aberrant (Figure 3.14, 
B1). In contrast when RNA2 was co-expressed, 35% of particles were 32 nm or 
smaller and 18% were 44 nm and larger (Figure 3.14, C and D). Similarly, the 
majority of particles were 38 nm in diameter (47%) (Figure 3.14, compare C4 to D4). 
A proportion of the particles were aberrant. These particles also had a wide 
assortment of shapes, but few were miss formed or appeared to have collapsed, as 
was observed when P71 mRNA was co-expressed. Particles purified from cells co-
expressing viral RNA had the largest size distribution.
  
 
These results signified that HaSV particle assembly is affected by the increased 
presence of viral RNA. The wide size distribution seen when viral RNA was 
expressed with P71 may represent particles which co-packaged cellular RNA and 
viral RNA, with the RNA dictating the final shape of the virus. In order to determine 
the species of RNA encapsidated in the VLPs, RNA was purified from the VLPs. 
The RNA was then subjected to Northern analysis and the blots were probed for viral 
RNA to determine if the VLPs specifically encapsidated their own RNA.  
 
Initially it was important to determine if the viral RNA was being expressed off the 
expression constructs. Total yeast RNA was analysed by Northern analsysis after an 
incubation time of 24 hours and 48 hours. Both P17 mRNA and RNA2, at 
nucleotides 1941 and 2489 respectively, were detected from the total yeast lysates 
(Figure 3.15, A, lanes 1-4). The levels of RNA decreased from 24 to 48 hours, which 
was most likely due to mRNA degradation in the yeast cells (Figure 3.15, A, lanes 2 
and 4).  
 74
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14 Effect of co-expressing viral RNA on HaSV VLP assembly. (A-D) Transmission electron micrograph and (E) size distribution of 
virus particles from 100 particles counted. Solid black and white arrows indicate particles that closely resemble wild-type HaSV particles or miss 
formed particles respectively. Stripped arrows indicate particles that are significantly smaller than wild-type HaSV particles. The VLPs were 
purified from cells expression P71 without (-RNA; A) or with (P17mRNA; B  or PGADH-RNA2; C) one of the RNA transcripts as indicated. 
Cells were incubated in SMM with 0.1% glucose for 48 hours at 28°C, 80 mM acetic acid was added and the culture incubated for a further 200 
minutes at 28°C. The bar represents 50 nm in each micrograph.  
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Figure 3.15 HaSV VLPs do not have the ability to encapsidate transcribed P71 
mRNA and RNA2 in yeast. (A) Northern analysis of total RNA extracted from cells 
expressing P71 with P17 mRNA or RNA2 in glucose–starvation medium for 48 
hours at 28ºC probed for (+) RNA2. (B) Northern analysis of RNA extracted from 
VLPs which were purified through a 10-40% sucrose gradient from cells expressing 
P71 with or without viral RNA (P17 mRNA/RNA2) probed for (+) RNA2 as 
indicated above. 
 
Next, RNA was extracted from 7 µg of VLPs purified from each experimental 
system and probed for the presence of the HaSV P71 coding sequence, using a 
negative sense RNA2 probe corresponding to nucleotides 2309-766 of the P71 
coding sequence (Appendix 2, Figure A2.2). No HaSV RNA was detected in any of 
the VLPs purified from the yeast expression systems (Figure 3.15, B, lanes 1-3). 
Only the positive control was detected, which represented 42 ng of genomic RNA 
extracted from 2.45×1011 particles (Figure 3.15, B, lane 4). Approximately 1.5 µg of 
RNA was loaded from each VLP preparation, which represented RNA from 
1.75×1011 particles. So if the amount of viral RNA required for detection by 
Northern analysis was 42 ng, then less than 2.8% of the total RNA from each viral 
RNA preparation (expressing RNA2 and P71) represented viral RNA. This would 
indicate that less than 4.38×109 particles encapsidated RNA2 or mRNA. If 
approximately half of the particles purified from cells expressing P71 and viral RNA 
represented wild-type HaSV (approximately 50% of particles had a diameter of 38 
nm), and its assumed that these particles encapsidated viral RNA only, then less than 
2.2 ×109 particles contained viral RNA. These results indicated that the majority of 
the RNA species encapsidated by the VLPs represented cellular RNA. This data 
indicates that the VLPs produced in yeast do not encapsidate viral RNA specifically.  
 
  
75 
2.6
1.9
1.3
3.6
H
a
SV
24 48
RNA2
mRNA
A B
1 2 3 4 5
RNA2
H
a
SV
1 2 3 4
2.6
3.6
m
R
N
A
m
R
N
A
R
N
A2
-
R
N
A
R
N
A2
m
R
N
A
R
N
A2
H
a
SV
H
a
SV
m
R
N
A
m
R
N
A
R
N
A2
-
R
N
A
R
N
A2
m
R
N
A
R
N
A2
 
 76
3.4 DISCUSSION 
Viral RNA was thought to play a crucial role in the assembly of omegatetraviruses as 
genomic RNA has been shown to be an essential component of the inner capsid shell 
in other RNA viruses (Fisher and Johnson, 1993; Tang et al., 2001). NωV and HaSV 
have been shown to package their own mRNA by a replication-independent 
mechanism and the authors hypothesised that the message contained encapsidation 
signals (Agrawal and Johnson, 1995; Gordon et al., 2001). Similarly it was believed 
that viral RNA was the rate-limiting component during assembly. It was expected 
that the HaSV VLPs would specifically encapsidate viral RNA in the yeast cells. To 
answer this question P71 was co-expressed with viral RNA. 
  
3.4.1 Viral RNA and VLP assembly 
Data presented in this chapter shows that efficient VLP assembly in yeast cells 
requires a threshold concentration of p71. The increase in p71 levels detected in 
crude cell extracts when viral RNA was expressed with medium-level P71 indicated 
that the RNA might offer p71 limited stability. In some way the RNA may play a 
role in protecting p71 from proteolytic degradation in vitro, prehaps by increasing the 
solubility of p71. This was shown to be true when high levels of both RNA2 and P71 
were co-expressed. The eventual disappearance of p71 however suggested that the 
protein was degraded by proteolysis. A more logical argument was that the increased 
levels of RNA expressed caused a shock response in the cells. This would cause the 
expression of a toxic response, which would improve the folding of p71, making it 
more soluble.  
 
Expression of high-level P71 and P71 mRNA appeared to improve the assembly of 
the VLPs. The spontaneous maturation of p71 in this system indicated that high-
levels of viral RNA might induce apoptosis through the increased metabolic load of 
expressing two genes within the same cell. The continued presence of p71 even after 
VLP purification indicated that the p71 which remained, had assembled. The 
inability of the particles to mature indicated that they may require an acidic pH. In 
vivo maturation with acetic acid successfully matured the remaining p71. The levels 
of p64 detected were similar when increased levels or no additional viral RNA was 
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expressed. This indicated that the viral RNA ultimately had no effect on the 
efficiency of assembly of the VLPs. This result substantiates the previous 
observation that chaperone proteins (elicited by a shock response imposed by 
expression of additional RNA) enabled improved protein folding which led to the 
increased stability (Santoro, 1996).  
 
The fact that the VLPs did not encapsidate either mRNA or RNA2 indicate that the 
packaging mechanism of the VLPs was random. It appeared that the VLPs had the 
ability to assemble without any detectable viral RNA. This indicates that the particles 
must have encapsidated cellular RNAs as omegatetraviruses and nodaviruses do not 
form empty particles devoid of RNA (Fisher and Johnson, 1993; Agrawal and 
Johnson, 1995). This result contradicts those of Agrawal and Johnson (1995), who 
reported that baculoviral-derived NωV VLPs encapsidated P70 mRNA. The 
concentrations of viral RNA produced in yeast may have been insufficient for 
encapsidation of their RNA. Considering that baculoviral expression of heterologous 
proteins may represent a 3-fold increase in expression levels when compared to yeast 
expression using PGADH (Cousens et al., 1987; Miller, 1988). This could be one 
possible reason why the capsid encoding sequence of NωV was encapsidated in 
baculoviral-derived VLPs (Agrawal and Johnson, 1995).  
 
In the absence of replicating RNA the HaSV VLPs may encapsidate random RNAs. 
Replication-dependent encapsidation is required in FHV (Venter et al., 2005; Venter 
and Schneemann, 2007). In the absence of replication the FHV VLPs encapsidate 
cellular RNA (Venter and Schneemann, 2007). This requirement for replication 
competent transcripts ensures that the RNA and capsid subints are in association with 
one another (Venter et al., 2005). The omegatetraviruses may co-package their 
genome, like the nodaviruses (Schneemann et al., 1994; Krishna and Schneemann, 
1999). In the absence of RNA1, RNA2 may not be packaged.  
 
Another possibility is that the additional 5’ extension on the RNA2 may have 
interfered with its ability to be encapsidated. The exact transcriptional start of the 
hybrid promoter used for the expression of high-level HaSV RNA2 is unknown. It is 
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possible that a number of additional nucleotides exist at the 5’ end of the mRNA, 
which could interfere with viral RNA encapsidation.  
 
3.4.2 VLP morphology 
TEM analysis revealed that the there was a wide distribution of VLP sizes in the 
presence or absence of viral RNA. A significantly higher proportion of VLPs with a 
diameter of 38 nm in size (which correspond to wild-type virus particles) were 
detected when additional viral RNA was expressed with P71 compared to when no 
additional RNA was expressed with P71. In contrast the majority of particles (39%) 
purified from the control (expression of P71 alone) were 32 nm in diameter. In some 
instances the particles appeared to be aberrant, which could have been as a 
consequence of these particles failing to encapsidate RNA. This RNA is believed to 
stabilise the interior of the particle (Munshi et al., 1996; Helgstrand et al., 2004). The 
distribution of particle sizes may be a result of mismaturation (Taylor, 2003) as a 
result of the particles encapsidating random RNAs. Therefore, it is possible that the 
RNA may dictate the overall assembled intermediate and the way in which the 
particles mature. 
 
The formation of T=1 particles has been elucidated by the cryoEM reconstruction of 
baculovirus-derived HaSV VLPs purified at pH of 6.0 (Taylor, 2003). These 
particles were missing their γ–peptide and thus only bent contacts could form 
between the subunits. This would dictate that they only had the ability to form the 
T=1 arrangement. In addition the interior of these particles contained disordered 
RNA. In contrast, cryoEM image reconstruction of HaSV T=4 particles purified at 
pH 5.0 revealed that RNA forms a highly ordered structure. This is similar to the 
scenario in PaV particles (Tang et al., 2001; Taylor, 2003). The structure of HaSV 
procapsids at pH 7.6 and the subsequent transition to mature capsids at pH 5.0 was 
almost identical to the model elucidated for NωV VLPs by Canady et al. (2000). 
Taylor (2003) also purified an intermediate particle (like NωV), which did not 
represent procapsids or mature capsids. It is possible that both the T=1 and larger 
intermediate particles were purified in this study. The T=1 particles had a diameter of 
24 nm (Taylor, 2003), which could represent the VLPs purified when no additional 
viral RNA was co-expressed with P71. 
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A similar result was obtained for the T=4 Aura virus (AV) and T=3 Brome mosaic 
virus (BMV), where formation of the particles was a direct consequence of the type 
of RNA encapsidated (Krol et al., 1999; Zhang et al., 2002). In the case of BMV, the 
T=3 quasi-equivalent symmetry of wild-type BMV was achieved when genomic 
RNA was packaged. BMV particles which encapsidated random mRNAs formed 
particles with a T =2 quasi-equivalent symmetry. The viral RNA was hypothesised to 
nucleate the capsid subunits which are only associated through weak hydrophobic 
interactions when viral RNA was not present (Krol et al., 1999). Similarly, Hepatitis 
B virus forms T=3 and T=4 particles under certain conditions and bromoviruses have 
been shown to form T=1 and even larger T=4 or T=7 particles (Lane, 1981; Zlotnick 
et al., 1996). These larger T=7 particles have also been shown to form in 
bacteriophage P22 particles (Thuman–Commike et al., 1998). So in terms of this 
study, the different sized particles most likely represent particles with different quasi-
equivalent symmetries. The large distribution of particles could represent T=1, T=2, 
T=3 and T=7 symmetry, where the structure of the particle was dictated by the RNA 
they encapsidated.  
 
 The high–levels of p71 produced from the hybrid promoter ensure that there was an 
abundance of subunits in association with one another. An acidic pH has been shown 
to drive the maturation event in particles. It seems that the symmetry of these 
particles may be tightly regulated by the RNA they encapsidate and a certain 
complement or size of encapsidated RNA ensures formation of particles with a T=4 
conformation. In essence the acidic pH forces the particles to mature even if they are 
assembled in a different way to wild-type virions. 
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CHAPTER 4.  EXPLOITING THE POTENTIAL OF 
NODAVIRAL REPLICATION SYSTEMS FOR THE 
ASSEMBLY OF OMEGATETRAVIRUS VLPs 
 
4.1 INTRODUCTION 
The inability of the virus particles to encapsidate viral RNA may be a consequence 
of the insufficient RNA levels produced by transcription. The virus particles may 
require a replication-dependent encapsidation mechanism to specifically package 
viral RNA. Replication would ensure that the RNA and capsid protein are present at 
high concentrations in the vicinity of one another.  
 
In Chapter 3, it was shown that HaSV VLPs assembled in yeast cells did not 
specifically encapsidate capsid mRNA or HaSV RNA2. There are several potential 
explanations including: (1) the effect of small non-viral extensions at the 5' end of 
the RNA2 transcript; (2) RNA encapsidation requires the presence of a further factor 
such as, for example, a host factor (3) as in the nodaviruses, tetravirus RNA 
encapsidation is replication-dependent; (4) or as in the nodaviruses, the 
omegatetraviruses use a co-packaging mechanism where both RNA1 and RNA2 are 
required for viral RNA packaging. 
 
The nodaviruses are infectious and replicate their genomes in a wide variety of cells 
which include insects, plants, mammals and yeast (Scotti et al., 1983; Selling et al., 
1990; Ball et al., 1992; Price et al., 1996; 2005).  In yeast, the levels of replicating 
RNA produced approach the levels of ribosomal RNA and the levels of FHV RNA1 
and RNA3 replicated in yeast can represent as many as 32 000 and 120 000 copies 
per cell respectively (Price et al., 1996; 2005). The relative ratios of the RNA 
molecules replicated are similar to what was reported for Drosophila cells (Price et 
al., 1996; 2000). The ability of FHV and NoV to produce very high levels of RNA 
during replication in yeast has been exploited to produce heterologous proteins (Price 
et al., 2002; 2005). Unlike RNA1, the only regions important for FHV RNA2 
synthesis appear to be within the first 14 nucleotides, the last 50 to 60 nucleotides 
and an internal region between nucleotides 538 and 616 (Ball and Li, 1993; Ball et 
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al., 1994). Price et al., (2005) showed that nucleotides 53 to 423 were dispensable for 
NoV RNA2 replication. Thus, as long as these sequences are present, heterologous 
sequences inserted into the FHV or NoV RNA2 will be replicated by the viral 
replicase (Price et al., 2002; 2005) By fusing the HIS3 gene to the first 11 amino 
acids of the capsid-encoding sequence of FHV and NoV in RNA2, the growth of the 
yeast strain in the absence of histidine was dependent on the RNA molecule being 
replicated by the viral replicase (Price et al., 2002; 2005). A similar result was 
obtained by constructing a RNA2-based replicon for the replication-dependent 
synthesis of URA2 (Price et al., 2002).  
 
Dorrington et al. (2007) explored the possibility of using these nodavirus replication 
systems to replicate HaSV and NωV capsid-encoding sequences in yeast cells. The 
FHV and NoV capsid-encoding sequences were replaced with the capsid-encoding 
sequence of either HaSV or NωV while retaining the 5’ and 3’ ends of RNA2 
required for nodavirus RNA1-dependent replication (Figure 4.1). The GAL1 
promoter, for which the transcription start is well characterised (Johnson and Davis, 
1984), and the Hepatitis delta virus (HDV) ribozyme were used to ensure the 
transcripts carried the correct 5' and 3' ends, respectively. 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 Schematic representation of the recombinant system designed for NoV-
based replication of NωV P70 designed by Dorrington et al. (2007). The capsid 
encoding sequences, P70, was fused upstream from the first 14 nucleotides and 
downstream from either the last 287 (14) or 865 (2) nucleotides of NoV RNA2, 
replacing the NoV VCAP. (2) and (14) are related to the Northern blot (Figure 4.2) 
indicating constructs with the last 287 or 865 nucleotides of NoV RNA2 upstream 
from NωV P70.  
 
(2) 865 nt
(14) 287 nt
AUG
NoV RNA2, 1336 nt
NoV Protein a
NωV   VCAP (p70) NωV  (2) 
AUG
AUG
NoV 
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The replication system of FHV has been one of the most excessively studied ss (+) 
RNA virus. For this reason Dorrington et al. (2007) wanted to determine if the FHV 
RNA1-derived RdRp had the ability to replicate the FHV RNA2-HaSV (P71) or 
NωV (P71) chimeras in vivo. The levels of positive sense RNA2 detected from both 
chimeras were low, with higher levels of the NoV RNA2-based P70 chimera being 
detected when compared to the P71 construct (Figure 4.2). The levels of positive 
sense RNA2 detected for the positive control were significantly higher than the two 
RNA2 chimeras (Figure 4.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2 Northern blot analysis of transcription-derived FHV and NoV RNA2 
replication in yeast cells. The blots were either probed for positive (+RNA2) or 
negative (-RNA2) sense FHV/NoV RNA2 from plasmid-initiated RNA2 replication 
as indicated. RNA from yeast cells expressing either wild-type FHV or NoV RNA1 
(R1) in conjunction with either wild-type FHV or NoV RNA2 (R2) or a HaSV or 
NωV capsid precursor RNA2 chimera (R2-P71 or R2-P70 respectively) are shown. 
The solid and open arrows indicate the relative positions of +/- sense wild-type 
RNA2 or the +/- sense NoV RNA2NωV/HaSV chimera respectively. The primary 
transcripts that have not been cleaved by the HDV ribozyme are also shown. The 
shortened FHV RNA2 chimeric replication products generated by the FHV replicase 
are shown  (Dorrington et al., 2007).  
 
It appeared that the chimeras were being replicated inefficiently. A high 
concentration of truncated products were detected (Figure 4.2), indicating that the 
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FHV RdRp constantly produced shortened transcripts. This indicated that the P71 
and P70 genes were not compatible with the FHV RdRp.  There was some evidence 
that negative sense RNA2 could be detected for the two chimeras, indicating that the 
RNAs had the ability to replicate in the yeast cells. 
 
The production of truncated replication products led Dorrington et al. (2007) to 
determine whether the NoV replication system would efficiently replicate 
omegatetravirus capsid-encoding sequences. The observation that higher levels of the 
NωV-based RNA2 chimera were replicated when compared to the HaSV-based 
RNA2 chimera, led to the investigation of possibility using the NoV replication 
system for NωV P70 only (Figure 4.2). Two NωV constructs were investigated for 
their potential to be replicated by the NoV RNA1-dependent replicase. The 
constructs contained the first 18 nucleotides of the NoV RNA2 5’ sequence, followed 
by the NωV P70 sequence downstream from either the last 865 nucleotides (2) or 
287 nucleotides (14) of NoV RNA2 (Figure 4.1). Positive and negative sense RNA2 
were detected for both chimeras. The presence of the negative strands indicated that 
both constructs were replicating in vivo (Figure 4.2). No truncated RNA products 
were observed suggesting that the NoV replication system was compatible with the 
NoV RNA1-dependent replicase. In addition, the NoV replication system had the 
ability to replicate an RNA2-based chimera containing the P70 cDNA. 
 
This chapter describes a NoV replication system for the de novo synthesis of 
omegatetravirus VLPs with the aim of determining if replication results in the 
specific encapsidation of viral RNA. 
 
4.2 MATERIALS AND METHODS 
 
4.2.1 Microbial strains and culture conditions 
 Yeast strain INVScI was used for PGADH-derived P70 expression. Yeast strain 
BY4733 (Matα, his3∆200, leu2∆0, met15∆0, trp1∆63, ura3∆0) (Brachmann et al., 
1998) was used for the PGAL1-derived expression of NoV RNA1, NoV RNA2 and the 
NoV RNA2-NωV P70 chimera. Strain INVScI was maintained on SMM    
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(Appendix 6) agar (1.5%) with 0.002% histidine, 0.002% tryptophan, 0.01% leucine 
(Sigma) and 2% glucose (volume/volume) to select for pMT13 (section 4.4), which 
carries a URA3 auxotrophic marker (Kaiser et al., 1994). Strain BY4733 was 
maintained on SMM agar (1.5%) with 0.002% histidine, 0.002% uracil, 0.002% 
methionine (Sigma) and 2% glucose (volume/volume) to select for plasmids with 
LEU2 and TRP1 auxotrophic markers. Transformations, patching of colonies and the 
method of inoculation into liquid media were performed as described in Section 
2.2.5. 
 
4.2.2 Yeast expression constructs 
Expression plasmids used in this study are listed in Table 4.1. Plasmid TpGN1 
carries the complete NoV RNA1 encoding the replicase gene cloned into the vector 
Tp with a TRP1 selectable marker (Figure 4.3). Plasmid LpGN2 encodes the 
complete NoV RNA2 cloned into the vector Lp with a LEU2 selectable marker 
(Figure 4.3).  
 
Table 4.1 Characteristics of expression constructs used in this chapter.   
Plasmid 
Name 
Yeast 
Origin of 
replication 
Selectable 
Marker 
Promoter cDNA Reference 
TpGN1 2µ  TRP1 PGAL1 NoV 
RNA1 
Price et al., 
2005 
LpGN2 2µ  LEU2 PGAL1 NoV 
RNA2 
Price et al., 
2005 
LpGNωV 2µ  LEU2 PGAL1 NoV 
RNA2-
NωV P70 
chimera 
Dorrington et 
al., 2007 
pMT13 2µ  URA3 PGADH NωV P70 This study 
 
The NωV P70 coding sequence was expressed from pMT13. The plasmid LpGNωV 
contains the NωV capsid coding sequence flanked by the first 18 nucleotides of NoV 
RNA2 at the 5’ end and the last 865 nucleotides of NoV RNA2 at the 3’ end (Figure 
4.3).  
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Figure 4.3 Diagrammatic representation of plasmids TpGN1, LpGN2 and LpGNωV 
used for the expression of NoV RNA1, NoV RNA2 and a NoV RNA2-NωV P70 
chimera respectively. The vectors contain a LEU2 or TRP1 auxotrophic marker and 
all vectors contain a Hepatitis delta virus ribozyme (HDV ribozyme) for production 
of authentic 3’ ends and a gene encoding a β-lactamase enzyme for ampicillin 
resistance (AMP-R).   
 
 
 
LpGN2
8002 bp
PGAL1
NoV RNA2
LEU2
AMP-R
HDV Ribozyme
2u ORI
Cla I (3404)
Pst I (8002)
Sma I (1430)
Xma I (1428)
Ava I (1428)
Ava I (4255)
Apa LI (4951)
Apa LI (5448)
Apa LI (6694)
EcoR I (2917)
EcoR I (7364)
EcoR I (7376)
ATAAAAGTACTGCAGTAAACAAC
TATTTTCATGACGTCATTTGTTG
PGAL1 NoV RNA2Pst I
ATAAAAGTACTGCAGTATTGAAT
TATTTTCATGACGTCATAACTTA
PGAL1 NoV RNA1Pst I
TpGN1
9009 bp
TRP1
NoV RNA1
AMP-R
2u ORI
HDV Ribozyme
PGAL1
BamH I (2849)
Hind III (8372) Nco I (839)
Pst I (1)
EcoR I (979)
EcoR I (8384) Cla I (549)
Cla I (2082)
Cla I (2349)
Cla I (5238)
AAGTACTGCAGTAAACAACCAATAACACCATGGACATG
TTCATGACGTCATTTGTTGGTTATTGTGGTACCTGTAC
PstI NcoI
NoV RNA2 5’PGAL1 3’ NωV P70 5’
AACAATAATGCTAATGTCAC
TTGTTATTACGATTACAGTG
NoV RNA2 3’NωV P70 3’
LpGNwV
9482 bp
NoV RNA2 3'
PGAL1
NoV RNA2 5'
AMP- R
LEU2
NwV P70
2u ORI
HDV Ribozyme
NoV VCAP 3'
Cla I (4867)
Nco I (1)
Pst I (9465)
EcoR I (219)
EcoR I (4380)
EcoR I (8827)
EcoR I (8839)
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4.2.3 Construction of NωV P70 expression vector, pMT13 
Plasmid pFBωIIILG, which carries the P70-encoding cDNA sequence (du Plessis et 
al., 2005), was used to construct the P70 expression vector pMT13.  A 1448 bp Bam 
HI / Sma I fragment was excised from pFBIIILG1, representing the first 1440 
nucleotides of the NωV P70 coding sequence, was inserted into the same restriction 
sites of pAV16MT, generating pMT10 (Figure 4.4, Step I). The 236 bp sequence 
between the GAPDH translational start and the translational start of p70, was deleted 
by reverse PCR inserting an optimal Kozak sequence for efficient translational using 
primers MT5 (Appendix 4; Table A4.1) and MT2 (Appendix 4; Table A4.1) (Figure 
4.4, Step II). A 762 bp Bcl I / Eco RI fragment from the resulting plasmid (pMT11), 
was inserted into pMT4 (Figure 4.4, Step III).  Next, a 1889 bp Eco RI / Xho I 
fragment representing the remainder of the P70 coding sequence was inserted into 
pMT12, generating pMT13 (Figure 4.4, Step IV). The expression construct pMT13 is 
a multicopy vector for the PGADH-derived expression of P70 and carries a URA3 
auxotrophic marker. 
 
4.2.4 P70 expression 
INVScI cells were transformed with pMT4 or pMT13 and plated onto SMM agar 
(1.5%) with 0.002% histidine, 0.002% tryptophan, 0.01% leucine and 2% glucose. 
The transformants were incubated at 28°C for 3 days and patched as indicated 
before. Patched cells were re-suspended into a small volume of dddH2O and 
inoculated into SMM with 0.002% histidine, 0.002% tryptophan, 0.01% leucine, 
0.1% glucose and 5% glycerol at an OD600nm of 0.1. The culture was initially 
incubated at 28°C for 12 hours. Ethanol was then added to a final concentration of 
3% or no additional carbon source was added (carbon-limiting). The culture was 
incubated at 28°C and p70 expression monitored by removing two OD600nm units of 
culture at specific intervals. Total yeast lysates were prepared as indicated before 
(section 2.2.6) for Western analysis and all blots were probed with anti-NωV 
antibodies. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 Diagrammatic representation of the construction of the NωV P70 expression vector, pMT13. The restriction enzymes utilized for each cloning step are 
highlighted in bold font and the steps followed represented by Roman numerals. The 5’ end of the ADH2 promoter and 5’end of the GAPDH untranslated region are 
represented by ADH2 5’ and GAPDH respectively. NωV P70 refers to the capsid encoding sequence for NωV and AMP-R refers to a gene that encodes a β-
lactamase enzyme for ampicillin resistance. 
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Apa LI (848)
Apa LI (2874)
Apa LI (4120)
Ava I (1439)
Ava I (2107)Ava I (6253)
Pst I (2104)
Pst I (5160)
Pst I (5648)
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4.2.5 Transcription–dependent NoV replication of a NoV RNA2-NωV P70 
chimera. 
BY4733 cells were co-transformed with TpGN1 (NoV RNA1) and either LpGN2 (NoV 
RNA2), LpGNωV (NoV RNA2-NωVP70 chimera) or Tp. The transformants were 
plated onto SMM agar (1.5%) with 0.002% histidine, 0.002% methionine, 0.002% uracil 
and 2% glucose. The plates were incubated at 28°C for 3 days and patched as described 
before. Patched cells were re-suspended in a small volume of sterile dddH2O and 
inoculated into SMM with 0.002% histidine, 0.002% methionine, 0.002% uracil, 0.1% 
glucose and 2% galactose at an OD600nm of 0.1. The cells were incubated at 28°C and 
p71 production monitored by removing two OD600nm units of culture at 24 hours and 48 
hours incubation. Total and soluble yeast lysates were prepared as discussed previously 
(section 2.2.6) for Western analysis. Blots were probed with anti-NωV antibodies 
obtained from Professor Donald Hendry (Department of Microbiology, Biochemistry 
and Biotechnology, Rhodes University). 
 
4.2.6 Northern analysis. 
Total yeast RNA was purified from ten OD600nm units of cell culture using a hot phenol 
method described by Leeds et al., (1991) (section 3.2.4). RNA was purified from 
sucrose gradient purified NωV VLPs using the RNAgents kit (Promega) according to 
the manufacturer’s instructions.  
 
Strand-specific 32P-ATP-labeled RNA probes were generated by in vitro transcription of 
a PCR product containing bacteriophage RNA polymerase T7/SP6 using the 
Riboprobe kit (Promega) (Price et al., 2005). The appropriate sense NoV RNA1 and 
RNA2 probes corresponded to nucleotides 2732 to 3204 and nucleotides 1100 to 1336 
respectively (Price et al., 2005). To synthesise the negative sense NωV RNA2 probe 
plasmid pCW17R (Cheryl Walter, Rhodes University, Figure 4.5) was linearised with 
Nco I and transcribed by in vitro transcription with [α-32P]-CTP using SP6 RNA 
polymerase (Riboprobe kit, Promega). Excess radioisotopes, dNTPs and salts were 
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removed using the QIAquick PCR Purification Kit (Qiagen). The purified total yeast 
RNA or RNA purified from the VLPs was resolved on a 1% agarose gel containing 2% 
formaldehyde at 120 volts for approximately 2.5 hours in 1 × MOPS buffer. After 
electrophoresis the RNA was transferred by capillary transfer to a Hybond N+ nylon 
membrane (Amersham) in 20 × SSC buffer (Appendix 7, A7.3). The membrane was 
briefly rinsed in 2 × SSC and then baked at 80°C for 2 hours. After incubation the 
membrane was place in a hybridisation bottle to which pre-heated (65°C) hybridization 
solution (Appendix 7, A7.3) was added and the membrane allowed to pre-hybridise at 
60°C for 4 hours with rotation. The solution was poured off and fresh pre-warmed 
hybridisation solution added, which contained 2 × 106 cpm of radiolabelled probe. 
Hybridisation was allowed to proceed overnight with rotation at 60°C. After incubation 
the membrane was briefly rinsed in wash buffer (0.2% SSC and 0.2% SDS) at room 
temperature and then washed twice at 65°C for 2 to 4 hours. The membrane was dried 
with 3MM Watmann, wrapped in cling wrap and exposed to a Phosphor storage screen 
(Amersham Biosciences). The image on the screen was processed using a Molecular 
Dynamics PhosphorImager and quantitated using ImageQuant software (Amersham 
Biosciences).
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 Diagrammatic representation of pCW17R  which was used to generate the 
NωV RNA2 negative sense RNA probe. The vector was generated by inserting a PCR 
fragment, which included the entire NωV RNA2 sequence, into pGEM-T Easy 
(Promega). The resultant plasmid contains the entire NωV RNA2 cDNA flanked by 
bacteriophage RNA polymerase T7 and SP6. Plasmid pCW17R confers resistance to 
ampicillin (AMP-R) for selection in E. coli.    
pCW 17 R
4947 bp
AMP-R
NwV P70
T7
SP6
Ava I (1499)
Nco I (38)
Pst I (2021)
Sma  I (1501)
Xma I (1499)
Apa I (15)
Nsi I (2060)
Apa LI (908)
Apa LI (2764)
Apa LI (4010)
EcoR I (53)
EcoR I (278)
EcoR I (2003)
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4.2.7 Purification of NωV-like particles from infected N. capensis larvae 
Virus particles were purified from N. capensis larvae collected in 2002 from the Western 
Province of South Africa according to a protocol described by Morris et al. (1979). 
Approximately 250 g of larvae were homogenised in 3.3 volumes (weight/volume) of 
ice-cold larval homogenisation buffer (LHB) [0.2% β-mercaptoethanol 
(volume/volume), 0.5 M Tris-Cl (pH 7.5), 0.01 M Na2EDTA (pH 8.0) and 250 mL    
butan-1-ol (volume/volume)] at 4°C. The supernatant was clarified by centrifugation at            
8000 rpm for 15 minutes at 4°C in a Beckman JA-10 rotor. The pellet was re-extracted 
as indicated above and the supernatants pooled. The volume of the clarified supernatant 
was measured, 8% polyethyleneglycol (PEG) 6000 (weight/volume) and 0.1 M NaCl 
added and the mixture stirred at room temperature for 1 hour. The proteins in the 
supernatant were allowed to precipitate at 4°C for 3 hours and collected by 
centrifugation at 8000 rpm for 15 minutes at 4°C in a Beckman JA-10 rotor. The 
supernatant was discarded and the pellet re-suspended in one-tenth volume 
(volume/volume), which represented the volume of the original homogenate in             
0.1 M Tris-EDTA (pH 7.5). The protein suspension was centrifuged at 8000 rpm for    
10 minutes at 4°C in a Beckman JA-20 rotor to remove any insoluble proteins. The 
supernatant was then layered onto 2 mL of 30% sucrose [prepared in EB (50 mM     
Tris-Cl (pH 7.5), 250 mM NaCl)] and centrifuged at 40000 rpm in a SW-28 rotor at 
11°C for one hour and fifteen minutes. The supernatant was discarded and pellet allowed 
to re-suspended in 500 µL of EB at 4°C overnight. 
 
4.3 RESULTS 
In the previous chapters it was found that HaSV VLPs assembled in yeast encapsidated 
no viral RNA. One possible explanation for this was RNA encapsidation is replication-
dependent. It was hypothesised that viral replication allowed for replicated RNA and 
capsid assembly to occur in close proximity within the site of replication. This would 
enable higher levels of viral RNA encapsidation by the VLPs. An in vivo replication 
system is not available for the omegatetraviruses, as they are not infectious in tissue 
 92
culture. It was therefore decided to explore the possibility of using a yeast-based 
replication system based upon the nodavirus NoV to determine whether proximity of the 
capsid protein and RNA would result in specific viral RNA encapsidation.  
 
4.3.1 Assembly of NωV VLPs in yeast 
Agrawal and Johnson (1995) showed that the expression of the capsid-encoding 
sequence of NωV using a baculoviral expression system allowed p70 to assemble and 
mature into VLPs. VLPs produced by this highly productive system were used by 
Canady et al. (2000; 2001) and Taylor et al. (2002) for detailed analysis of the process 
of procapsid maturation. The first step was to confirm the assembly of NωV VLPs in 
yeast cells expressing P70 (the NωV capsid protein precursor-encoding gene). The 
expression vector pMT13 was constructed, in which the NωV P70 coding sequence was 
fused to the translational start of the GAPDH gene.  This plasmid was transformed into 
yeast cells and expression of P70 was induced by carbon-limitation or induction with 
ethanol.   
 
Western analysis of cell-free extracts showed the presence of p70 even at the time of 
induction (Figure 4.6, A, lanes 2 and 3).  After 2 hours, a band co-migrating with the 
wild-type NωV capsid protein, p62, was detected suggesting that as with HaSV, NωV 
VLPs might be undergoing spontaneous maturation in vivo (Figure 4.6, A, lanes 5, 6, 8 
and 9 as compared with lane 10). There was no apparent difference in the levels of p70 
and p64 in cells grown in carbon-limiting medium versus those induced with ethanol 
(Figure 4.6, A, lane 8 vs. lane 9).  As with HaSV, the proportion of p70 versus p62 
appeared to be approximately equal, suggesting that VLP assembly was not as efficient 
as in virus-infected cells. To confirm that p70 and p62 detected by Western analysis 
represents assembled procapsids and mature capsids respectively, VLPs were purified 
from cells expressing PGADH-derived P70 in carbon-limiting medium for 16 hours. TEM 
analysis confirmed that the predominant type of particle purified represented wild-type 
NωV with a mean diameter of 40 nm (Figure 4.6, B).  
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Figure 4.6 Assembly of NωV VLPs in yeast. (A) Western analysis of total yeast lysates 
from cells containing pMT4 or pMT13 initially incubated in SMM with 0.1% glucose 
and 5% glycerol for 12 hours at 28°C. Ethanol was then added to a final concentration of 
3% (EtOH) or no additional carbon source was added (Gluc, -ve; carbon-limiting) to the 
media. Arrows indicate the relative positions of proteins migrating at 70 kDa and 62 kDa 
and NωV represents wild-type NωV used as a positive control. (B) TEM analysis of 
VLPs (NωV VLPs) or wild-type NωV (wt NωV) purified by sucrose gradient 
ultracentrifugation from cells expressing P70 incubated in carbon-limiting media for 16 
hours at 28°C. The bar represents 50nm. 
 
4.3.2 Transcription–dependent NoV replication of the NoV RNA2-NωV P70 
chimera in yeast. 
Having established that NωV VLPs were able to assemble and mature in yeast cells, the 
next step was to confirm the results of Dorrington et al. (2007) with respect to 
replication of an NoV RNA2-NωV P70 chimera in yeast cells. The plasmid LpGNωV, 
(Figure 4.3), constructed by Kyle Johnson (University of Alabama at Birmingham) was 
designed such that the NωV P70 coding sequence was flanked at the 5’ end by the first 
18 nucleotides and at the 3’ end by the last 865 nucleotides of NoV RNA2. The 
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minimum sequences required for replication of RNA2 by the NoV replicase were 
retained.  The coding sequence for the NoV RNA2-NωV P70 chimera was flanked by 
the GAL1 promoter and the HDV ribozyme such that the 5' and 3' ends of the transcript 
would be authentic relative to NoV RNA2.  LpGNωV was transformed into yeast cells 
together with TpGN1 (expressing the NoV RNA1 encoding the viral replicase). 
Expression of RNA1 and the NoV RNA2-NωV P70 chimera was induced by growing 
the cells in medium containing galactose.  RNA was extracted from the cells and probed 
by Northern analysis for the presence of (+) and (-) sense RNA2. The (+) sense NoV 
RNA2-NωV P70 chimera (2899 nucleotides) could be detected 24 hours after induction 
with an approximately two-fold increase detected after 48 hours (Figure 4.7 compare 
lane 8 to 7). In addition, the mRNA transcript, which acted as a template for replication 
and migrated at a slower rate than the replicated RNA was also detected (Figure 4.7).  
The smaller size of the replicated RNA when compared to mRNA is due to the activity 
of the HDV ribozyme which cleaves downstream of the 3' end of the NoV RNA2 
sequence to remove the terminator and poly (A) tail of the transcript.   
 
Only the NoV RNA2-NωV P70 mRNA sequence was detected in the absence of the 
NoV replicase and there was no negative transcript due to the absence of replication 
(Figure 4.7, lanes 3, 11 and 12). The (-) NoV RNA2-NωV P70 chimera was detected in 
cells with TpGN1 and LpGNωV (Figure 4.7, lanes 9 and 10). In contrast no (-) NoV 
RNA2-NωV P70 chimera could be detected in cells without the NoV replicase (Figure 
4.7, lanes 11 and 12). As expected, the NoV RNA2-NωV P70 chimera mRNA was not 
detected. This confirmed that the NoV RNA2-NωV P70 chimera was being replicated 
by the NoV replicase. This experiment also showed that substantially higher levels of 
the NωV P70-encoding RNA was present in cells as a result of replication when 
compared to the level of mRNA produced by transcription (Figure 4.7, compare lanes 17 
and 18 with 21 and 22). 
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Figure 4.7 Northern blot hybridisation analysis of plasmid–initiated NoV RNA2 
replication in yeast cells. NoV R2+, NoV R2- and NωV p70 indicate Northern blot 
hybridisations to positive (+) and negative (-) sense RNAs as indicated. Total yeast RNA 
was extracted using a hot phenol method from cells induced for expression of NoV 
RNA1 (R1; TpGN1), NoV RNA2 (R2; LpGN2), NωV P70 (p70; pMT13) or an NoV 
RNA2-NωV P70 chimera (R2-p70; LpGNωV) as indicated using the GAL1 promoter 
for the induction times indicated. Solid arrowheads indicate the relative positions of the 
NoV RNA2-NωV P70 chimera and wild-type NoV RNA2, while open arrowheads 
indicate primary transcripts, which have not been cleaved by the HDV ribozyme. 
 
4.3.3 Expression of NωV P70 and assembly of NωV VLPs 
To determine whether the NωV P70 sequence encoded by the NoV RNA2-NωV P70 
chimera resulting from replication was translated, cell-free extracts were examined for 
the presence of p70. Western analysis of total and soluble yeast protein from cells which 
co-expressed the NoV RNA2-NωV P70 chimera (LpGNωV) and NoV RNA1 (TpGN1) 
showed the presence of p70 and p62 after 24 hours of incubation (Figure 4.8, lanes 1 and 
2). At 48 hours incubation an increase in the level of p70 and p62 were detected (Figure 
4.8, lanes 3 and 4). In cells expressing the NoV RNA2-NωV P70 chimera only (no 
replicase) both p70 and p62 were detected after 24 hours (Figure 4.8, lane 5). However, 
at 48 hours the level of p70 appeared to have substantially decreased (Figure 4.8, 
compare lanes 7 and 8 with lanes 5 and 6). The decreased levels of protein detected were 
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a result of the ceasing of transcription from the GAL1 promoter after a prolonged 
incubation time (Figure 4.7, compare lane 3 to 4). In contrast, the replication-dependent 
synthesis would ensure the continued translation of the protein resulting in the elevated 
levels detected. These results demonstrated that translation of p70 by a replication 
competent transcript produced more protein than transcription alone.  Furthermore, p70 
translated from replicated RNA was able to mature in vivo implying that the VLPs were 
assembled. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8 Replication-dependent assembly of NωV VLPs in vitro. Western analysis of 
total (i) and soluble (s) yeast lysates prepared from cells containing TpGN1 and 
LpGNωV (R1 + R2-p70) or LpGωV only (R2-p70), incubated in SMM with 0.1% 
glucose and 2% galactose for the times indicated at 28ºC. Arrows indicate protein 
migrating at the approximate molecular weighs of 70, 62 and 57 kDa. (+) refers to a 
virus which is serologically related to wild-type NωV (NωV-like).   
 
4.3.4 RNA encapsidation in NωV VLPs  
To determine whether the VLPs (formed from p70 translated from replicated RNA) 
encapsidated the NωV P70-encoding transcript, VLPs were purified from cells co-
expressing NoV RNA1 (TpGN1) and the NoV RNA2-NωV P70 chimera (LpGNωV) 
after 48 hours incubation as indicated before. To determine which species of RNAs were 
being encapsidated, RNA was purified from the VLPs and analysed. The RNA from the 
VLPs was compared to the RNA extracted from wild-type NoV particles. RNAs 
corresponding to NoV RNA1 and NoV RNA2 as well as an RNA1-RNA2 dimer (Ball, 
L.A personal communication) were detected from wild-type NoV particles (Figure 4.9, 
A, lane 2). In contrast, the NωV VLPs appeared to encapsidate RNA migrating at 
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approximately the same size as the NoV RNA1-RNA2 dimer. This suggested the 
presence of cellular RNAs in the VLPs rather than the replication-derived transcripts 
(Figure 4.9, A, lane 2). 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9 RNA encapsidation by NωV VLPs in yeast cells. VLPs were purified from 
cells co-expressing PGAL1–derived NoV RNA1 (TpGN1) and the NoV RNA2-NωV P70 
chimera (LpGNωV) incubated in SMM with 0.01% glucose and 2% galactose for 48hrs 
at 28°C. (A) Agarose gel electrophoresis of RNA purified from NωV VLPs and wild-
type NoV. The relative positions at which the genomic RNAs of NoV resolved on the 
agarose gel are indicated. Northern analysis of RNA purified from the NωV VLPs 
probed for positive sense NoV RNA1, NoV RNA3 (B) and NoV RNA2 (C). Solid 
arrowheads indicate the relative positions of NoV RNA1, NoV RNA2, NoV RNA3 and 
a NoV RNA1/RNA2 dimer. (+) represents NoV RNA and (-) in each case refers to mock 
RNA. 
 
The RNA purified from the VLPs was probed for positive sense NoV RNA1, NoV 
RNA3 and NoV RNA2. As expected, the Northern blot revealed the presence of all three 
RNAs in the positive control (Figure 4.9, B and C, lane 2). This however, was not the 
case for the NωV VLPs, where small amounts of NoV RNA1 and NoV RNA3 were 
detected, but no RNA corresponding to the NoV RNA2-NωV P70 chimera was 
observed (Figure 4.9, B and C, lane 1). The amount of RNA3 detected in the NωV VLPs 
was higher than RNA1. These results indicated that the VLPs randomly encapsidated 
RNA that was in abundance during assembly. This resulted in the VLPs encapsidating a 
mixture of viral and cellular RNAs. 
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4.4 DISCUSSION 
Price et al (1996; 2005) demonstrated that nodavirus replication systems could be 
applied to the synthesis of heterologous proteins. These viruses were also shown to 
replicate their genomes to high-levels in yeast cells. In addition the nodaviruses 
encapsidate their genomic RNA in a replication-dependent mechanism (Venter et al., 
2005). In the absence of replication, the virus particles encapsidate random cellular 
mRNAs (Venter et al., 2005; Venter and Schneemann, 2007). Replication-dependent 
encapsidation ensure that the viral RNA and capsid protein are in constant contact with 
one another (Venter et al., 2005). To mimic this situation during omegatetravirus 
assembly, a nodavirus replication system was developed for the de novo synthesis of 
NωV VLPs    
 
PGADH-derived expression of the capsid coding sequence of NωV (P70) in yeast resulted 
in the assembly of VLPs, which had the ability to mature in vivo. Similarly, the 
replication of a NoV RNA2-NωV P70 chimera resulted in translation of p70 and 
assembly of NωV VLPs that had the ability to mature. The relative levels of VLPs 
detected as a result of replication compared to transcription, showed that more VLPs 
were produced in the replication-dependent system. These results correlated with earlier 
observations for the assembly of HaSV VLPs where increased translation led to 
improved assembly. 
  
 
The ability of the VLPs to encapsidate nodaviral RNA1 and RNA3 but not the NoV 
RNA2-NωV P70 chimera suggested that RNA encapsidation by the NωV VLPs may be 
random and the RNAs most likely to be encapsidated are those that are the most 
prevalent.  Thus the NωV VLPs might package the NoV RNA because they are the most 
abundant RNAs in close proximity to the assembling particles. The absence of any 
detectable levels of the NoV RNA2-NωV P70 chimera in the NωV VLPs indicates that, 
as with co-expression of HaSV P71 mRNA, the 5’ and 3’ ends of the wild-type NωV 
RNA2 might encode encapsidation signals ensuring their specific encapsidation. This 
would imply that the NωV particle encapsidates the NoV genomic RNAs non-
specifically, in the same way as cellular RNAs. The encapsidation of the genomic RNA 
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in the omegatetraviruses may be co-packaged. In the absence of RNA1 or full length 
RNA2 the VLPs encapsidate RNA randomly. A system could be developed where full 
length NωV RNA1 and RNA2 chimeras were constructed that were flanked by the NoV 
RNA2 sequences required for NoV RNA1-dependent replication. In this way it may be 
possible to replicate NωV RNA1 and RNA2 by the NoV replicase.  
 
The hybrid NoV replication system is potentially useful as an alternative to the 
transcriptional production of omegatetravirus capsid protein precursor-encoding mRNA 
with the resulting assembly of VLPs. The system has however, no effect upon the ability 
of VLPs to specifically encapsidate tetraviral RNA. This implies that there are other 
factors involved in RNA encapsidation. 
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CHAPTER 5. GENERAL DISCUSSION AND 
CONCLUSIONS 
 
The principal aim of this thesis was to study the assembly of omegatetravirus particles in 
yeast focussing on the encapsidation of viral RNA.  Two different approaches were used 
to achieve this aim. Capsid precursor protein was translated from mRNA produced by 
transcription or capsid precursor protein was produced via replication. The first 
approach was based upon the experimental system developed by Venter (2001). The 
system was inefficient in terms of VLP assembly. This system was optimised by 
significantly increasing the expression of the capsid precursor protein. The second 
system relied upon the replication of a chimeric NoV RNA2-NωV P70 template 
encoding the NωV capsid precursor gene, by the replicase of NoV.   
 
5.1 ASSEMBLY OF HaSV AND NωV VLPS IN YEAST 
PGADH-derived expression of HaSV P71 resulted in higher levels of p71 compared to 
expression of HaSV P71 from PGAL1.  Both expression systems were able to support 
VLP assembly. However, the PGADH system was much more efficient and resulted in 
spontaneous maturation of VLPs in vivo. Similarly, expression of the NωV capsid 
encoding sequence (P70) with the hybrid promoter resulted in the assembly of VLPs. 
The assembly of the VLPs was more efficient but the equal proportion of p71 versus p64 
and p70 versus p62 detected in the cell free extracts suggested that a substantial 
proportion of the VLPs did not mature. The improved assembly of the VLPs was 
believed to be as a consequence of the elevated P71 mRNA concentrations transcribed 
from the hybrid promoter. TEM analysis of the particles isolated from yeast cells co-
expressing viral RNA revealed that there was a large distribution in VLPs size and 
morphology. The large distribution of particles observed by acetic acid maturation as 
opposed to spontaneous maturation in vivo may be due to the stabilisation of the 
particles at a low pH. Only VLPs, which resembled wild-type HaSV, were purified by 
spontaneous maturation in vivo. This may be because the particles were unstable before 
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maturation and subsequently degraded during VLP purification. When no additional 
RNA was co-expressed, the majority of particles were smaller than wild-type HaSV 
capsids. Similarly, baculoviral expression of P71 and in vitro maturation at a pH of 6.0 
resulted in the assembly of smaller T=1 HaSV VLPs (Taylor, 2003). At a pH of 5.0 
Taylor (2003) managed to purify virus particles, which were representative of wild-type 
virions. This raises an interesting question. Are the VLPs that differ from wild-type 
virions a result of mismaturation as was observed by Taylor (2003)? It is possible that 
correct maturation may only occur at a specific pH and in the presence of RNA near the 
cleavage site? In the absence of either one of these requirements, virus particles mature 
with different symmetries and during assembly, the virus particles may encapsidate a 
certain complement of RNAs, which dictates the final mature structure of the VLPs. The 
ability of the VLPs to assemble by expressing P71 with PGADH, indicated that the rate-
limiting factor during assembly was the protein concentration and not the viral RNA as 
was previously proposed by Venter (2001).  
 
5.2 RNA ENCAPSIDATION 
The success of the omegatetravirus lifecycle relies on their ability to efficiently replicate 
and package their genomes. The rate at which assembly of these particles occurred in 
yeast was hypothesized to be governed by the ability of these virus particles to 
encapsidate viral RNA (Venter, 2001). The improved assembly when high-level P71 and 
P71 mRNA were co-expressed was not as a consequence of viral RNA being 
encapsidated. This suggested that neither P71 mRNA nor RNA2 contain any 
encapsidation signals. This result also contradicted the earlier observation that the 
capsid-encoding message of both NωV and HaSV were encapsidated in the VLPs 
(Agrawal and Johnson, 1995; Gordon et al., 2001). Expression of HaSV P71 and the 
genomic RNAs in plant protoplasts was proposed to result in the assembly of infectious 
VLPs (Gordon et al., 2001). In addition to the encapsidation of the P71 message, 
Gordon et al. (2001) also detected RNA1 in the VLPs. Surprisingly no RNA2 was 
detected. The production of infectious virus would require the encapsidation of RNA2. 
This suggests two possible scenarios. Firstly, the diseased larvae from the bioassays may 
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have an inherent HaSV infection, which was manifested by stressing the animals. 
Secondly, RNA2 may be present at low levels resulting in few VLPs encapsidating the 
RNA2 molecule. If the latter scenario is true, then both the message and RNA2 contain 
an encapsidation signal. However the results presented here show otherwise. The HaSV 
VLPs in this study must have encapsidated cellular RNA (Agrawal and Johnson, 1995).  
 
In the nodaviruses, encapsidation of cellular RNA was observed in PaV and FHV VLPs 
that were assembled from capsid protein translated from mRNA (Schneemann et al., 
1993; Krishna et al., 2003; Johnson et al., 2004; Venter and Schneemann 2007). Only 
6% of the RNA packaged in PaV VLPs represented genomic RNA. Northern analysis of 
the RNA purified from the HaSV VLPs indicated that less than 2.8% of the total RNA 
analysed represented viral RNA. In PaV VLPs the RNA formed a helical cage of RNA 
similar to wild-type PaV (Tang et al., 2001; Johnson et al., 2004). Like the nodaviruses 
it is possible that the HaSV VLPs package a mixture of viral RNA and cellular mRNAs 
in the absence of replication. It was hypothesised that even though the hybrid promoter 
produced significantly higher levels of the RNA transcripts, the concentrations of RNA 
expressed were low and not in the vicinity of the capids. This resulted in the particles 
encapsidating cellular RNAs. Furthermore, the ability of the VLPs to assemble in the 
absence of additional viral RNA indicated that the particles possibly encapsidated 
random cellular RNAs, which contributed to the instability of the particles.  
 
There were a number of possible explanations why viral RNA was not encapsidated: 
1. Absence of encapsidation signals. The P71 mRNA and RNA2 do not carry an 
encapsidation signal as was originally proposed (Gordon et al., 2001). This is supported 
by Gordon et al. (2001), where no RNA2 was encapsidated in VLPs assembled in plant 
protoplasts. 
 
2. Precise copies of viral RNA.  Because the exact transcriptional start of PGADH is 
unknown, there would have been several additional nucleotides at the 5’ end. Extensions 
at the 5’ end of the RNA may interfere with the ability of the RNA to be accommodated 
into the capsid shell or may block encapsidation signals. This theory could be tested by 
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co-expressing P71 with PGAL1-derived RNA2, for which the transcriptional start of the 
promoter is known. The disadvantage of using PGAL is that low levels of RNA2 would be 
produced. The transcriptional start of PGADH could be determined by primer extension 
and a precise fusion between RNA2 and -1 of the promoter could be constructed.  The 
advantage of using this promoter would ensure high-level expression of exact RNA2 
transcripts. 
 
3.  Sequential packaging.  RNA1 might be required for the packaging of RNA2 in HaSV 
VLPs. In the nodaviruses RNA1 and RNA2 are co-packaged in equimolar 
concentrations (Schneemann et al., 1994; Krishna and Schneemann, 1999). Gordon et 
al. (2001) detected RNA1 in plant protoplast-derived HaSV VLPs. Interestingly no 
RNA2 was encapsidated and Gordon et al. (2001) hypothesised that RNA1 can be 
encapsidated in the absence of RNA2. There is evidence to suggest that FHV requires 
dimerisation of both RNAs for efficient packaging (Krishna and Schneemann, 1999). 
However, Venter et al. (2005) showed that RNA2 was packaged in the absence of 
RNA1. Critical to this process is the requirement for RNA2 replication, suggesting that 
packaging occurs in an ordered manner where RNA2 was packaged before RNA1 
(Venter et al., 2005). This may indicate that viral RNA encapsidation is replication-
dependent in the omegatetraviruses.     
 
It is now widely acknowledged that the tetraviruses most likely evolved from the 
nodaviruses and it is possible that this method of packaging displayed by the 
nodaviruses may be an evolutionary advantage, ensuring that both RNAs are efficiently 
packaged in the virus particle (Johnson et al., 1994; Johnson and Reddy, 1998). On the 
other hand the omegatetraviruses could adopt a different strategy, whereby RNA1 is 
required to be packaged first in order for RNA2 to be packaged. RNA1 could open the 
binding site for RNA2 exposing residues important for its binding. This sequential 
manner of RNA packaging would ensure that the encapsidation event is specific. This 
model would be largely inefficient, as it would require a high initial concentration of 
RNA1 to be readily available for the capsid subunits to encapsidate. To test this 
hypothesis RNA1 and RNA2 could be co-expressed using different promoters. RNA1 
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could be expressed with the GADH promoter and RNA2 with the GAL1 promoter. In 
this way high levels of RNA1 could be initially expressed under glucose-starvation 
conditions with RNA2 expression induced by the addition of galactose.  
 
4.  A role for p17.  Recent data generated in the laboratory by Vlok (2006) suggests that 
p17, which is encoded by a conserved ORF that overlaps the capsid protein precursor 
ORF in all three omegatetraviruses, might play an important role in virus particle 
assembly. Vlok showed that p17 was present in infected H. armigera larval midgut cells. 
The presence of the protein in wild-type HaSV virus particles at approximately 1/10–
1/20 the concentration of the capsid protein was also detected (Vlok, 2006). As 
structural studies have identified the presence of only the capsid protein and as the 
assembly of VLPs requires only expression of the capsid protein precursor, it is unlikely 
that p17 interacts directly with the capsid shell. However, p17 might interact with and 
possibly order viral RNA during encapsidation in the omegatetraviruses. 
 
Since the expression system used in this study does not include the expression of p17, 
(no p17 was translated from the RNA2 construct, results not shown), the absence of this 
protein might account for the lack of viral RNA encapsidation. To test this hypothesis an 
expression system could be devised in yeast where P17 is expressed from a single, 
chromosomal copy and P71 or viral RNA from multicopy expression vectors. This 
would mimic the elevated expression levels of P17 and P71 that have been detected in 
infected insect midgut cells.  
 
5. Replication-dependent packaging of viral RNA.    
In the omegatetraviruses RNA encapsidation may be coupled to replication. This seems 
likely if one considers the argument that most if not all ss (+) RNA viruses replicate in 
association with membranes (for a review see Salonen et al., 2004). This ensures that the 
capsid and RNA are in close contact with one another. The NoV replicase had the ability 
to replicate a NoV RNA2-NωV P70 chimeric replicon, which contained the capsid-
encoding sequence of NωV. Replication of the NoV RNA2-NωV P70 chimera resulted 
in the de novo synthesis of NωV VLPs, which had the ability to encapsidate the NoV 
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RNA1 and RNA3. This was not expected because the nodaviruses co-package RNA1 
and RNA2 in equal quantities. The ability of the VLPs to encapsidate RNA3 suggested 
that RNA packaging was random and dependent on RNA that was present at the highest 
concentrations in the proximity of the assembling VLPs. These results indicated that the 
close proximity of the viral RNA and capsid protein might occur for the encapsidation of 
the NoV RNAs 
 
5.3 THE ROLE OF APOPTOSIS IN THE LIFE CYCLE OF 
TETRAVIRUSES 
The work presented here suggests that there may be a possible link between HaSV VLP 
maturation and apoptosis in vivo. Two possible scenarios exist to explain how apoptosis 
could be triggered in the yeast cells. Firstly the ability of the VLPs to mature earlier in 
cells expressing P71 compared to the negative control suggests that the metabolic load 
of the mRNA transcripts and subsequent translation of p71 may induce apoptosis 
(results not shown). Second p71 could specifically induce apoptosis like some 
picornaviruses (Carthy et al., 1998; Barco et al., 2000; Calandria et al., 2004; Liu et al., 
2004). In both these cases apoptosis may be important in the lifecycle of the virus 
because the response of H. armigera to HaSV infection culminates in cell sloughing, 
which has been linked to apoptosis (Brookes et al., 2002). Induction of apoptosis by the 
virus could ensure two biological advantages. First, induction of apoptosis causes 
acidification of the cytosol, which may be required for maturation of the virus, and 
secondly, apoptosis may be used as a mechanism for cellular exit.   
 
Another point to consider is that FHV replicates as spherules in the outer mitochondrial 
membrane (Miller et al., 2001). In this case the protein and RNA are always in close 
association with one another (Venter et al., 2005). Tetraviruses may need to replicate in 
situ with cellular organelles. The trigger for maturation might be caused by the 
acidification of the cytosol by mitochondrial (Ludovico et al., 2002) or lysosomal 
(Nilsson et al., 2006) lysis. In the laboratory, the HaSV replicase has been shown to 
localise to either the lysosomes or endosomes, but further research is required to 
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conclusively demonstrate this (James Short, unpublished data). It seems feasible that the 
virus would replicate in association with the organelles to cause the acidification 
required during maturation. Replication in association with cellular membranes would 
also ensure that the RNA, capsid proteins and replication factors are localized and 
concentrated for assembly (Ahlquist et al., 2003). Membrane complexes could also offer 
the virus particles protection and ensure that the host translational factors do not out 
compete the replicating RNA (Ahlquist et al., 2003).  
 
5.4 CONCLUDING REMARKS 
While the mechanism of omegatetravirus maturation has been elucidated in vitro, little is 
known about how these viruses enter their host, replicate their genomes, assemble and 
mature in vitro. An expression system was developed to study the assembly of HaSV 
VLPs in yeast. The work presented in this dissertation indicates that the virus almost 
certainly required a high concentration of capsid precursor protein during assembly. The 
ability of the virus to specifically encapsidate its own RNA may not rely on viral RNA 
and capsid protein association in the vicinity of one another. Instead the 
omegatetraviruses may require replication for specific assembly. Replication of the virus 
in association with organelles could also induce apoptosis reducing the pH of the 
immediate environment where assembly occurs, causing maturation. The challenges, 
which arose from this work indicate that in the absence of a wild-type replication 
system, the virus may assemble and encapsidate RNA in a different way. In order to 
study the assembly and RNA encapsidation mechanisms of the omegatetraviruses, a 
wild-type replication system needs to be developed.  
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APPENDIX 1. BACTERIAL AND YEAST STRAINS 
 
Table A1.1 Bacterial and yeast strains used in this study 
Strain Genotype Reference 
S. cerevisiae INVScI Matα, trp1 - 289, his3 ∆1, 
leu2, ura3-52 
Invitrogen 
S. cerevisiae INVScI 3#20.1  Matα, his3, P71:LEU2::p71, 
trp1, ura3) 
Venter (2001) 
S. cerevisiae INVScI L+  Matα, his3, LEU2, trp1, ura3 Venter (2001) 
S. cerevisiae BY4733  Matα, his3∆200, leu2∆0, 
met15∆0, trp1∆63, ura3∆0 
Brachmann et al., 1998 
E. coli DH5α 
           
            
 
 
 
 
F-(80dlacZ M15) (lacZYA-
argF)U169hsdR17(r-m+) 
recA1 endA1 relA1 deoR 
 
 
Hanahan, 1983 
 
 
 
 
 
 
E. coli JM110 rpsL (Strr) thr leu thi-1 lacY 
galK galT ara tonA tsx dam 
dcm supE44 ∆(lac-proAB) [F´ 
traD36 proAB lacIqZ∆M15] 
 
Yanisch-Perron et al., 1985 
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APPENDIX 2.  SEQUENCE OF THE HaSV GENOME 
 
       1                                          Met Tyr Ala Lys   
       1  GUUCUGCCUC CCCCGGACGG UAAAUAUAGG GGAACA AUG UAC GCG AAA  
           
       5  Ala Thr Asp Val Ala Arg Val Tyr Ala Ala Ala Asp Val Ala 
      49  GCG ACA GAC GUG GCG CGU GUC UAC GCC GCG GCA GAU GUC GCC  
 
      19  Tyr Ala Asn Val Leu Gln Gln Arg Ala Val Lys Leu Asp Phe 
      91  UAC GCG AAC GUA CUG CAG CAG AGA GCA GUC AAG UUG GAC UUC 
 
      33  Ala Pro Pro Leu Lys Ala Leu Glu Thr Leu His Arg Leu Tyr 
     133  GCC CCG CCA CUG AAG GCA CUA GAA ACC CUC CAC AGA CUG UAC 
 
      47  Tyr Pro Leu Arg Phe Lys Gly Gly Thr Leu Pro Pro Thr Gln 
     175  UAU CCG CUG CGC UUC AAA GGG GGC ACU UUA CCC CCG ACA CAA 
 
      61  His Pro Ile Leu Ala Gly His Gln Arg Val Ala Glu Glu Val 
     217  CAC CCG AUC CUG GCC GGG CAC CAA CGU GUC GCA GAA GAG GUU  
 
      75  Leu His Asn Phe Ala Arg Gly Arg Ser Thr Val Leu Glu Ile 
     259  CUG CAC AAU UUC GCC AGG GGA CGU AGC ACA GUG CUC GAG AUA  
 
      89  Gly Pro Ser Leu His Ser Ala Leu Lys Leu His Gly Ala Pro  
     301  GGG CCG UCU CUG CAC AGC GCA CUU AAG CUA CAU GGG GCA CCG  
 
     103  Asn Ala Pro Val Ala Asp Tyr His Gly Cys Thr Lys Tyr Gly  
     343  AAC GCC CCC GUC GCA GAC UAU CAC GGG UGC ACC AAG UAC GGC  
 
     117  Thr Arg Asp Gly Ser Arg His Ile Thr Ala Leu Glu Ser Arg  
     385  ACC CGC GAC GGC UCG CGA CAC AUU ACG GCC UUA GAG UCU AGA 
 
     131  Ser Val Ala Thr Gly Arg Pro Glu Phe Lys Ala Asp Ala Ser 
     427  UCC GUC GCC ACA GGC CGG CCC GAG UUC AAG GCC GAC GCC UCA 
 
     145  Leu Leu Ala Asn Gly Ile Ala Ser Arg Thr Phe Cys Val Asp  
     469  CUG CUC GCC AAC GGC AUU GCC UCC CGC ACC UUC UGC GUC GAC  
 
     159  Gly Val Gly Ser Cys Ala Phe Lys Ser Arg Val Gly Ile Ala 
     511  GGA GUC GGC UCU UGC GCG UUC AAA UCG CGC GUU GGA AUU GCC  
 
     173  Asn His Ser Leu Tyr Asp Val Thr Leu Glu Glu Leu Ala Asn  
     553  AAU CAC UCC CUC UAU GAC GUG ACC CUA GAG GAG CUG GCC AAU  
 
Figure A2.1 RNA sequence of HaSV RNA1 (Genome sequence accession number: U18246).  The 
amino acid sequence of the replicase gene is shown above the sequence. 
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     187  Ala Phe Glu Asn His Gly Leu His Met Val Arg Ala Phe Met   
     595  GCG UUU GAG AAC CAC GGA CUU CAC AUG GUC CGC GCG UUC AUG  
 
     201  His Met Pro Glu Glu Leu Leu Tyr Met Asp Asn Val Val Asn  
     637  CAC AUG CCA GAA GAG CUG CUC UAC AUG GAC AAC GUG GUU AAU  
 
     215  Ala Glu Leu Gly Tyr Arg Phe His Val Ile Glu Glu Pro Met 
     679  GCC GAG CUC GGC UAC CGC UUC CAC GUU AUU GAA GAG CCU AUG  
 
     229  Ala Val Lys Asp Cys Ala Phe Gln Gly Gly Asp Leu Arg Leu  
     721  GCU GUG AAG GAC UGC GCA UUC CAG GGG GGG GAC CUC CGU CUC  
 
     243  His Phe Pro Glu Leu Asp Phe Ile Asn Glu Ser Gln Glu Arg  
     763  CAC UUC CCU GAG UUG GAC UUC AUC AAC GAG AGC CAA GAG CGG 
 
     257  Arg Ile Glu Arg Leu Ala Ala Arg Gly Ser Tyr Ser Arg Arg  
     805  CGC AUC GAG AGG CUG GCC GCC CGC GGC UCC UAC UCC AGA CGC  
 
     271  Ala Val Ile Phe Ser Gly Asp Asp Asp Trp Gly Asp Ala Tyr  
     847  GCC GUC AUU UUC UCC GGC GAC GAC GAC UGG GGU GAU GCG UAC  
 
     285  Leu His Asp Phe His Thr Trp Leu Ala Tyr Leu Leu Val Arg  
     889  UUA CAC GAC UUC CAC ACA UGG CUC GCC UAC CUA CUG GUG AGG 
 
     299  Asn Tyr Pro Thr Pro Phe Gly Phe Ser Leu His Ile Glu Val  
     931  AAC UAC CCC ACU CCG UUU GGU UUC UCA CUC CAU AUA GAA GUC 
 
     313  Gln Arg Arg His Gly Ser Ser Ile Glu Leu Arg Ile Thr Arg 
     973  CAG AGG CGC CAC GGC UCC AGC AUU GAG CUG CGC AUC ACU CGC  
 
     327  Ala Pro Pro Gly Asp Arg Met Leu Ala Val Val Pro Arg Thr 
    1015  GCG CCA CCU GGA GAC CGC AUG CUG GCC GUC GUC CCA AGG ACG 
 
     341  Ser Gln Gly Leu Cys Arg Ile Pro Asn Ile Phe Tyr Tyr Ala   
    1057  UCC CAA GGC CUC UGC AGA AUC CCA AAC AUC UUU UAU UAC GCC   
 
     355  Asp Ala Ser Gly Thr Glu His Lys Thr Ile Leu Thr Ser Gln  
    1099  GAC GCG UCG GGC ACU GAG CAU AAG ACC AUC CUU ACG UCA CAG 
  
     369  His Lys Val Asn Met Leu Leu Asn Phe Met Gln Thr Arg Pro 
    1141  CAC AAA GUC AAC AUG CUG CUC AAU UUU AUG CAA ACG CGU CCU  
 
     383  Glu Lys Glu Leu Val Asp Met Thr Val Leu Met Ser Phe Ala  
    1183  GAG AAG GAA CUA GUC GAC AUG ACC GUC UUG AUG UCG UUC GCG  
 
     397  Arg Ala Arg Leu Arg Ala Ile Val Val Ala Ser Glu Val Thr  
    1225  CGC GCU AGG CUG CGC GCG AUC GUG GUC GCC UCA GAA GUC ACC  
 
     411  Glu Ser Ser Trp Asn Ile Ser Pro Ala Asp Leu Val Arg Thr 
    1267  GAG AGC UCC UGG AAC AUC UCA CCG GCU GAC CUG GUC CGC ACU 
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     425  Val Val Ser Leu Tyr Val Leu His Ile Ile Glu Arg Arg Arg 
    1309  GUC GUG UCU CUU UAC GUC CUC CAC AUC AUC GAG CGC CGA AGG  
 
     439  Ala Ala Val Ala Val Lys Thr Ala Lys Asp Asp Val Phe Gly  
    1351  GCU GCG GUC GCU GUC AAG ACC GCC AAG GAC GAC GUC UUU GGA 
 
     453  Glu Thr Ser Phe Trp Glu Ser Leu Lys His Val Leu Gly Ser 
    1393  GAG ACU UCG UUC UGG GAG AGU CUC AAG CAC GUC UUG GGC UCC  
 
     467  Cys Cys Gly Leu Arg Asn Leu Lys Gly Thr Asp Val Val Phe 
    1435  UGU UGC GGU CUG CGC AAC CUC AAA GGC ACC GAC GUC GUC UUU  
 
     481  Thr Lys Arg Val Val Asp Lys Tyr Arg Val His Ser Leu Gly  
    1477  ACU AAG CGC GUC GUC GAU AAG UAC CGA GUC CAC UCG CUC GGA  
 
     495  Asp Ile Ile Cys Asp Val Arg Leu Ser Pro Glu Gln Val Gly  
    1519  GAC AUA AUC UGC GAC GUC CGC CUG UCC CCU GAA CAG GUC GGC  
 
     509  Phe Leu Pro Ser Arg Val Pro Pro Ala Arg Val Phe His Asp  
    1561  UUC CUG CCG UCC CGC GUA CCA CCU GCC CGC GUC UUU CAC GAC  
 
     523  Arg Glu Glu Leu Glu Val Leu Arg Glu Ala Gly Cys Tyr Asn  
    1603  AGG GAA GAG CUU GAG GUC CUU CGC GAA GCU GGC UGC UAC AAC  
 
     537  Glu Arg Pro Val Pro Ser Thr Pro Pro Val Glu Glu Pro Gln  
    1645  GAA CGU CCG GUA CCU UCC ACU CCU CCU GUG GAG GAG CCC CAA  
 
     551  Gly Phe Asp Ala Asp Leu Trp His Ala Thr Ala Ala Ser Leu  
    1687  GGU UUC GAC GCC GAC UUG UGG CAC GCG ACC GCG GCC UCA CUC  
 
     565  Pro Glu Tyr Arg Ala Thr Leu Gln Ala Gly Leu Asn Thr Asp  
    1729  CCC GAG UAC CGC GCC ACC UUG CAG GCA GGU CUC AAC ACC GAC  
 
     579  Val Lys Gln Leu Lys Ile Thr Leu Glu Asn Ala Leu Lys Thr  
    1771  GUC AAG CAG CUC AAG AUC ACC CUC GAG AAC GCC CUC AAG ACC  
 
     593  Ile Asp Gly Leu Thr Leu Ser Pro Val Arg Gly Leu Glu Met  
    1813  AUC GAC GGG CUC ACC CUC UCC CCA GUC AGA GGC CUC GAG AUG  
 
     607  Tyr Glu Gly Pro Pro Gly Ser Gly Lys Thr Gly Thr Leu Ile  
    1855  UAC GAG GGC CCG CCA GGC AGC GGC AAG ACG GGC ACC CUC AUC  
 
     621  Ala Ala Leu Glu Ala Ala Gly Gly Lys Ala Leu Tyr Val Ala  
    1897  GCC GCC CUU GAG GCC GCG GGC GGU AAA GCA CUU UAC GUG GCA  
 
     635  Pro Thr Arg Glu Leu Arg Glu Ala Met Asp Arg Arg Ile Lys  
    1939  CCC ACC AGA GAA CUG AGA GAG GCU AUG GAC CGG CGG AUC AAA 
 
     649  Pro Pro Ser Ala Ser Arg Thr Gln His Val Ala Leu Ala Ile  
    1981  CCG CCG UCC GCC UCG CGU ACG CAA CAU GUC GCC CUU GCG AUU 
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     663  Leu Arg Arg Ala Thr Ala Glu Gly Ala Pro Phe Ala Thr Val  
    2023  CUC CGU CGU GCC ACC GCC GAG GGC GCC CCU UUC GCU ACC GUG  
 
     677  Val Ile Asp Glu Cys Phe Met Phe Pro Leu Val Tyr Val Ala  
    2065  GUU AUC GAC GAG UGC UUC AUG UUC CCG CUC GUG UAC GUC GCG  
 
     691  Ile Val His Ala Leu Ser Pro Ser Ser Arg Ile Val Leu Val 
    2107  AUC GUG CAC GCC UUG UCC CCG AGC UCA CGA AUA GUC CUU GUA  
 
     705  Gly Asp Val His Gln Ile Gly Phe Ile Asp Phe Gln Gly Thr  
    2149  GGG GAC GUC CAC CAA AUC GGG UUU AUA GAC UUC CAA GGC ACA  
 
     719  Ser Ala Asn Met Pro Leu Val Arg Asp Val Val Lys Gln Cys  
    2191  AGC GCG AAC AUG CCG CUC GUU CGC GAC GUC GUU AAG CAG UGC  
 
     733  Arg Arg Arg Thr Phe Asn Gln Thr Lys Arg Cys Pro Ala Asp  
    2233  CGU CGG CGC ACU UUC AAC CAA ACC AAG CGC UGU CCG GCC GAC  
 
     747  Val Val Ala Thr Thr Phe Phe Gln Ser Leu Tyr Pro Gly Cys  
    2275  GUC GUU GCC ACC ACG UUU UUC CAG AGC UUG UAC CCC GGG UGC  
 
     761  Thr Thr Thr Ser Gly Cys Val Ala Ser Ile Ser His Val Ala  
    2317  ACA ACC ACC UCA GGG UGC GUC GCA UCC AUC AGC CAC GUC GCC  
 
     775  Pro Asp Tyr Arg Asn Ser Gln Ala Gln Thr Leu Cys Phe Thr  
    2359  CCA GAC UAC CGC AAC AGC CAG GCG CAA ACG CUC UGC UUC ACG  
 
     789  Gln Glu Glu Lys Ser Arg His Gly Ala Glu Gly Ala Met Thr   
    2401  CAG GAG GAA AAG UCG CGC CAC GGG GCU GAG GGC GCG AUG ACU  
 
     803  Val His Glu Ala Gln Gly Arg Thr Phe Ala Ser Val Ile Leu  
    2443  GUG CAC GAA GCG CAG GGA CGC ACU UUU GCG UCU GUC AUU CUG  
 
     817  His Tyr Asn Gly Ser Thr Ala Glu Gln Lys Leu Leu Ala Glu  
    2485  CAU UAC AAC GGC UCC ACA GCA GAG CAG AAG CUC CUC GCU GAG  
 
     831  Lys Ser His Leu Leu Val Gly Ile Thr Arg His Thr Asn His  
    2527  AAG UCG CAC CUU CUA GUC GGC AUC ACG CGC CAC ACC AAC CAC  
 
     845  Leu Tyr Ile Arg Asp Pro Thr Gly Asp Ile Glu Arg Gln Leu  
    2569  CUG UAC AUC CGC GAC CCG ACA GGU GAC AUU GAG AGA CAA CUC  
 
     859  Asn His Ser Ala Lys Ala Glu Val Phe Thr Asp Ile Pro Ala  
    2611  AAC CAU AGC GCG AAA GCC GAG GUG UUU ACA GAC AUC CCU GCA  
 
     873  Pro Leu Glu Ile Thr Thr Val Lys Pro Ser Glu Glu Val Gln  
    2653  CCC CUG GAG AUC ACG ACU GUC AAA CCG AGU GAA GAG GUG CAG  
 
     887  Arg Asn Glu Val Met Ala Thr Ile Pro Pro Gln Ser Pro Thr  
    2695  CGC AAC GAA GUG AUG GCA ACG AUA CCC CCG CAG AGU CCC ACG  
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     901  Pro His Gly Ala Ile His Leu Leu Arg Lys Asn Phe Gly Asp  
    2737  CCG CAC GGA GCA AUC CAU CUG CUC CGC AAG AAC UUC GGG GAC  
 
     915  Gln Pro Asp Cys Gly Cys Val Ala Leu Ala Lys Thr Gly Tyr  
    2779  CAA CCC GAC UGU GGC UGU GUC GCU UUG GCG AAG ACC GGC UAC  
 
     929  Glu Val Phe Gly Gly Arg Ala Lys Ile Asn Val Glu Leu Ala  
    2821  GAG GUG UUU GGC GGU CGU GCC AAA AUC AAC GUA GAG CUU GCC  
 
     943  Glu Pro Asp Ala Thr Pro Lys Pro His Arg Ala Phe Gln Glu  
    2863  GAA CCC GAC GCG ACC CCG AAG CCG CAU AGG GCG UUC CAG GAA  
 
     957  Gly Val Gln Trp Val Lys Val Thr Asn Ala Ser Asn Lys His  
    2905  GGG GUA CAG UGG GUC AAG GUC ACC AAC GCG UCU AAC AAA CAC  
 
     971  Gln Ala Leu Gln Thr Leu Leu Ser Arg Tyr Thr Lys Arg Ser  
    2947  CAG GCG CUC CAG ACG CUG UUG UCC CGC UAC ACC AAG CGA AGC  
 
     985  Ala Asp Leu Pro Leu His Glu Ala Lys Glu Asp Val Lys Arg  
    2989  GCU GAC CUG CCG CUA CAC GAA GCU AAG GAG GAC GUC AAA CGC  
 
     999  Met Leu Asn Ser Leu Asp Arg His Trp Asp Trp Thr Val Thr  
    3031  AUG CUA AAC UCG CUU GAC CGA CAU UGG GAC UGG ACU GUC ACU  
 
    1013  Glu Asp Ala Arg Asp Arg Ala Val Phe Glu Thr Gln Leu Lys 
    3073  GAA GAC GCC CGU GAC CGA GCU GUC UUC GAG ACC CAG CUC AAG  
 
    1027  Phe Thr Gln Arg Gly Gly Thr Val Glu Asp Leu Leu Glu Pro  
    3115  UUC ACC CAA CGC GGC GGC ACC GUC GAA GAC CUG CUG GAG CCA  
 
    1041  Asp Asp Pro Tyr Ile Arg Asp Ile Asp Phe Leu Met Lys Thr  
    3157  GAC GAC CCC UAC AUC CGU GAC AUA GAC UUC CUU AUG AAG ACU  
 
    1055  Gln Gln Lys Val Ser Pro Lys Pro Ile Asn Thr Gly Lys Val  
    3199  CAG CAG AAA GUG UCG CCC AAG CCG AUC AAU ACG GGC AAG GUC 
 
    1069  Gly Gln Gly Ile Ala Ala His Ser Lys Ser Leu Asn Phe Val  
    3241  GGG CAG GGG AUC GCC GCU CAC UCA AAG UCU CUC AAC UUC GUC  
 
    1083  Leu Ala Ala Trp Ile Arg Ile Leu Glu Glu Ile Leu Arg Thr  
    3283  CUC GCC GCU UGG AUA CGC AUA CUC GAG GAG AUA CUC CGU ACC  
 
    1097  Gly Ser Arg Thr Val Arg Tyr Ser Asn Gly Leu Pro Asp Glu  
    3325  GGG AGC CGC ACG GUC CGG UAC AGC AAC GGU CUC CCC GAC GAA  
 
    1111  Glu Glu Ala Met Leu Leu Glu Ala Lys Ile Asn Gln Val Pro  
    3367  GAA GAG GCC AUG CUG CUC GAA GCG AAG AUC AAU CAA GUC CCA  
 
    1125  His Ala Thr Phe Val Ser Ala Asp Trp Thr Glu Phe Asp Thr  
    3409  CAC GCC ACG UUC GUC UCG GCG GAC UGG ACC GAG UUU GAC ACC  
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    1139  Ala His Asn Asn Thr Ser Glu Leu Leu Phe Ala Ala Leu Leu  
    3451  GCC CAC AAU AAC ACG AGU GAG CUG CUC UUC GCC GCC CUU UUA  
 
    1153  Glu Arg Ile Gly Thr Pro Ala Ala Ala Val Asn Leu Phe Arg  
    3493  GAG CGC AUC GGC ACG CCU GCA GCU GCC GUU AAU CUA UUC AGA 
 
    1167  Glu Arg Cys Gly Lys Arg Thr Leu Arg Ala Lys Gly Leu Gly  
    3535  GAA CGG UGU GGG AAA CGC ACC UUG CGA GCG AAG GGU CUA GGC  
 
    1181  Ser Val Glu Val Asp Gly Leu Leu Asp Ser Gly Ala Ala Trp  
    3577  UCC GUU GAA GUC GAC GGU CUG CUC GAC UCC GGC GCA GCU UGG  
 
    1195  Thr Pro Cys Arg Asn Thr Ile Phe Ser Ala Ala Val Met Leu  
    3619  ACG CCU UGC CGC AAC ACC AUC UUC UCU GCC GCC GUC AUG CUC  
 
    1209  Thr Leu Phe Arg Gly Val Lys Phe Ala Ala Phe Lys Gly Asp  
    3661  ACG CUC UUC CGC GGC GUC AAG UUC GCA GCU UUC AAA GGC GAC  
 
    1223  Asp Ser Leu Leu Cys Gly Ser His Tyr Leu Arg Phe Asp Ala  
    3703  GAC UCG CUC CUC UGU GGU AGC CAU UAC CUC CGU UUC GAC GCU 
 
    1237  Ser Arg Leu His Met Gly Glu Arg Tyr Lys Thr Lys His Leu  
    3745  AGC CGC CUU CAC AUG GGC GAA CGU UAC AAG ACC AAA CAU UUG  
 
    1251  Lys Val Glu Val Gln Lys Ile Val Pro Tyr Ile Gly Leu Leu  
    3787  AAG GUC GAG GUG CAG AAA AUC GUG CCG UAC AUC GGA CUC CUC  
 
    1265  Val Ser Ala Glu Gln Val Val Leu Asp Pro Val Arg Ser Ala  
    3829  GUC UCC GCU GAG CAG GUC GUC CUC GAC CCU GUC AGG AGC GCU  
 
    1279  Leu Lys Ile Phe Gly Arg Cys Tyr Thr Ser Glu Leu Leu Tyr  
    3871  CUC AAG AUA UUU GGG CGC UGC UAC ACA AGC GAA CUC CUU UAC  
 
    1293  Ser Lys Tyr Val Glu Ala Val Arg Asp Ile Thr Lys Gly Trp  
    3913  UCC AAG UAC GUG GAG GCU GUG AGA GAC AUC ACC AAG GGC UGG  
 
    1307  Ser Asp Ala Arg Tyr His Ser Leu Leu Cys His Met Ser Ala  
    3955  AGU GAC GCC CGC UAC CAC AGC CUC CUG UGC CAC AUG UCA GCA 
 
    1321  Cys Tyr Tyr Asn Tyr Ala Pro Glu Ser Ala Ala Tyr Ile Ile  
    3997  UGC UAC UAC AAU UAC GCG CCG GAG UCU GCG GCG UAC AUC AUC  
 
    1335  Asp Ala Val Val Arg Phe Gly Arg Gly Asp Phe Pro Phe Glu  
    4039  GAC GCU GUU GUU CGC UUU GGG CGC GGC GAC UUC CCG UUU GAA  
 
    1349  Gln Leu Arg Val Val Arg Ala His Val Gln Ala Pro Asp Ala  
    4081  CAA CUG CGC GUG GUG CGU GCC CAU GUG CAG GCA CCC GAC GCU  
 
    1363  Tyr Ser Ser Thr Tyr Pro Ala Asn Val Arg Ala Ser Cys Leu  
    4123  UAC AGC AGC ACG UAU CCG GCU AAC GUG CGC GCA UCG UGC CUU  
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    1377  Asp His Val Phe Glu Pro Arg Gln Ala Ala Ala Pro Ala Gly  
    4165  GAC CAC GUC UUC GAG CCC CGC CAG GCC GCC GCC CCG GCA GGU  
 
    1391  Phe Val Ala Thr Cys Ala Lys Pro Glu Thr Pro Ser Ser Leu  
    4207  UUC GUU GCG ACA UGU GCG AAG CCG GAA ACG CCU UCU UCA CUU  
 
    1405  Thr Ala Lys Ala Gly Val Ser Ala Thr Thr Ser His Val Ala  
    4249  ACC GCG AAA GCU GGU GUU UCU GCG ACU ACA AGC CAC GUU GCG  
 
    1419  Thr Gly Thr Ala Pro Pro Glu Ser Pro Trp Asp Ala Pro Ala  
    4291  ACU GGG ACU GCG CCC CCG GAG UCU CCA UGG GAU GCA CCU GCA  
 
    1433  Ala Asn Ser Phe Ser Glu Leu Leu Thr Pro Glu Thr Pro Ser  
    4333  GCC AAC AGC UUU UCG GAG UUA UUG ACA CCG GAG ACC CCG UCC  
 
    1447  Thr Ser Ser Ser Ala Val Ile Val Phe Ile Gly Leu Leu Tyr  
    4375  ACA UCA UCC UCG GCC GUC AUC GUC UUC AUC GGA CUC CUC UAC  
 
    1461  Ile Val Trp Lys Val Ala Gln Trp Trp Arg His Arg Lys Arg  
    4417  AUC GUG UGG AAG GUC GCU CAG UGG UGG AGA CAC CGC AAG AGG  
 
    1475  Thr Glu Asp Leu Asn Ser Arg Lys Pro Pro Ser Gln Asp Arg  
    4459  ACA GAA GAC UUG AAC AGC AGA AAG CCG CCU UCG CAA GAC AGG  
 
    1489  Gln Ser Arg Ser Ser Glu Cys Leu Asp Arg Ser Gly Glu Arg  
    4501  CAA UCA CGC UCG UCU GAA UGU CUG GAC AGA AGC GGA GAA AGG  
 
    1503  Thr Gly Ser Ser Leu Thr Ala Pro Thr Ala Pro Ser Pro Ser  
    4543  ACA GGC AGU UCG UUA ACU GCC CCC ACU GCU CCG AGC CCC UCA  
 
    1517  Phe Ser Phe Ser Glu Arg Ala Arg Leu Ala Thr Gly Pro Thr  
    4585  UUC UCA UUU UCG GAA AGA GCU CGA CUG GCG ACC GGG CCG ACU  
 
    1531  Val Ala Ala Ala Thr Ser Pro Ser Ala Thr Pro Ser Cys Ala  
    4627  GUC GCC GCU GCG ACA UCA CCU UCG GCA ACC CCA UCC UGC GCC 
 
    1545  Thr Asp Gln Val Ala Ala Arg Thr Thr Pro Asp Phe Ala Pro  
    4669  ACG GAC CAG GUU GCC GCG AGG ACC ACG CCG GAC UUU GCG CCU 
 
    1559  Phe Leu Gly Ser Gln Ser Ala Arg Ala Val Ser Lys Pro Tyr 
    4711  UUC CUG GGU UCC CAG UCU GCC CGU GCU GUC UCG AAG CCG UAC  
 
    1573  Arg Pro Pro Thr Thr Ala Arg Trp Lys Glu Val Thr Pro Leu  
    4753  CGG CCC CCC ACG ACU GCC CGU UGG AAA GAA GUC ACC CCG CUC  
 
    1587  His Ala Trp Lys Gly Val Thr Gly Asp Arg Pro Glu Val Arg  
    4795  CAC GCG UGG AAG GGC GUG ACC GGA GAC CGA CCG GAA GUC AGG  
 
    1601  Glu Asp Pro Glu Thr Ala Ala Val Val Gln Ala Leu Ile Ser  
    4837  GAG GAC CCG GAG ACA GCG GCG GUC GUC CAG GCU CUG AUC AGC  
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    1615  Gly Arg Tyr Pro Gln Lys Thr Lys Leu Ser Ser Asp Ala Ser  
    4879  GGC CGU UAU CCU CAG AAG ACG AAG CUU UCC UCC GAC GCA UCC  
 
    1629  Lys Gly Tyr Ser Arg Thr Lys Gly Cys Ser Gln Ser Thr Ser  
    4921  AAA GGC UAC UCA AGA ACU AAG GGA UGC UCA CAA UCC ACC UCU  
 
    1643  Phe Pro Ala Pro Ser Ala Asp Tyr Gln Ala Arg Asp Cys Gln  
    4963  UUU CCU GCC CCG AGU GCG GAU UAC CAG GCC CGC GAC UGC CAG  
 
    1657  Thr Val Arg Val Cys Arg Ala Ala Ala Glu Met Ala Arg Ser 
    5005  ACA GUC CGA GUC UGC CGC GCC GCU GCA GAG AUG GCG CGC UCA 
 
    1671  Cys Ile His Glu Pro Leu Ala Ser Ser Ala Ala Ser Ala Asp 
    5047  UGU AUU CAC GAG CCG UUG GCU UCA UCU GCC GCC AGU GCC GAC 
 
    1685  Leu Lys Arg Ile Arg Ser Thr Ser Asp Ser Val Pro Asp Val  
    5089  UUG AAG CGC AUA CGC UCU ACC UCG GAC UCU GUU CCC GAU GUA  
 
    1699  Lys Ile Ser Lys Ser Ala   
    5131  AAG AUC AGC AAG AGC GCA UGAAGGAACA AAAUUAGUUU CCUUGUUCGU    
 
    5179  AAACAAGGUG GUCCCUCCCA UUGAGGUAAA GACUCUGGUG AGUCCUCAAC   
 
    5229  GUUACUCGUU GAGUCUGCUG CGGUUCGAUU CCAUUCCCAA GCAGCAAAGG  
 
    5279  GUGCGCAACU AGUACGGCGC CCCCUGGGAU ACCA 
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       1  GUUUUUCUUU CUUUACCAAG UGUGGUAAAA UUUAAACAAA GAAGAAAACC  
 
      51  AGGACCGUAA CCCGGCCCUU ACACACCUCG AGUCCGUGAC CACCGGAUUA  
 
     101  UACGUCGCCC ACCACACGGC GCCUUUUCCG ACCACUCUCG AGAGUCGUUG  
 
     151  GGAGUUUCGU CCGUGACCAC CCGGUUGGCA GUCGACAGAC GCUUCCGGAC  
 
     201  CACUAGAACC UCCUCGAGCG ACGCACACAC AGCACACACA CCGCCUUAGC  
 
     251  UGCACCUACG GCAGCGUUGA UAGCGCGGAU UUAUGAGCGA GCACACCAUC  
 
     301  GCCCACUCCA UCACAUUACC ACCCGGUUAC ACCCUUGCCC UAAUACCCCC  
 
       1                   Met Gly Asp Ala Gly Val Ala Ser Gln  
     351  UGAACCUGAA GCAGG AUG GGA GAU GCU GGA GUG GCG UCA CAG  
 
      10  Arg Pro His Asn Arg Arg Gly Thr Arg Asn Val Arg Val Ser  
     393  CGA CCU CAC AAC CGU CGC GGA ACC CGU AAC GUU CGG GUC AGC  
    
      24  Ala Asn Thr Val Thr Val Asn Gly Arg Arg Asn Gln Arg Arg  
     435  GCC AAC ACC GUC ACC GUC AAU GGU AGA AGA AAC CAA CGG CGU  
    
      38  Arg Thr Gly Arg Gln Val Ser Pro Pro Asp Asn Phe Thr Ala  
     477  CGG ACC GGA AGG CAA GUU UCU CCC CCU GAC AAU UUC ACC GCU  
    
      52  Ala Ala Gln Asp Leu Ala Gln Ser Leu Asp Ala Asn Thr Val  
     519  GCU GCA CAA GAC CUC GCG CAA AGC CUU GAC GCC AAC ACC GUC  
    
      66  Thr Phe Pro Ala Asn Ile Ser Ser Met Pro Glu Phe Arg Asn  
     561  ACU UUC CCC GCU AAC AUC UCU AGC AUG CCC GAA UUC CGG AAU  
    
      80  Trp Ala Lys Gly Lys Ile Asp Leu Asp Ser Asp Ser Ile Gly  
     603  UGG GCC AAG GGA AAG AUC GAC CUC GAC UCC GAU UCC AUC GGC    
 
      94  Trp Tyr Phe Lys Tyr Leu Asp Pro Ala Gly Ala Thr Glu Ser  
     645  UGG UAC UUC AAG UAC CUU GAC CCA GCG GGU GCU ACA GAG UCU  
    
     108  Ala Arg Ala Val Gly Glu Tyr Ser Lys Ile Pro Asp Gly Leu  
     687  GCG CGC GCC GUC GGC GAG UAC UCG AAG AUC CCU GAC GGC CUC  
    
     122  Val Lys Phe Ser Val Asp Ala Glu Ile Arg Glu Ile Tyr Asn  
     729  GUC AAG UUC UCC GUC GAC GCA GAG AUA AGA GAG AUC UAU AAC  
    
     136  Glu Glu Cys Pro Val Val Thr Asp Val Ser Val Pro Leu Asp 
     771  GAG GAG UGC CCC GUC GUC ACU GAC GUG UCC GUC CCC CUC GAC 
 
     150  Gly Arg Gln Trp Ser Leu Ser Ile Phe Ser Phe Pro Met Phe 
     813  GGC CGC CAG UGG AGC CUC UCG AUU UUC UCC UUU CCG AUG UUC 
    
Figure A2.2  RNA sequence of HaSV RNA2 (Genome sequence accession number: L37299).  
The amino acid sequence of the capsid precursor protein gene is shown above the sequence. 
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     164  Arg Thr Ala Tyr Val Ala Val Ala Asn Val Glu Asn Lys Glu  
     855  AGA ACC GCC UAC GUC GCC GUA GCG AAC GUC GAG AAC AAG GAG 
 
     178  Met Ser Leu Asp Val Val Asn Asp Leu Ile Glu Trp Leu Asn  
     897  AUG UCG CUC GAC GUU GUC AAC GAC CUC AUC GAG UGG CUC AAC  
 
     192  Asn Leu Ala Asp Trp Arg Tyr Val Val Asp Ser Glu Gln Trp  
     939  AAU CUC GCC GAC UGG CGU UAU GUC GUU GAC UCU GAA CAG UGG  
    
     206  Ile Asn Phe Thr Asn Asp Thr Thr Tyr Tyr Val Arg Ile Arg  
     981  AUU AAC UUC ACC AAU GAC ACC ACG UAC UAC GUC CGC AUC CGC  
    
     220  Val Leu Arg Pro Thr Tyr Asp Val Pro Asp Pro Thr Glu Gly  
    1023  GUU CUA CGU CCA ACC UAC GAC GUU CCA GAC CCC ACA GAG GGC  
    
     234  Leu Val Arg Thr Val Ser Asp Tyr Arg Leu Thr Tyr Lys Ala  
    1065  CUU GUU CGC ACA GUC UCA GAC UAC CGC CUC ACU UAU AAG GCG  
    
     248  Ile Thr Cys Glu Ala Asn Met Pro Thr Leu Val Asp Gln Gly  
    1107  AUA ACA UGU GAA GCC AAC AUG CCA ACA CUC GUC GAC CAA GGC  
    
     262  Phe Trp Ile Gly Gly Gln Tyr Ala Leu Thr Pro Thr Ser Leu  
    1149  UUU UGG AUC GGC GGC CAG UAC GCU CUC ACC CCG ACU AGC CUA 
 
     276  Pro Gln Tyr Asp Val Ser Glu Ala Tyr Ala Leu His Thr Leu  
    1191  CCG CAG UAC GAC GUC AGC GAG GCC UAC GCU CUG CAC ACU UUG 
 
     290  Thr Phe Ala Arg Pro Ser Ser Ala Ala Ala Leu Ala Phe Val 
    1233  ACC UUC GCC AGA CCA UCC AGC GCC GCU GCA CUC GCG UUU GUG 
    
     304  Trp Ala Gly Leu Pro Gln Gly Gly Thr Ala Pro Ala Gly Thr  
    1275  UGG GCA GGU UUG CCA CAG GGU GGC ACU GCG CCU GCA GGC ACU 
 
     318  Pro Ala Trp Glu Gln Ala Ser Ser Gly Gly Tyr Leu Thr Trp 
    1317  CCA GCC UGG GAG CAG GCA UCC UCG GGU GGC UAC CUC ACC UGG  
    
     332  Arg His Asn Gly Thr Thr Phe Pro Ala Gly Ser Val Ser Tyr 
    1359  CGC CAC AAC GGU ACU ACU UUC CCA GCU GGC UCC GUU AGC UAC  
    
     346  Val Leu Pro Glu Gly Phe Ala Leu Glu Arg Tyr Asp Pro Asn   
    1401  GUU CUC CCU GAG GGU UUC GCC CUU GAG CGC UAC GAC CCG AAC  
    
     360  Asp Gly Ser Trp Thr Asp Phe Ala Ser Ala Gly Asp Thr Val  
    1443  GAC GGC UCU UGG ACC GAC UUC GCU UCC GCA GGA GAC ACC GUC  
    
     374  Thr Phe Arg Gln Val Ala Val Asp Glu Val Val Val Thr Asn  
    1485  ACU UUC CGG CAG GUC GCC GUC GAC GAG GUC GUU GUG ACC AAC  
    
     388  Asn Pro Ala Gly Gly Gly Ser Ala Pro Thr Phe Thr Val Arg  
    1527  AAC CCC GCC GGC GGC GGC AGC GCC CCC ACC UUC ACC GUG AGA  
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     402  Val Pro Pro Ser Asn Ala Tyr Thr Asn Thr Val Phe Arg Asn  
    1569  GUG CCC CCU UCA AAC GCU UAC ACC AAC ACC GUG UUU AGG AAC  
    
     416  Thr Leu Leu Glu Thr Arg Pro Ser Ser Arg Arg Leu Glu Leu  
    1611  ACG CUC UUA GAG ACU CGA CCC UCC UCU CGU AGG CUC GAA CUC  
    
     430  Pro Met Pro Pro Ala Asp Phe Gly Gln Thr Val Ala Asn Asn  
    1653  CCU AUG CCA CCU GCU GAC UUU GGA CAG ACG GUC GCC AAC AAC  
    
     444  Pro Lys Ile Glu Gln Ser Leu Leu Lys Glu Thr Leu Gly Cys  
    1695  CCG AAG AUC GAG CAG UCG CUU CUU AAA GAA ACA CUU GGC UGC 
 
     458  Tyr Leu Val His Ser Lys Met Arg Asn Pro Val Phe Gln Leu  
    1737  UAU UUG GUC CAC UCC AAA AUG CGA AAC CCC GUU UUC CAG CUC 
 
     472  Thr Pro Ala Ser Ser Phe Gly Ala Val Ser Phe Asn Asn Pro 
    1779  ACG CCA GCC AGC UCC UUU GGC GCC GUU UCC UUC AAC AAU CCG  
    
     486  Gly Tyr Glu Arg Thr Arg Asp Leu Pro Asp Tyr Thr Gly Ile  
    1824  GGU UAU GAG CGC ACA CGC GAC CUC CCG GAC UAC ACU GGC AUC 
    
     500  Arg Asp Ser Phe Asp Gln Asn Met Ser Thr Ala Val Ala His 
    1863  CGU GAC UCA UUC GAC CAG AAC AUG UCC ACC GCU GUG GCC CAC  
    
     514  Phe Arg Ser Leu Ser His Ser Cys Ser Ile Val Thr Lys Thr  
    1905  UUC CGC UCA CUC UCC CAC UCC UGC AGU AUC GUC ACU AAG ACC  
    
     528  Tyr Gln Gly Trp Glu Gly Val Thr Asn Val Asn Thr Pro Phe  
    1947  UAC CAG GGU UGG GAA GGC GUC ACG AAC GUC AAC ACG CCU UUC  
    
     542  Gly Gln Phe Ala His Ala Gly Leu Leu Lys Asn Glu Glu Ile 
    1989  GGC CAA UUC GCG CAC GCG GGC CUC CUC AAG AAU GAG GAG AUC  
    
     556  Leu Cys Leu Ala Asp Asp Leu Ala Thr Arg Leu Thr Gly Val  
    2031  CUC UGC CUC GCC GAC GAC CUG GCC ACC CGU CUC ACA GGU GUC  
    
     570  Tyr Pro Ala Thr Asp Asn Phe Ala Ala Ala Val Ser Ala Phe  
    2073  UAC CCC GCC ACU GAC AAC UUC GCG GCC GCC GUU UCU GCC UUC  
    
     584  Ala Ala Asn Met Leu Ser Ser Val Leu Lys Ser Glu Ala Thr  
    2115  GCC GCG AAC AUG CUG UCC UCC GUG CUG AAG UCG GAG GCA ACG  
    
     598  Ser Ser Ile Ile Lys Ser Val Gly Glu Thr Ala Val Gly Ala  
    2157  UCC UCC AUC AUC AAG UCC GUU GGC GAG ACU GCC GUC GGC GCG  
    
     612  Ala Gln Ser Gly Leu Ala Lys Leu Pro Gly Leu Leu Met Ser 
    2199  GCU CAG UCC GGC CUC GCG AAG CUA CCC GGA CUG CUA AUG AGU  
    
     626  Val Pro Gly Lys Ile Ala Ala Arg Val Arg Ala Arg Arg Ala                                                
    2241  GUA CCA GGG AAG AUU GCC GCG CGU GUC CGC GCG CGC CGA GCG  
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     640  Arg Arg Arg Ala Ala Arg Ala Asn 
    2283  CGC CGC CGC GCC GCU CGU GCC AAU UAGUUUGCUC GCUCCUGUUU 
 
    2327  CGCCGUUUCG UAAAACGGCG UGGUCCCGCA CAUUACGCGU ACCCUAAAGA 
 
    2377  CUCUGGUGAG UCCCCGUCGU UACACGACGG GUCUGCCGCG GUUCGAUUCC 
 
    2427  AUUCCCAAGC GGCAAGAAGG ACGUAGUUAG CUCUGCGUCC CUCGGGAUAC 
 
    2477  CA 
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APPENDIX 3.  SEQUENCE OF THE ADH2-GAPDH PROMOTER 
 
  
  
       1 GATCCTTCAA TATGCGCACA TACGCTGTTA TGTTCAAGGT CCCTTCGTTT AAGAACGAAA GCGGTCTTCC TTTTGAGGGA 
 CTAGGAAGTT ATACGCGTGT ATGCGACAAT ACAAGTTCCA GGGAAGCAAA TTCTTGCTTT CGCCAGAAGG AAAACTCCCT  
                                                      
      81 TGTTTCAAGT TGTTCAAATC TATCAAATTT GCAAATCCCC AGTCTGTATC TAGAGCGTTG AATCGGTGAT GCGATTTGTT 
 ACAAAGTTCA ACAAGTTTAG ATAGTTTAAA CGTTTAGGGG TCAGACATAG ATCTCGCAAC TTAGCCACTA CGCTAAACAA 
  
     161 AATTAAATTG ATGGTGTCAC CATTACCAGG TCTAGATATA CCAATGGCAA ACTGAGCACA ACAATACCAG TCCGGATCAA 
 TTAATTTAAC TACCACAGTG GTAATGGTCC AGATCTATAT GGTTACCGTT TGACTCGTGT TGTTATGGTC AGGCCTAGTT 
 
     241 CTGGCACCAT CTCTCCCGTA GTCTCATCTA ATTTTTCTTC CGGATGAGGT TCCAGATATA CCGCAACACC TTTATTATGG 
 GACCGTGGTA GAGAGGGCAT CAGAGTAGAT TAAAAAGAAG GCCTACTCCA AGGTCTATAT GGCGTTGTGG AAATAATACC  
  
     321 TTTCCCTGAG GGAATAATAG AATGTCCCAT TCGAAATCAC CAATTCTAAA CCTGGGCGAA TTGTATTTCG GGTTTGTTAA 
 AAAGGGACTC CCTTATTATC TTACAGGGTA AGCTTTAGTG GTTAAGATTT GGACCCGCTT AACATAAAGC CCAAACAATT 
  
     401 CTCGTTCCAG TCAGGAATGT TCCACGTGAA GCTATCTTCC AGCAAAGTCT CCACTTCTTC ATCAAATTGT GGAGAATACT 
 GAGCAAGGTC AGTCCTTACA AGGTGCACTT CGATAGAAGG TCGTTTCAGA GGTGAAGAAG TAGTTTAACA CCTCTTATGA 
                                                                         
     481 CCCAATGCTC TTATCTATGG GACTTCCGGG AAACACAGTA CCGATACTTC CCAATTCGTC TTCAGAGCTC ATTGTTTGTT 
 GGGTTACGAG AATAGATACC CTGAAGGCCC TTTGTGTCAT GGCTATGAAG GGTTAAGCAG AAGTCTCGAG TAACAAACAA 
  
     561 TGAAGAGACT AATCAAAGAA TCGTTTTCTC AAAAAAATTA ATATCTTAAC TGATAGTTTG ATCAAAGGGG CAAAACGTAG 
 ACTTCTCTGA TTAGTTTCTT AGCAAAAGAG TTTTTTTAAT TATAGAATTG ACTATCAAAC TAGTTTCCCC GTTTTGCATC 
 
     641 GGGCAAACAA ACGGAAAAAT CGTTTCTCAA ATTTTCTGAT GCCAAGAACT CTAACCAGTC TTATCTAAAA ATTGCCTTAT 
 CCCGTTTGTT TGCCTTTTTA GCAAAGAGTT TAAAAGACTA CGGTTCTTGA GATTGGTCAG AATAGATTTT TAACGGAATA 
 
     721 GATCCGTCTC TCCGGTTACA GCCTGTGTAA CTGATTAATC CTGCCTTTCT AATCACCATT CTAATGTTTT AATTAAGGGA 
 CTAGGCAGAG AGGCCAATGT CGGACACATT GACTAATTAG GACGGAAAGA TTAGTGGTAA GATTACAAAA TTAATTCCCT 
 
     801 TTTTGTCTTC ATTAACGGCT TTCGCTCATA AAAATGTTAT GACGTTTTGC CCGCAGGCGG GAAACCATCC ACTTCACGAG 
 AAAACAGAAG TAATTGCCGA AAGCGAGTAT TTTTACAATA CTGCAAAACG GGCGTCCGCC CTTTGGTAGG TGAAGTGCTC 
 
     881 ACTGATCTCC TCTGCCGGAA CACCGGGCAT CTCCAACTTA TAAGTTGGAG AAATAAGAGA ATTTCAGATT GAGAGAATGA 
 TGACTAGAGG AGACGGCCTT GTGGCCCGTA GAGGTTGAAT ATTCAACCTC TTTATTCTCT TAAAGTCTAA CTCTCTTACT 
 
     961 AAAAAAAAAA CCCTGAAAAA AAAGGTTGAA ACCAGTTCCC TGAAATTATT CCCCTACTTG ACTAATAAGT ATATAAAGAC 
 TTTTTTTTTT GGGACTTTTT TTTCCAACTT TGGTCAAGGG ACTTTAATAA GGGGATGAAC TGATTATTCA TATATTTCTG 
 
    1041 GGTAGGTATT GATTGTAATT CTGTAAATCT ATTTCTTAAA CTTCTTAAAT TCTACTTTTA TAGTTAGTCT TTTTTTTAGT 
 CCATCCATAA CTAACATTAA GACATTTAGA TAAAGAATTT GAAGAATTTA AGATGAAAAT ATCAATCAGA AAAAAAATCA 
 
    1121 TTTAAAACAC CAAGAACTTA GTTTCGAATA AACACACATA AACAAA AUG                                         
 AAATTTTGTG GTTCTTGAAT CAAAGCTTAT TTGTGTGTAT TTGTTT TAC                                       
 
 
 
 
Figure A3.1. Sequence of the ADH2-GAPDH promoter. The 5’ end of the ADH2 promoter and 
GAPDH 5’ untranslated region are highlighted in yellow and green respectively respectively. The 
ADH2 UAS is underlined and in bold font. The TATAA element of the GAPDH gene is depicted in 
bold font. The translational start of GAPDH is shown.  
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APPENDIX 4.  PRIMERS 
 
Table A4.1
 Primers used during the course of this study 
 
Primer Gene Location Direct/ 
Compliment 
Sequence 
MT1 HaSV P71 nts 366-389 of RNA2 D ATGGGAGATGCTGGAGTGGCGTCA 
MT2 GAPDH 35 nts of the GAPDH 5’ untranslated region, 2 
bases downstream from the GAPDH  translational 
start 
C TGTTTATGTGTGTTTATTCGAAACTAAGTT 
MT5 NωV P70 1 to 22 D ATGGACAGTAACTCAGCCTCCG 
KM2R NωV P70 313 to 334 C GTACTCACCGACGGCACGAGC 
MT6F GAPDH
 
– 
HaSV P71  
The last 18 nts of the GAPDH 5’ untranslated 
region and nts 1–26 of HaSV P71 
D CGAATAAACACACATAAACGACGTCAGATGCTGGAGTGGCGTCACA
MT7R GAPDH
 
– 
HaSV P71 
The last 18 nts of the GAPDH 5’ untranslated and 
nts 1-26 of HaSV P71 
C TGTGACGCCACTCCAGCATCTGACGTCGTTTATGTGTGTTTATTCG 
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APPENDIX 5.  THERMAL CYCLING PARAMETERS 
 
 
Program 1 (Section 2.2.4)   
1 ×  94°C for 90sec 
10 × 94°C for 45sec 
53 °C for 90sec 
68°C for 4min 
1 × 68°C for 4min 
 
Program 2 (Section 3.2.1)   
1 ×  95°C for 30sec 
18 × 95°C for 30sec 
63 °C for 1min 
68°C for 10min 
 
 
Program 3 (Section 3.2.4)   
1 ×  94°C for 90sec 
10 × 94°C for 45sec 
63 °C for 45sec 
72°C for 4min 
1 × 72°C for 4min 
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APPENDIX 6.  GROWTH MEDIA 
 
Luria-Bertani agar/broth (Sambrook et al., 1989) 
Per litre: 10 g peptone 
                5 g yeast extract 
                         5 g NaCl 
                         
∗
 15 g Agar 
∗
 omit for liquid medium. 
 
Synthetic Minimal Medium (SMM) (Kaiser et al., 1994) 
Per liter: 1.7 g yeast nitrogen base (YNB) without amino acids and ammonium sulphate 
(Difco). 
                         5 g Ammonium sulphate 
                        20 g glucose 
                       
∗
 15 g Agar 
∗
 omit for liquid medium. 
Supplements (Sigma) were added subsequent to autoclaving at the following final concentrations 
(mg/L): 
Uracil   20 
L - Tryptohan  20 
L - Histidine  20 
L - Leucine            100  
 
Yeast Extract, Peptone, Dextrose Medium (YEPD)  
Per liter: 2% yeast extract (weight/volume) 
1% peptone (weight/volume)  
2% glucose (volume/volume) 
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APPENDIX 7. GENERAL METHODS 
 
A7.1 TUNEL Test (from Frank Madeo University of Tübingen – personal 
communication) 
 
Buffers and solutions: 
• Buffer B (10x): 350 mM KPP, 5 mM MgCl2 
• 37% formaldehyde (Sigma) 
• Glucuronidase / arylsulfatase (Roche) 
• Lyticase (Sigma, 1000 U/ml) 
• PBS: 25 mM KPP; 0,9% (w/v) NaCl (pH 7.0) 
• 0,3% H2O2 in methanol (100µl H2O2 in 10 ml methanol) 
• Permeabilisation solution: 0.1% Triton X-100 (Merck), 0.1% (w/v) sodium citrate 
• TUNEL-mix: enzyme solution in TUNEL-buffer 1:10 (Roche) 
• Converter-POD (Roche) 
• DAB-substrate: substrate solution in peroxide buffer 1:10 (Roche) 
  
Method: 
Approximately 1 mL of culture was microfuged at 2500 ×g for 5 minutes. The supernatant was 
discarded and the pellet was washed in 500 µL of buffer B. The washed pellet was re-suspended 
in 1 mL of buffer B to which 120 µL of 37% formaldehyde was added. The suspension was 
incubated at room temperature for 1 hour. The fixed cells were washed 3 times in buffer B 
containing 1.2 M sorbitol. The washed pellet was re-suspended in 330 µL of buffer B containing 
1.2 M sorbitol. In order to digest the cell wall of the yeast cells, 75 µL glucuronidase / 
arylsulfatase  (Roche) and 120 U lyticase (Sigma) were added to the suspension. The suspension 
was vortexed and incubated at 28°C for 2 hours. The cells were washed in 500 µL buffer B 
containing 1.2 M sorbitol and the pellet was re-suspended in 30µL buffer B containing 1.2 M 
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sorbitol. Approximately 30 µL of cells was applied to each window of polylysine (10mg/mL) 
coated slide. The cells were allowed to settle for 30 minutes and the excess buffer was removed 
with Watman 3MM paper. The slide was allowed to dry at room temperature. At this point the 
slide can be stored for up to 4 weeks at 4°C. These cells can now be tested by TUNEL or the 
nuclei can be stained with DAPI. 
 
The slide was washed twice with PBS and incubated with 0.3% methanol for 30 minutes. The 
methanol was removed with 3MM Watman paper and the slide was washed with PBS. Allow the 
slide to dry and add 20 µl TUNEL-mix to each window for 1 hour in a humid chamber at 37°C. 
Remove the mixture and wash the slide three times with PBS. Allow the slide to dry and add    
20 µl converter-POD to each window. Incubate the slide for 30 minutes in a humid chamber at 
37°C and remove the liquid. Wash the slide three times with PBS and add 30 µl DAB-substrate 
to each window. Incubate the slide for 10 minutes at room temperature, remove the liquid, wash 
the slide three times with PBS and allow to dry. Add a small amount of Kaisers mounting 
gelatine (Merck) to each window, cover with a cover slip and view with a light microscope. 
 
A7.2 DAPI staining (from Frank Madeo University of Tübingen – personal 
communication) 
 
Buffers and solutions: 
 
PBS as in section A7.1 
1 µg/ml DAPI (4,6-diamidino-2-phenylindole) (Roche) in PBS 
 
Method: 
Wash each window containing fixed yeast cells twice with PBS and add 30 µL of 1 µg/mL of 
DAPI. Incubate the slide in a dark room for 15 minutes at room temperature. Wash the slide 6 
times with PBS, allow the slide to dry, apply a small amount Kaisers mounting gelatine (Merck) 
to each window, cover with a cover slip and view with a epifluorescence microscope. 
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A7.3 Reagents for Northern analysis 
 
50 × Denhardt’s solution  
1% (w/v) Ficoll 400 (Sigma) 
1% (w/v) Polyvinylpyrrolidone (PVP; Sigma PVP-360) 
1% (w/v) BSA (Sigma, faction V) 
 
Salmon sperm DNA (10mg/mL) 
Dissolve 1g sodium salt type III DNA from salmon testes (Sigma D – 1626) in 100mL ddH2O. 
Sheer with a syringe fitted with an 18g needle, passing it through 2 or 3 times. Boil the solution 
to denature the DNA and aliquot. Store at -20°C.  
 
Hybridization solution 
50% de–ionized formamide 
50 mM NaPO4 
800 mM NaCl 
1 mM EDTA (pH 8) 
1 × Denhardt’s solution 
250 µg/mL salmon sperm DNA 
0.5% SDS 
 
20 × MOPS 
0.4 M MOPS 
0.01 M NaOAc 
20 mM EDTA  
 
20 × SSC (pH 7.0) 
3 M NaCl 
0.3 M sodium citrate 
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